data_2rn0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rn0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.427 -1.585 0 N-CA-C 110.143 -0.317 . . . . 2.16 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.27 -44.59 97.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 113.004 0.742 . . . . 1.29 113.004 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.24 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 118.617 -1.233 . . . . 1.07 108.012 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.77 -42.41 99.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.813 -1.539 . . . . 1.84 110.806 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.08 -37.84 86.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 1.52 110.647 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.1 m -70.2 -41.2 74.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.834 -0.621 . . . . 0.59 109.931 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.02 -46.5 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.97 -0.752 . . . . 1.33 108.97 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.9 mtp -62.08 -43.97 97.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.54 -0.754 . . . . 1.04 111.502 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.11 -43.97 88.77 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.947 -0.861 . . . . 0.17 110.947 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.9 81.36 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.622 0.725 . . . . 1.04 112.356 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 704' ' ' ILE . 90.8 mt -63.65 -43.43 98.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.542 -1.208 . . . . 1.92 110.925 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -40.96 96.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 2.37 111.466 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.87 -38.06 89.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.11 0.957 . . . . 1.88 113.065 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 707' ' ' ILE . 41.0 mt -65.44 -42.82 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.736 -1.575 . . . . 1.9 109.464 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.06 -41.92 92.78 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.735 -1.121 . . . . 0.18 110.83 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 14.8 mt -63.1 -44.06 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.102 -0.639 . . . . 2.23 110.113 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.3 92.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.383 -0.527 . . . . 1.04 109.678 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.32 82.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.573 -0.451 . . . . 1.04 110.526 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -40.05 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.976 0.417 . . . . 2.28 111.899 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.36 -43.26 98.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.079 1.141 . . . . 1.85 114.079 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 65.2 mt -65.59 -42.45 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.49 -1.3 . . . . 2.11 107.49 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -52.93 -52.39 58.04 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 118.036 -1.466 . . . . 0.29 107.468 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -39.15 93.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.0 -1.0 . . . . 1.15 109.915 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 18.9 tp -58.98 -45.41 90.66 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.357 -1.719 . . . . 2.33 106.357 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 56.5 mt -53.06 -55.56 22.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.219 -1.392 . . . . 1.38 108.942 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.318 -0.775 0 N-CA-C 115.704 1.742 . . . . 1.71 115.704 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.947 0.403 . . . . 1.0 110.803 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.25 -41.32 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.371 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.29 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.741 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.31 -42.47 99.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.414 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.9 -40.37 97.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 1.0 111.138 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 16.6 m -66.45 -41.32 89.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.046 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.329 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -62.76 -41.67 99.33 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.58 -43.42 94.55 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.46 -1.056 . . . . 1.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.02 75.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 1.0 111.786 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.43 -43.38 96.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.071 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.46 -44.45 94.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.725 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.96 -41.55 97.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.007 0.432 . . . . 1.0 111.997 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.4 mt -62.55 -42.62 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.02 -42.05 92.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.5 -44.52 94.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.104 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.88 91.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.86 -46.78 86.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.022 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.1 -40.75 96.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.952 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.83 -43.46 98.74 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 46.5 pt -66.73 -36.34 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.636 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -56.59 -48.81 76.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.361 -0.935 . . . . 1.0 108.97 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.97 -38.26 85.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.044 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 717' ' ' LEU . 1.2 mm? -62.91 -38.78 92.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.42 -45.49 93.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 113.119 0.785 . . . . 1.0 113.119 -177.594 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.404 0.145 . . . . 1.0 111.229 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.82 -40.86 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.712 0.291 . . . . 1.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.0 -47.25 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.384 0.611 . . . . 1.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 98.3 mt -64.7 -41.25 96.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.83 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 45.1 mt -61.55 -40.58 95.22 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 17.7 m -68.02 -38.6 82.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.305 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.37 -46.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.7 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.84 -41.39 99.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.78 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.64 -46.0 79.79 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.91 -0.662 . . . . 1.0 111.794 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.98 -49.6 75.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.0 111.546 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.25 -43.19 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.617 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.89 -44.09 94.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.787 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.76 -41.69 97.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.269 0.557 . . . . 1.0 111.344 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.44 -43.33 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.177 -0.92 . . . . 1.0 109.769 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.78 96.58 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.134 -1.186 . . . . 1.0 110.134 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.49 -43.28 97.72 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.877 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.7 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -65.37 -45.2 85.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.199 -0.601 . . . . 1.0 110.987 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.39 -40.86 97.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.481 . . . . 1.0 111.253 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.85 -44.01 97.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.655 -0.702 . . . . 1.0 112.287 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.15 -43.35 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -54.31 -48.86 70.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 119.135 -1.026 . . . . 1.0 108.902 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -40.5 86.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.27 -39.1 91.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -45.04 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.826 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 C--N 1.33 -0.261 0 N-CA-C 112.929 0.714 . . . . 1.0 112.929 -177.892 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.852 0.358 . . . . 1.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.16 -42.09 94.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.173 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 57.1 t -61.99 -47.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.772 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.57 -42.04 99.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.08 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.3 -40.96 98.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.3 m -68.83 -36.83 78.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.704 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.72 -45.22 95.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.006 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.63 -42.05 98.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.852 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.03 93.02 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.142 -1.028 . . . . 1.0 110.959 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.11 95.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.2 -43.67 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.0 110.28 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.94 -41.7 97.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.507 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.3 -42.61 99.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 1.0 111.726 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.95 -42.89 97.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.913 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.22 -40.9 92.46 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.47 -44.07 97.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.165 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.28 75.92 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.082 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.85 82.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -41.73 99.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.139 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.09 -42.41 99.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.036 0.754 . . . . 1.0 113.036 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.08 -42.61 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -54.94 -49.2 71.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.157 -1.017 . . . . 1.0 109.317 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.92 -39.54 89.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.508 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 70.5 mt -61.07 -39.34 89.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.8 -53.13 60.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.117 -0.633 . . . . 1.0 111.208 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.006 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.684 0.278 . . . . 1.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.35 -41.98 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.13 -47.32 93.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.245 0.545 . . . . 1.0 109.976 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 99.5 mt -63.66 -41.81 98.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.094 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.9 -38.24 87.63 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.311 0.577 . . . . 1.0 110.682 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 21.0 m -67.64 -40.39 84.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.73 -46.12 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.731 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -61.96 -41.6 98.17 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.541 . . . . 1.0 112.391 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.97 85.76 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.733 -0.746 . . . . 1.0 112.022 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.2 77.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 1.0 111.622 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -43.93 97.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.857 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.5 -41.34 96.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.037 0.384 . . . . 1.0 112.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.58 -41.5 98.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.309 0.576 . . . . 1.0 111.459 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.28 -42.51 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.954 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.4 -42.39 95.7 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.88 -43.64 98.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.85 85.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.33 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.52 84.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.772 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.7 -38.64 91.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.97 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.29 -42.71 99.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 4.2 mm -64.19 -43.22 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.271 0.558 . . . . 1.0 109.51 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -54.43 -50.33 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.346 -0.942 . . . . 1.0 109.295 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -37.98 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.511 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.98 -41.42 96.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.81 -50.08 72.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.687 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -178.708 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.48 0.181 . . . . 1.0 111.226 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.75 -42.11 90.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 1.0 111.027 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.9 -48.27 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.704 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.51 -41.65 98.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.517 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 29.3 mt -62.86 -40.0 96.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.708 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.3 m -68.86 -38.69 79.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.543 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.52 -44.75 98.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.693 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.4 mtp -62.87 -39.86 95.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.753 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.38 -44.81 72.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.589 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.54 81.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 30.8 pt -67.33 -40.85 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.194 -0.602 . . . . 1.0 110.443 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.66 -43.94 92.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.605 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.38 -41.22 96.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.479 -0.489 . . . . 1.0 111.654 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.98 -42.99 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.023 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.95 93.94 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.16 -44.53 95.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.54 91.37 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.67 96.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.89 -0.724 . . . . 1.0 109.882 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.95 -40.57 98.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.97 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.9 -42.12 99.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 714' ' ' ILE . 88.0 mt -62.66 -43.17 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -55.37 -49.79 71.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.156 -1.017 . . . . 1.0 108.539 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -41.99 96.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.019 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.57 -42.06 98.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.932 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.98 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.998 -0.681 . . . . 1.0 111.895 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -178.123 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 111.479 0.177 . . . . 1.0 111.479 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.96 -43.39 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.691 0.281 . . . . 1.0 111.283 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.45 -48.07 88.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.343 -0.543 . . . . 1.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.03 -41.73 99.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.393 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.0 mt -62.02 -40.74 96.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.118 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.7 m -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 1.0 109.891 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.28 -46.87 94.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.995 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 91.9 mtp -63.2 -41.62 99.19 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.9 -44.35 92.01 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.9 -0.666 . . . . 1.0 111.708 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.25 95.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.15 -44.03 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.96 -42.69 97.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.376 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.37 -41.29 98.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 1.0 111.698 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.5 -43.25 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.538 -0.755 . . . . 1.0 109.997 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.59 -41.34 97.25 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.394 -0.821 . . . . 1.0 111.049 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.38 -43.27 98.08 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.48 87.57 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.16 -47.3 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.61 -39.72 94.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 1.0 112.006 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.16 -43.45 98.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.891 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.54 -43.6 98.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -54.95 -50.37 69.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 1.0 108.957 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -37.45 80.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.771 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.39 -41.12 98.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.77 -47.88 83.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.758 -178.61 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.529 0.149 0 N-CA-C 111.925 0.343 . . . . 1.0 111.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.21 -43.79 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.65 -48.56 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.999 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.3 -40.85 97.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.07 -40.27 97.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.3 m -65.66 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.81 -46.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.866 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.3 mtp -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.831 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.45 -43.98 91.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.576 -0.821 . . . . 1.0 111.064 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.05 87.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.998 0.427 . . . . 1.0 111.818 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.21 -44.44 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.558 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.734 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.62 -41.89 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 1.0 112.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.36 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.614 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.82 96.64 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.081 -1.208 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.81 -46.15 86.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.628 0.251 . . . . 1.0 110.436 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.1 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 1.0 110.038 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.3 99.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -39.82 95.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.575 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.4 -44.18 95.41 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.68 -43.57 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.987 0.422 . . . . 1.0 110.02 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.06 -49.13 69.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.081 -1.047 . . . . 1.0 108.891 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -37.91 83.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.017 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.83 -41.66 96.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.09 -54.93 40.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.029 -0.669 . . . . 1.0 111.276 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 719' ' ' ILE . 96.5 mt . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.626 0.251 . . . . 1.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.16 -41.39 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.219 0.452 . . . . 1.0 112.219 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.19 -47.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 1.0 110.396 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.23 96.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.584 -0.734 . . . . 1.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.47 -41.33 98.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.12 0.486 . . . . 1.0 110.475 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 50.2 m -64.95 -41.97 95.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.955 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.51 -45.38 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.44 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.3 mtp -61.66 -41.48 97.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.649 -0.421 . . . . 1.0 111.005 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.17 -46.51 64.6 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 69.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.069 0.461 . . . . 1.0 111.567 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.71 -43.46 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.94 -42.84 99.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.172 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.61 -41.58 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 1.0 112.084 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 707' ' ' ILE . 87.9 mt -62.16 -42.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.009 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.6 -40.68 98.22 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.19 -45.1 93.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.749 0.309 . . . . 1.0 110.428 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.28 85.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.09 97.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.84 -42.03 97.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.632 0.605 . . . . 1.0 112.632 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.16 -42.93 99.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.45 -42.56 96.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -55.54 -50.3 70.37 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.358 -0.937 . . . . 1.0 108.66 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.45 -38.01 76.62 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.203 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.99 -40.59 98.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.908 -0.717 . . . . 1.0 111.269 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.808 0.337 . . . . 1.0 111.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.81 -41.89 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.969 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.66 -47.69 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.305 -0.558 . . . . 1.0 110.156 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.13 -42.2 96.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.539 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.14 -37.77 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.078 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.4 m -67.54 -40.0 85.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.071 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.61 -46.0 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.032 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.7 mtp -61.17 -42.64 98.93 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.82 -45.22 89.73 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.533 -0.841 . . . . 1.0 111.201 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.05 85.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.31 -44.04 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.134 0.492 . . . . 1.0 110.493 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.26 -42.16 96.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.703 -0.681 . . . . 1.0 111.152 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 1.0 111.739 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.85 -44.38 99.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.5 95.06 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.676 -0.97 . . . . 1.0 110.676 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.27 -44.54 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.042 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.65 88.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.195 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.95 97.54 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.355 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.1 -40.21 95.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.083 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 36.3 mt -63.79 -43.94 94.81 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.848 0.684 . . . . 1.0 112.848 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.0 pt -65.84 -38.13 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.388 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -56.4 -47.53 78.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 118.783 -1.167 . . . . 1.0 109.076 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -39.19 89.23 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.363 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.24 -40.1 92.77 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.91 -52.92 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.328 0.585 . . . . 1.0 110.891 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 1.0 112.548 -179.162 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.462 0.142 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.23 -41.63 93.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 1.0 110.882 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.56 -47.95 90.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.421 -0.512 . . . . 1.0 110.551 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.32 -40.69 98.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.538 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.51 -38.44 89.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 69.9 m -66.08 -40.38 90.79 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.612 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.47 -45.27 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 1.0 111.102 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.9 mtp -62.07 -42.24 98.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 1.0 112.308 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.91 -44.17 92.34 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.531 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.72 -44.63 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.257 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.27 -41.57 96.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.736 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.03 -42.47 97.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.147 0.499 . . . . 1.0 112.238 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 707' ' ' ILE . 93.7 mt -63.73 -43.07 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.004 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.81 94.28 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.236 -1.146 . . . . 1.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.29 -43.42 97.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.625 -0.43 . . . . 1.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.74 91.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.32 93.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.84 -40.52 97.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.578 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.77 -43.62 98.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.9 -42.81 97.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -53.39 -50.55 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.846 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -40.14 91.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.314 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.29 -42.92 96.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.99 -49.11 77.38 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.019 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 92.7 mt . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.669 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.0 -42.46 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.662 0.268 . . . . 1.0 111.329 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.92 -47.79 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.392 0.615 . . . . 1.0 109.885 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.55 -41.28 98.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.129 -0.942 . . . . 1.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.31 -39.55 93.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.574 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.6 m -64.53 -40.94 96.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.701 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.79 -45.52 98.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 86.6 mtp -61.63 -42.4 98.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.816 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.01 -45.52 87.04 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.627 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.32 -49.59 75.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.649 0.611 . . . . 1.0 112.649 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.58 -43.41 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.671 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.4 mt -64.44 -40.81 96.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.83 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.64 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 15.4 tt -67.31 -33.27 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.28 97.91 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.42 -1.472 . . . . 1.0 109.42 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.47 -46.09 87.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.268 -0.466 . . . . 1.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.33 88.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.7 89.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.578 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.5 -41.26 98.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.8 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.86 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.99 -42.37 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -55.07 -48.91 72.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.963 -1.095 . . . . 1.0 109.411 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -43.35 98.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.009 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 717' ' ' LEU . 2.4 mm? -62.3 -39.32 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.16 -48.32 82.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.163 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 77.8 mt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -178.356 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.51 -37.67 80.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.689 -0.405 . . . . 1.0 111.317 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.28 -48.57 88.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.066 -0.654 . . . . 1.0 109.728 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.52 -40.88 98.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.968 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.1 -38.7 92.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.358 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 53.0 m -65.95 -44.29 85.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.265 0.468 . . . . 1.0 112.265 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 7.2 m -63.89 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 119.348 -0.941 . . . . 1.0 110.516 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.6 mtp -62.02 -42.29 99.0 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.738 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.18 -44.15 87.53 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.502 -0.856 . . . . 1.0 111.282 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 19.0 tt -65.25 -39.9 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.316 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.37 -43.27 95.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.009 -0.277 . . . . 1.0 111.66 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.64 -42.1 95.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.38 -37.07 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.2 -0.6 . . . . 1.0 109.792 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.62 97.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.54 -43.66 98.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 1.0 110.388 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.44 85.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.69 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.9 -39.37 94.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 111.318 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.39 -43.03 99.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.867 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.22 -43.83 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -55.37 -49.65 71.72 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -38.85 87.11 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.091 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.4 -41.06 96.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.43 -45.01 96.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.381 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 719' ' ' ILE . 88.0 mt . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 113.018 0.747 . . . . 1.0 113.018 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 694' ' ' LEU . 10.4 mp . . . . . 0 C--O 1.226 -0.145 0 N-CA-C 111.642 0.238 . . . . 1.0 111.642 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.96 -42.87 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.715 0.293 . . . . 1.0 110.982 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.71 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.073 -0.651 . . . . 1.0 109.771 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.68 -42.02 99.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.927 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.36 -39.12 93.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.287 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.32 -38.28 81.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.079 0.466 . . . . 1.0 110.566 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.02 -45.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.128 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.34 -40.57 96.81 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.528 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.87 62.2 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.461 -0.876 . . . . 1.0 111.443 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.79 79.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.586 0.587 . . . . 1.0 112.586 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.54 -41.92 91.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.48 -40.02 89.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.42 -43.43 98.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.73 -35.72 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.575 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.66 -41.78 97.56 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.654 -1.378 . . . . 1.0 109.654 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.41 -43.43 97.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.42 87.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.569 -0.453 . . . . 1.0 109.94 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.25 94.12 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.155 -0.618 . . . . 1.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.73 -41.1 98.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.226 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.84 -43.11 99.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.15 -42.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.03 -49.95 67.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 118.959 -1.097 . . . . 1.0 108.618 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.6 86.14 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.245 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.65 -42.86 93.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.92 -49.49 77.26 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.731 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 113.302 0.853 . . . . 1.0 113.302 -178.646 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.68 -42.01 90.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.917 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.61 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.166 -0.614 . . . . 1.0 110.236 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.68 -42.06 98.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.93 -41.04 97.49 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.665 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 37.3 m -68.29 -41.09 81.48 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 80.4 t -62.61 -45.59 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.006 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.8 mtp -63.02 -42.11 99.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.875 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.97 -45.12 75.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.75 92.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.758 0.313 . . . . 1.0 111.316 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 86.0 mt -65.02 -44.6 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.246 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.93 -41.07 95.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.335 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -41.86 98.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.094 0.473 . . . . 1.0 112.073 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.83 -43.47 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.111 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -55.25 -42.79 83.47 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.281 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.33 -43.36 97.97 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.138 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.42 83.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.97 0.414 . . . . 1.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.79 -48.28 77.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.36 -39.24 93.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.098 0.407 . . . . 1.0 112.098 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.12 -42.67 99.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 1.0 111.99 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.37 -42.81 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.756 . . . . 1.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -54.23 -47.16 72.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.009 -1.076 . . . . 1.0 108.998 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -41.45 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.742 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.81 -41.75 98.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.9 -49.93 75.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.912 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 1.0 112.479 -178.598 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 694' ' ' LEU . 10.8 mp . . . . . 0 CA--C 1.522 -0.104 0 N-CA-C 111.631 0.234 . . . . 1.0 111.631 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -42.46 94.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.618 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.28 -47.86 91.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.576 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.81 -41.68 99.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.258 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.09 -38.09 89.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.5 m -66.87 -43.37 83.74 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.03 -41.61 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.466 -0.894 . . . . 1.0 110.359 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.2 mtp -62.58 -42.11 99.36 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 121.099 -0.24 . . . . 1.0 111.051 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.16 88.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.53 78.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 1.0 111.463 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.74 -43.57 98.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.134 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.18 -44.65 94.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.29 -41.54 98.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 1.0 112.059 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.44 -42.86 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.018 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.71 95.31 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.75 -43.39 96.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.764 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.56 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.286 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.52 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.116 -0.634 . . . . 1.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.33 -41.61 98.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.836 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.39 -43.63 98.37 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.936 0.717 . . . . 1.0 112.936 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.4 -42.99 98.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -55.46 -48.4 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.128 -1.029 . . . . 1.0 108.313 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.88 -41.03 95.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.978 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.6 -42.02 91.64 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.37 -47.74 82.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.769 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -178.631 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 81.9 mt . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.914 0.387 . . . . 1.0 111.287 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 63.2 t -58.45 -42.46 84.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.95 -47.55 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 121.114 0.483 . . . . 1.0 109.808 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.22 -41.82 99.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.252 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.35 -38.86 91.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 1.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.82 -39.16 80.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.141 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 69.9 t -62.65 -44.92 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.067 0.46 . . . . 1.0 109.93 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.6 mtp -62.36 -41.91 98.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.129 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.61 -45.58 75.69 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.73 -0.748 . . . . 1.0 111.69 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.08 73.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.33 0.492 . . . . 1.0 112.33 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.07 -43.42 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.728 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.7 mt -64.39 -43.18 95.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.172 0.434 . . . . 1.0 112.172 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.81 -42.84 97.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.326 -0.55 . . . . 1.0 111.9 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.66 -43.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.426 -0.806 . . . . 1.0 110.637 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.62 94.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.35 -43.81 98.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.13 89.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.775 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.726 -0.789 . . . . 1.0 110.475 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.65 -40.83 96.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.15 -43.32 95.55 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.386 0.884 . . . . 1.0 113.386 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.9 pt -65.8 -39.37 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.327 -0.549 . . . . 1.0 109.676 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -54.37 -50.4 67.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.353 -0.939 . . . . 1.0 108.817 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -40.02 89.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.558 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.17 -42.12 94.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.461 -0.496 . . . . 1.0 109.916 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.38 -50.12 74.18 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.763 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 694' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.754 0.312 . . . . 1.0 111.422 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.53 -40.98 90.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.105 0.478 . . . . 1.0 110.806 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.3 -46.9 95.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.76 -41.88 99.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.119 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.93 -39.17 93.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.07 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.9 m -66.61 -38.28 86.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.533 -0.758 . . . . 1.0 109.915 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -61.75 -41.67 97.98 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.62 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.34 -45.52 60.5 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.629 -0.796 . . . . 1.0 111.743 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.31 77.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.94 -41.01 89.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.464 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.757 -0.377 . . . . 1.0 111.459 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 36.7 mt -62.18 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 12.3 tt -66.5 -34.37 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.189 -0.605 . . . . 1.0 109.881 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.22 -43.02 95.64 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.35 -42.71 98.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.94 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.4 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.9 -47.77 79.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.12 -38.48 91.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.755 0.312 . . . . 1.0 111.632 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.37 -44.45 96.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.534 . . . . 1.0 112.421 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.32 -42.76 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.587 . . . . 1.0 109.625 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -55.78 -50.07 71.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.293 -0.963 . . . . 1.0 109.185 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -38.09 85.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.327 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.11 -42.11 94.01 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.28 -50.75 71.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.049 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -178.367 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.857 0.361 . . . . 1.0 110.708 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.44 -41.89 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.362 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.3 -46.74 96.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.3 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.63 -42.42 99.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.264 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.67 -40.08 95.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.959 0.409 . . . . 1.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.9 m -66.92 -39.94 87.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.142 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.54 -46.03 96.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.311 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.76 -41.27 97.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.675 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.37 -45.01 71.49 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.352 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.11 85.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.744 0.276 . . . . 1.0 111.744 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 32.0 mm -64.12 -43.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.277 0.561 . . . . 1.0 109.852 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 5.5 tt -64.26 -41.76 96.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 111.791 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.62 -44.13 97.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.998 0.74 . . . . 1.0 112.998 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 707' ' ' ILE . 36.7 pt -66.0 -39.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.494 -0.483 . . . . 1.0 110.506 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.82 97.26 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.147 -1.181 . . . . 1.0 110.147 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.38 -44.62 96.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.41 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.68 89.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.231 -0.587 . . . . 1.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.32 -42.12 98.96 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 111.687 0.255 . . . . 1.0 111.687 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.02 -43.2 99.38 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.42 -43.08 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -53.91 -49.17 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.204 -0.998 . . . . 1.0 108.685 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -36.47 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.298 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.84 -42.85 98.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.28 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.43 -51.03 70.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.587 -0.845 . . . . 1.0 111.499 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 97.7 mt . . . . . 0 C--N 1.326 -0.416 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -178.329 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.232 0.14 0 N-CA-C 111.854 0.316 . . . . 1.0 111.854 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.97 -40.89 87.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.064 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.76 -48.46 88.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 1.0 110.357 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.67 -41.63 99.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.18 -39.66 93.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 1.0 110.56 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 26.7 m -66.72 -42.01 87.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.735 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.05 -46.11 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.902 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -62.11 -41.57 98.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.569 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.19 -44.78 85.65 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.148 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.35 92.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.709 -0.396 . . . . 1.0 111.702 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.7 mm -64.2 -43.79 97.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.23 -43.36 98.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.686 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.95 -40.68 95.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.272 -0.571 . . . . 1.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.16 -42.98 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.421 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.14 96.55 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.144 -0.935 . . . . 1.0 110.992 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.58 -42.9 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.933 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.4 94.57 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.563 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.67 86.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.609 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.67 -39.0 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.219 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.3 -44.23 95.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.21 -35.71 74.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -56.55 -49.11 75.78 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.224 -0.99 . . . . 1.0 109.291 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -38.23 82.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.669 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.06 -41.32 98.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.365 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.76 -50.11 74.78 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 119.893 -0.723 . . . . 1.0 110.962 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.427 -0.806 . . . . 1.0 112.086 -178.984 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.783 0.325 . . . . 1.0 111.221 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.49 -44.97 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.96 -47.01 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.804 -0.758 . . . . 1.0 109.644 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.43 -42.11 96.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.06 -39.51 92.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.054 0.454 . . . . 1.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 72.2 m -65.57 -39.78 92.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.802 179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.57 -47.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.227 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.74 -42.18 99.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.87 88.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.729 -0.748 . . . . 1.0 111.356 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.96 83.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.057 0.456 . . . . 1.0 112.154 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.14 -43.1 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.161 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.24 -45.67 90.47 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.44 -41.76 96.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.954 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.95 -43.49 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.462 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.24 -39.83 96.53 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.233 -1.147 . . . . 1.0 110.233 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.87 -42.46 99.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.27 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.446 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.7 88.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.822 -0.626 . . . . 1.0 112.217 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.73 -41.24 98.08 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.63 -43.68 98.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.621 -0.432 . . . . 1.0 112.029 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.84 -43.88 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -54.16 -49.17 69.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.281 -0.968 . . . . 1.0 108.954 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.326 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.7 -42.88 98.08 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.38 -48.05 83.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.111 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 112.854 0.687 . . . . 1.0 112.854 -178.272 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 109.003 -1.191 . . . . 14.81 109.003 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 686' ' ' GLU . 3.4 pm0 -73.9 -30.25 62.5 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.981 -1.859 . . . . 13.24 105.981 176.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.615 ' CB ' ' HZ3' ' A' ' 689' ' ' LYS . 0.4 OUTLIER -146.23 73.44 13.16 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 112.778 -2.01 . . . . 10.81 108.114 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -75.2 20.12 0.49 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 N-CA-C 108.077 -1.547 . . . . 10.06 108.077 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 691' ' ' PRO . 19.3 mttp -52.26 -43.6 64.47 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 104.141 -2.54 . . . . 10.66 104.141 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 689' ' ' LYS . . . 32.12 -89.85 0.01 OUTLIER Glycine 0 C--N 1.363 2.042 0 N-CA-C 105.752 -2.939 . . . . 5.58 105.752 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.62 ' N ' ' O ' ' A' ' 689' ' ' LYS . 0.5 OUTLIER -108.28 121.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 107.307 -1.843 . . . . 5.87 107.307 171.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 695' ' ' VAL . 16.6 m-20 -52.3 134.17 33.97 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.655 -3.091 . . . . 2.37 102.655 177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.85 -23.97 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 121.448 1.931 . . . . 2.13 107.52 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 692' ' ' ASP . 16.0 mt -64.74 -43.23 94.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 112.809 -1.996 . . . . 2.16 110.143 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 692' ' ' ASP . 48.8 t -64.27 -44.59 97.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 113.004 0.742 . . . . 1.29 113.004 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.24 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 118.617 -1.233 . . . . 1.07 108.012 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.77 -42.41 99.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.813 -1.539 . . . . 1.84 110.806 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.08 -37.84 86.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 1.52 110.647 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.1 m -70.2 -41.2 74.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.834 -0.621 . . . . 0.59 109.931 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.02 -46.5 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.97 -0.752 . . . . 1.33 108.97 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.9 mtp -62.08 -43.97 97.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.54 -0.754 . . . . 1.04 111.502 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.11 -43.97 88.77 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.947 -0.861 . . . . 0.17 110.947 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.9 81.36 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.622 0.725 . . . . 1.04 112.356 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 704' ' ' ILE . 90.8 mt -63.65 -43.43 98.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.542 -1.208 . . . . 1.92 110.925 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -40.96 96.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 2.37 111.466 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.87 -38.06 89.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.11 0.957 . . . . 1.88 113.065 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 707' ' ' ILE . 41.0 mt -65.44 -42.82 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.736 -1.575 . . . . 1.9 109.464 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.06 -41.92 92.78 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.735 -1.121 . . . . 0.18 110.83 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 14.8 mt -63.1 -44.06 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.102 -0.639 . . . . 2.23 110.113 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.3 92.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.383 -0.527 . . . . 1.04 109.678 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.32 82.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.573 -0.451 . . . . 1.04 110.526 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -40.05 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.976 0.417 . . . . 2.28 111.899 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.36 -43.26 98.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.079 1.141 . . . . 1.85 114.079 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 65.2 mt -65.59 -42.45 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.49 -1.3 . . . . 2.11 107.49 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -52.93 -52.39 58.04 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 118.036 -1.466 . . . . 0.29 107.468 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -39.15 93.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.0 -1.0 . . . . 1.15 109.915 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 18.9 tp -58.98 -45.41 90.66 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.357 -1.719 . . . . 2.33 106.357 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 723' ' ' ASP . 56.5 mt -53.06 -55.56 22.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.219 -1.392 . . . . 1.38 108.942 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 66.5 mt -70.88 -42.45 77.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 115.704 1.742 . . . . 1.71 115.704 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.455 ' C ' ' N ' ' A' ' 722' ' ' HIS . 96.3 m -66.83 -43.63 83.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 120.251 1.387 . . . . 1.31 111.972 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 722' ' ' HIS . 4.1 tt -61.8 -17.46 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.116 1.912 . . . . 2.17 107.582 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.486 ' CB ' ' O ' ' A' ' 721' ' ' ILE . 45.2 t60 104.25 91.19 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 108.679 -3.873 . . . . 5.06 108.403 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 722' ' ' HIS . 22.8 t0 -27.64 -81.87 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 124.324 1.015 . . . . 5.96 109.789 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.595 ' C ' ' H ' ' A' ' 726' ' ' GLU . 6.8 ttt85 174.51 -176.91 0.09 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.761 0.791 . . . . 9.48 109.467 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 727' ' ' PHE . 12.9 mttt -86.57 26.19 1.13 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.227 -2.138 . . . . 10.46 105.227 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 724' ' ' ARG . 14.8 pt-20 -38.88 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 CA-C-N 113.881 -1.509 . . . . 10.62 109.326 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 725' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.65 0 CA-C-N 114.692 -1.14 . . . . 12.83 109.243 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.479 0.637 0 N-CA-C 109.631 -0.95 . . . . 1.0 109.631 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.75 133.26 55.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.248 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 58.0 m 46.43 60.92 13.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.09 146.91 59.54 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.533 2.155 . . . . 1.0 112.565 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.85 145.77 26.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.804 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 64.31 -166.83 28.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -62.99 145.15 94.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.735 2.29 . . . . 1.0 111.811 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.55 141.3 42.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 1.0 110.115 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 40.3 pt -49.76 -27.57 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.084 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.62 -42.11 99.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.25 -41.32 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.371 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.29 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.741 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.31 -42.47 99.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.414 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.9 -40.37 97.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 1.0 111.138 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 16.6 m -66.45 -41.32 89.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.046 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.329 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -62.76 -41.67 99.33 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.58 -43.42 94.55 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.46 -1.056 . . . . 1.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.02 75.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 1.0 111.786 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.43 -43.38 96.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.071 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.46 -44.45 94.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.725 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.96 -41.55 97.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.007 0.432 . . . . 1.0 111.997 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.4 mt -62.55 -42.62 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.02 -42.05 92.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.5 -44.52 94.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.104 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.88 91.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.86 -46.78 86.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.022 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.1 -40.75 96.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.952 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.83 -43.46 98.74 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 46.5 pt -66.73 -36.34 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.636 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -56.59 -48.81 76.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.361 -0.935 . . . . 1.0 108.97 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.97 -38.26 85.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.044 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 717' ' ' LEU . 1.2 mm? -62.91 -38.78 92.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.42 -45.49 93.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 722' ' ' HIS . 21.2 tt -87.25 -35.05 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.119 0.785 . . . . 1.0 113.119 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 77.0 m -64.13 -44.8 91.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.128 -0.629 . . . . 1.0 110.85 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.58 -45.41 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.747 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 719' ' ' ILE . 40.1 m-70 -132.09 147.06 52.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.217 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -75.38 115.31 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.818 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.74 133.29 48.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.51 145.65 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.847 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 40.58 -117.59 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.796 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.523 -179.839 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo . . . . . 0 N--CA 1.484 0.952 0 N-CA-C 110.056 -0.786 . . . . 1.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -139.27 142.61 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.627 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 3.1 m 45.01 74.0 0.88 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.505 -0.77 . . . . 1.0 111.15 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.65 143.31 98.68 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.658 2.239 . . . . 1.0 112.794 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.15 -38.75 92.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 78.24 57.22 3.47 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.39 155.2 41.12 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 123.029 2.486 . . . . 1.0 112.766 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.94 149.64 48.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.891 0.853 . . . . 1.0 111.174 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 92.1 mt -65.66 -40.7 88.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.333 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.79 -41.16 97.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.229 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.82 -40.86 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.712 0.291 . . . . 1.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.0 -47.25 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.384 0.611 . . . . 1.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 98.3 mt -64.7 -41.25 96.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.83 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 45.1 mt -61.55 -40.58 95.22 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 17.7 m -68.02 -38.6 82.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.305 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.37 -46.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.7 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.84 -41.39 99.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.78 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.64 -46.0 79.79 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.91 -0.662 . . . . 1.0 111.794 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.98 -49.6 75.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.0 111.546 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.25 -43.19 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.617 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.89 -44.09 94.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.787 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.76 -41.69 97.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.269 0.557 . . . . 1.0 111.344 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.44 -43.33 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.177 -0.92 . . . . 1.0 109.769 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.78 96.58 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.134 -1.186 . . . . 1.0 110.134 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.49 -43.28 97.72 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.877 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.7 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -65.37 -45.2 85.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.199 -0.601 . . . . 1.0 110.987 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.39 -40.86 97.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.481 . . . . 1.0 111.253 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.85 -44.01 97.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.655 -0.702 . . . . 1.0 112.287 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.15 -43.35 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -54.31 -48.86 70.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 119.135 -1.026 . . . . 1.0 108.902 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -40.5 86.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.27 -39.1 91.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -45.04 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.826 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 73.1 mt -87.19 -35.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.929 0.714 . . . . 1.0 112.929 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 99.3 m -62.66 -45.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.61 -45.06 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.204 0.526 . . . . 1.0 110.197 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -43.13 149.32 0.22 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.384 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 725' ' ' LYS . 46.9 m-20 -65.09 -36.91 85.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.619 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 62.42 -44.17 0.18 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.404 0.44 . . . . 1.0 111.217 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 723' ' ' ASP . 99.2 mttt -61.72 -41.76 98.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.944 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -78.43 147.17 34.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 1.0 110.539 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 51.4 p90 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.935 -1.031 . . . . 1.0 110.777 179.698 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.481 0.758 0 N-CA-C 108.922 -1.222 . . . . 1.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.56 128.21 34.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.36 176.2 0.07 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.474 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.58 145.32 98.38 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.018 1.812 . . . . 1.0 112.029 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.82 -41.68 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.969 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 133.95 -164.09 24.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -62.37 141.99 89.26 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.85 2.367 . . . . 1.0 111.54 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.426 0.631 . . . . 1.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 27.6 pt -51.32 -30.88 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.64 -42.63 99.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.669 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.16 -42.09 94.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.173 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 57.1 t -61.99 -47.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.772 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.57 -42.04 99.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.08 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.3 -40.96 98.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.3 m -68.83 -36.83 78.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.704 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.72 -45.22 95.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.006 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.63 -42.05 98.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.852 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.03 93.02 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.142 -1.028 . . . . 1.0 110.959 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.11 95.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.2 -43.67 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.0 110.28 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.94 -41.7 97.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.507 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.3 -42.61 99.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 1.0 111.726 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.95 -42.89 97.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.913 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.22 -40.9 92.46 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.47 -44.07 97.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.165 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.28 75.92 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.082 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.85 82.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -41.73 99.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.139 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.09 -42.41 99.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.036 0.754 . . . . 1.0 113.036 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.08 -42.61 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -54.94 -49.2 71.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.157 -1.017 . . . . 1.0 109.317 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.92 -39.54 89.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.508 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 70.5 mt -61.07 -39.34 89.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.8 -53.13 60.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.117 -0.633 . . . . 1.0 111.208 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 722' ' ' HIS . 84.8 mt -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 96.4 m -65.51 -46.12 80.91 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.885 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.423 HG21 ' H ' ' A' ' 722' ' ' HIS . 19.8 tt -66.57 -43.93 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.311 -0.556 . . . . 1.0 110.118 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 719' ' ' ILE . 28.5 m80 -136.77 155.11 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -85.46 107.87 17.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 1.0 110.662 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -138.21 148.16 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.75 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 142.58 51.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.411 ' O ' ' OXT' ' A' ' 727' ' ' PHE . 79.4 tt0 -67.8 -37.71 82.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.974 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.411 ' OXT' ' O ' ' A' ' 726' ' ' GLU . 79.5 t80 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.974 -1.012 . . . . 1.0 111.126 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo . . . . . 0 N--CA 1.486 1.078 0 N-CA-C 110.164 -0.745 . . . . 1.0 110.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -61.65 146.18 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.055 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.23 173.16 5.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.298 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.21 -38.61 88.1 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.269 1.979 . . . . 1.0 111.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 690' ' ' GLY . 98.6 mttt -62.69 -42.24 99.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.022 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 689' ' ' LYS . . . 45.21 -172.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -59.11 141.98 98.77 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.467 2.111 . . . . 1.0 112.026 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -65.35 139.48 58.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.39 0.614 . . . . 1.0 110.085 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 694' ' ' LEU . 21.1 tt -71.7 -35.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.418 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . 0.41 ' N ' ' CG2' ' A' ' 693' ' ' ILE . 97.6 mt -63.37 -40.26 96.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.824 -1.08 . . . . 1.0 110.884 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.35 -41.98 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.13 -47.32 93.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.245 0.545 . . . . 1.0 109.976 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 99.5 mt -63.66 -41.81 98.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.094 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.9 -38.24 87.63 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.311 0.577 . . . . 1.0 110.682 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 21.0 m -67.64 -40.39 84.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.73 -46.12 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.731 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -61.96 -41.6 98.17 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.541 . . . . 1.0 112.391 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.97 85.76 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.733 -0.746 . . . . 1.0 112.022 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.2 77.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 1.0 111.622 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -43.93 97.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.857 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.5 -41.34 96.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.037 0.384 . . . . 1.0 112.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.58 -41.5 98.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.309 0.576 . . . . 1.0 111.459 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.28 -42.51 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.954 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.4 -42.39 95.7 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.88 -43.64 98.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.85 85.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.33 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.52 84.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.772 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.7 -38.64 91.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.97 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.29 -42.71 99.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 4.2 mm -64.19 -43.22 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.271 0.558 . . . . 1.0 109.51 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -54.43 -50.33 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.346 -0.942 . . . . 1.0 109.295 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -37.98 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.511 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.98 -41.42 96.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.81 -50.08 72.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.687 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.73 -42.83 83.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 76.9 m -61.68 -43.93 97.91 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.437 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 722' ' ' HIS . 17.9 tt -89.49 1.53 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.212 0.529 . . . . 1.0 109.666 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 721' ' ' ILE . 94.9 m-70 46.56 101.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.298 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -91.95 -0.65 57.49 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.362 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -137.02 144.75 43.42 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.823 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -112.69 126.76 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.829 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.13 -39.53 86.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.543 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.902 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 109.247 -1.097 . . . . 1.0 109.247 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.51 137.48 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.66 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.9 m -164.48 73.2 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.72 147.68 94.76 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.901 2.401 . . . . 1.0 111.315 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -59.37 -45.73 90.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.721 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -176.86 -171.01 40.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.138 -0.785 . . . . 1.0 111.138 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -59.27 145.17 98.67 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.458 2.105 . . . . 1.0 111.042 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -134.93 -34.99 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.691 0.758 . . . . 1.0 110.108 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.53 -41.32 88.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.351 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.06 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.226 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.75 -42.11 90.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 1.0 111.027 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.9 -48.27 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.704 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.51 -41.65 98.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.517 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 29.3 mt -62.86 -40.0 96.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.708 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.3 m -68.86 -38.69 79.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.543 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.52 -44.75 98.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.693 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.4 mtp -62.87 -39.86 95.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.753 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.38 -44.81 72.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.589 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.54 81.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 30.8 pt -67.33 -40.85 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.194 -0.602 . . . . 1.0 110.443 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.66 -43.94 92.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.605 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.38 -41.22 96.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.479 -0.489 . . . . 1.0 111.654 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.98 -42.99 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.023 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.95 93.94 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.16 -44.53 95.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.54 91.37 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.67 96.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.89 -0.724 . . . . 1.0 109.882 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.95 -40.57 98.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.97 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.9 -42.12 99.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 714' ' ' ILE . 88.0 mt -62.66 -43.17 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -55.37 -49.79 71.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.156 -1.017 . . . . 1.0 108.539 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -41.99 96.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.019 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.57 -42.06 98.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.932 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.481 ' O ' ' CE1' ' A' ' 722' ' ' HIS . 83.9 mt -60.98 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.998 -0.681 . . . . 1.0 111.895 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 35.6 mm -72.02 -41.41 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.5 m -62.09 -43.13 99.51 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.201 -0.312 . . . . 1.0 111.373 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.59 -47.42 93.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.672 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.481 ' CE1' ' O ' ' A' ' 718' ' ' LEU . 52.0 p-80 -140.22 139.32 35.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -98.52 113.1 24.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -62.3 -43.4 98.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.244 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.73 149.35 38.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.174 0.511 . . . . 1.0 110.781 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.52 -40.67 85.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.549 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.754 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.479 0.652 0 N-CA-C 109.375 -1.048 . . . . 1.0 109.375 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -107.97 135.78 48.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.55 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.4 OUTLIER -95.47 -178.34 0.77 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.917 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 12.5 Cg_exo -66.82 149.49 83.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.306 2.004 . . . . 1.0 111.543 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.01 -43.98 94.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.043 0.449 . . . . 1.0 110.24 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 66.4 177.27 7.88 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.22 146.8 58.42 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.531 2.154 . . . . 1.0 111.669 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -68.27 136.75 53.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.647 . . . . 1.0 110.751 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.32 -41.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.886 -1.052 . . . . 1.0 110.684 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.57 -40.58 97.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.96 -43.39 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.691 0.281 . . . . 1.0 111.283 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.45 -48.07 88.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.343 -0.543 . . . . 1.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.03 -41.73 99.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.393 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.0 mt -62.02 -40.74 96.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.118 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.7 m -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 1.0 109.891 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.28 -46.87 94.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.995 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 91.9 mtp -63.2 -41.62 99.19 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.9 -44.35 92.01 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.9 -0.666 . . . . 1.0 111.708 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.25 95.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.15 -44.03 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.96 -42.69 97.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.376 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.37 -41.29 98.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 1.0 111.698 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.5 -43.25 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.538 -0.755 . . . . 1.0 109.997 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.59 -41.34 97.25 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.394 -0.821 . . . . 1.0 111.049 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.38 -43.27 98.08 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.48 87.57 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.16 -47.3 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.61 -39.72 94.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 1.0 112.006 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.16 -43.45 98.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.891 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.54 -43.6 98.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -54.95 -50.37 69.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 1.0 108.957 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -37.45 80.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.771 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.39 -41.12 98.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.77 -47.88 83.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.82 -42.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.758 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.8 m -61.77 -44.17 97.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.068 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 722' ' ' HIS . 20.2 tt -87.42 -0.73 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.276 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 721' ' ' ILE . 67.2 m80 56.4 134.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.679 -0.692 . . . . 1.0 111.632 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 726' ' ' GLU . 95.5 m-20 -68.2 145.3 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.706 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.64 -39.8 94.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.706 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.53 -44.59 96.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.423 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 723' ' ' ASP . 83.6 tt0 -97.34 123.01 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.907 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.84 -179.61 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo . . . . . 0 N--CA 1.484 0.93 0 N-CA-C 109.908 -0.843 . . . . 1.0 109.908 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -67.33 -39.11 85.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.949 -0.301 . . . . 1.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 77.9 p -146.68 76.8 11.61 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.251 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.99 144.61 93.34 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.999 2.466 . . . . 1.0 111.681 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.77 145.29 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.162 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -155.45 169.75 33.37 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.664 -0.779 . . . . 1.0 111.437 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 693' ' ' ILE . 10.9 Cg_endo -57.9 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.69 2.26 . . . . 1.0 111.63 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 62.44 -46.34 0.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.724 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 691' ' ' PRO . 96.7 mt -69.87 -40.39 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.341 0.591 . . . . 1.0 111.016 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.65 -37.25 85.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.925 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.21 -43.79 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.65 -48.56 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.999 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.3 -40.85 97.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.07 -40.27 97.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.3 m -65.66 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.81 -46.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.866 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.3 mtp -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.831 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.45 -43.98 91.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.576 -0.821 . . . . 1.0 111.064 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.05 87.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.998 0.427 . . . . 1.0 111.818 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.21 -44.44 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.558 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.734 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.62 -41.89 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 1.0 112.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.36 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.614 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.82 96.64 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.081 -1.208 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.81 -46.15 86.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.628 0.251 . . . . 1.0 110.436 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.1 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 1.0 110.038 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.3 99.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -39.82 95.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.575 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.4 -44.18 95.41 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.68 -43.57 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.987 0.422 . . . . 1.0 110.02 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.06 -49.13 69.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.081 -1.047 . . . . 1.0 108.891 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -37.91 83.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.017 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.83 -41.66 96.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.09 -54.93 40.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.029 -0.669 . . . . 1.0 111.276 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 719' ' ' ILE . 96.5 mt -69.03 -42.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.5 m -64.05 -45.49 88.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.433 ' O ' ' CD2' ' A' ' 722' ' ' HIS . 96.1 mt -64.24 -45.99 94.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.865 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 721' ' ' ILE . 32.6 m170 -140.58 162.07 36.25 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.09 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 56.53 42.63 27.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.37 -43.15 99.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.421 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -86.91 136.74 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.222 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -94.12 140.41 29.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.114 -0.946 . . . . 1.0 110.66 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 109.712 -0.919 . . . . 1.0 109.712 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.74 -43.87 90.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 1.0 110.411 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.7 t -163.48 73.89 1.86 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.072 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.06 -30.31 78.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.844 2.362 . . . . 1.0 112.425 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -60.15 -42.16 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.54 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -166.2 78.71 0.12 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 120.423 -0.894 . . . . 1.0 111.743 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.515 ' C ' ' H ' ' A' ' 693' ' ' ILE . 39.2 Cg_exo -58.35 143.6 97.29 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.481 2.121 . . . . 1.0 112.626 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 62.54 -39.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 691' ' ' PRO . 35.7 pt -75.14 -35.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.998 0.428 . . . . 1.0 110.255 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.91 -39.05 90.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.007 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.16 -41.39 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.219 0.452 . . . . 1.0 112.219 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.19 -47.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 1.0 110.396 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.23 96.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.584 -0.734 . . . . 1.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.47 -41.33 98.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.12 0.486 . . . . 1.0 110.475 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 50.2 m -64.95 -41.97 95.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.955 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.51 -45.38 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.44 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.3 mtp -61.66 -41.48 97.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.649 -0.421 . . . . 1.0 111.005 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.17 -46.51 64.6 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 69.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.069 0.461 . . . . 1.0 111.567 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.71 -43.46 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.94 -42.84 99.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.172 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.61 -41.58 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 1.0 112.084 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 707' ' ' ILE . 87.9 mt -62.16 -42.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.009 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.6 -40.68 98.22 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.19 -45.1 93.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.749 0.309 . . . . 1.0 110.428 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.28 85.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.09 97.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.84 -42.03 97.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.632 0.605 . . . . 1.0 112.632 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.16 -42.93 99.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.45 -42.56 96.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -55.54 -50.3 70.37 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.358 -0.937 . . . . 1.0 108.66 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.45 -38.01 76.62 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.203 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.99 -40.59 98.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.908 -0.717 . . . . 1.0 111.269 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.47 -41.23 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 95.1 m -63.12 -44.51 95.4 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.963 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 722' ' ' HIS . 20.6 tt -66.44 -44.58 90.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.614 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.45 ' N ' ' CG2' ' A' ' 721' ' ' ILE . 48.5 t-80 -137.69 134.48 35.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.887 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -88.35 112.43 22.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.1 0.476 . . . . 1.0 110.599 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.9 143.48 39.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.684 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.91 -40.07 94.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.16 -38.92 89.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.452 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.06 -0.971 . . . . 1.0 110.649 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.487 1.146 0 N-CA-C 110.419 -0.646 . . . . 1.0 110.419 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.49 135.32 53.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.645 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 89.2 p -167.88 56.23 0.33 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.936 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.84 151.17 68.51 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.924 2.416 . . . . 1.0 112.148 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -94.79 -8.23 38.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.458 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -48.86 -53.31 18.38 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.686 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 23.5 Cg_exo -60.0 145.58 98.04 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.457 2.105 . . . . 1.0 112.653 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -65.92 133.66 51.36 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.225 0.536 . . . . 1.0 111.202 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 19.1 tt -73.87 -37.01 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.625 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.83 -40.27 96.2 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.066 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.81 -41.89 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.969 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.66 -47.69 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.305 -0.558 . . . . 1.0 110.156 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.13 -42.2 96.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.539 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.14 -37.77 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.078 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.4 m -67.54 -40.0 85.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.071 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.61 -46.0 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.032 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.7 mtp -61.17 -42.64 98.93 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.82 -45.22 89.73 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.533 -0.841 . . . . 1.0 111.201 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.05 85.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.31 -44.04 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.134 0.492 . . . . 1.0 110.493 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.26 -42.16 96.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.703 -0.681 . . . . 1.0 111.152 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 1.0 111.739 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.85 -44.38 99.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.5 95.06 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.676 -0.97 . . . . 1.0 110.676 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.27 -44.54 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.042 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.65 88.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.195 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.95 97.54 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.355 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.1 -40.21 95.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.083 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 36.3 mt -63.79 -43.94 94.81 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.848 0.684 . . . . 1.0 112.848 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.0 pt -65.84 -38.13 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.388 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -56.4 -47.53 78.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 118.783 -1.167 . . . . 1.0 109.076 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -39.19 89.23 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.363 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.24 -40.1 92.77 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.91 -52.92 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.328 0.585 . . . . 1.0 110.891 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.47 -42.27 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 1.0 112.548 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.1 m -63.08 -45.05 93.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.64 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 90.0 mt -87.19 -1.97 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.395 0.617 . . . . 1.0 109.835 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 52.36 171.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.099 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.2 143.68 57.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -70.59 135.48 48.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.168 0.508 . . . . 1.0 111.056 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 59.24 61.22 2.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.204 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.84 -42.27 99.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.729 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.847 -1.073 . . . . 1.0 110.093 179.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.484 0.913 0 N-CA-C 109.553 -0.98 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.16 -45.48 76.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.728 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.5 m -175.15 83.39 0.31 Allowed Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.542 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.39 146.61 95.66 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.208 1.939 . . . . 1.0 111.362 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.86 135.8 57.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 1.0 111.167 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 164.11 69.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.797 -0.921 . . . . 1.0 110.797 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -52.21 -42.92 56.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.541 2.16 . . . . 1.0 111.49 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -90.38 103.7 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.264 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.0 -31.85 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.027 -0.988 . . . . 1.0 110.405 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.41 -41.69 96.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.745 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.23 -41.63 93.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 1.0 110.882 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.56 -47.95 90.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.421 -0.512 . . . . 1.0 110.551 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.32 -40.69 98.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.538 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.51 -38.44 89.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 69.9 m -66.08 -40.38 90.79 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.612 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.47 -45.27 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 1.0 111.102 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.9 mtp -62.07 -42.24 98.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 1.0 112.308 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.91 -44.17 92.34 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.531 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.72 -44.63 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.257 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.27 -41.57 96.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.736 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.03 -42.47 97.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.147 0.499 . . . . 1.0 112.238 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 707' ' ' ILE . 93.7 mt -63.73 -43.07 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.004 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.81 94.28 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.236 -1.146 . . . . 1.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.29 -43.42 97.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.625 -0.43 . . . . 1.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.74 91.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.32 93.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.84 -40.52 97.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.578 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.77 -43.62 98.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.9 -42.81 97.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -53.39 -50.55 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.846 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -40.14 91.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.314 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.29 -42.92 96.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.99 -49.11 77.38 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.019 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 92.7 mt -67.84 -43.19 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 57.0 m -61.01 -44.96 96.65 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.712 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 722' ' ' HIS . 96.5 mt -89.15 -0.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.813 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 721' ' ' ILE . 74.6 m80 52.88 150.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.467 0.651 . . . . 1.0 112.511 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.78 -38.84 92.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.408 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -134.87 149.65 50.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.92 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -65.55 -39.85 92.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.895 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -130.92 137.26 49.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.854 -1.069 . . . . 1.0 110.723 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 N--CA 1.479 0.638 0 N-CA-C 109.613 -0.956 . . . . 1.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.81 -38.65 89.55 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.994 0.426 . . . . 1.0 110.3 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 7.7 t 47.12 71.83 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.606 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -61.55 146.85 96.6 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.851 2.367 . . . . 1.0 112.27 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.46 148.57 29.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 1.0 110.983 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.502 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -98.13 -48.38 1.9 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.889 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 36.5 Cg_exo -54.77 -37.96 91.92 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.734 2.289 . . . . 1.0 112.439 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 49.4 35.01 7.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.259 0.552 . . . . 1.0 110.467 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.23 -40.96 81.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.567 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.57 -40.6 95.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.193 -0.912 . . . . 1.0 112.262 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.0 -42.46 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.662 0.268 . . . . 1.0 111.329 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.92 -47.79 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.392 0.615 . . . . 1.0 109.885 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.55 -41.28 98.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.129 -0.942 . . . . 1.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.31 -39.55 93.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.574 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.6 m -64.53 -40.94 96.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.701 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.79 -45.52 98.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 86.6 mtp -61.63 -42.4 98.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.816 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.01 -45.52 87.04 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.627 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.32 -49.59 75.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.649 0.611 . . . . 1.0 112.649 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.58 -43.41 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.671 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.4 mt -64.44 -40.81 96.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.83 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.64 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 15.4 tt -67.31 -33.27 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.28 97.91 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.42 -1.472 . . . . 1.0 109.42 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.47 -46.09 87.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.268 -0.466 . . . . 1.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.33 88.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.7 89.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.578 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.5 -41.26 98.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.8 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.86 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.99 -42.37 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -55.07 -48.91 72.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.963 -1.095 . . . . 1.0 109.411 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -43.35 98.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.009 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 717' ' ' LEU . 2.4 mm? -62.3 -39.32 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.16 -48.32 82.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.163 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.28 -42.33 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 m -61.4 -44.76 96.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.414 -0.515 . . . . 1.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 20.0 tt -90.0 0.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.329 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 76.3 m80 39.6 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.429 -0.351 . . . . 1.0 110.341 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.31 -39.59 89.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 726' ' ' GLU . 30.6 ptt180 -60.46 -36.25 77.8 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.525 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 51.96 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.457 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 724' ' ' ARG . 84.8 tt0 -125.88 134.64 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.244 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.447 ' OXT' ' O ' ' A' ' 726' ' ' GLU . 46.7 t80 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.908 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.419 ' H2 ' ' H ' ' A' ' 686' ' ' GLU . 20.1 Cg_exo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 109.39 -1.042 . . . . 1.0 109.39 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.419 ' H ' ' H2 ' ' A' ' 685' ' ' PRO . 80.3 tt0 -66.23 -41.91 89.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.855 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 12.7 t -175.79 53.61 0.11 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 1.0 111.008 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 687' ' ' SER . 37.2 Cg_endo -67.33 -24.05 43.88 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.853 2.369 . . . . 1.0 112.246 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -40.88 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.659 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.87 69.48 1.29 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.32 -38.66 93.62 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.736 2.291 . . . . 1.0 111.662 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -88.08 112.1 22.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.074 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 35.4 pt -75.38 -30.82 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.876 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.93 -42.79 97.27 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.51 -37.67 80.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.689 -0.405 . . . . 1.0 111.317 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.28 -48.57 88.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.066 -0.654 . . . . 1.0 109.728 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.52 -40.88 98.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.968 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.1 -38.7 92.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.358 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 53.0 m -65.95 -44.29 85.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.265 0.468 . . . . 1.0 112.265 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 7.2 m -63.89 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 119.348 -0.941 . . . . 1.0 110.516 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.6 mtp -62.02 -42.29 99.0 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.738 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.18 -44.15 87.53 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.502 -0.856 . . . . 1.0 111.282 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 19.0 tt -65.25 -39.9 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.316 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.37 -43.27 95.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.009 -0.277 . . . . 1.0 111.66 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.64 -42.1 95.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.38 -37.07 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.2 -0.6 . . . . 1.0 109.792 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.62 97.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.54 -43.66 98.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 1.0 110.388 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.44 85.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.69 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.9 -39.37 94.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 111.318 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.39 -43.03 99.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.867 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.22 -43.83 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -55.37 -49.65 71.72 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -38.85 87.11 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.091 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.4 -41.06 96.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.43 -45.01 96.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.381 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 719' ' ' ILE . 88.0 mt -84.42 -37.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.018 0.747 . . . . 1.0 113.018 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.0 m -63.21 -44.33 95.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.323 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 722' ' ' HIS . 21.0 tt -65.15 -42.58 94.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.544 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.432 ' N ' ' CG2' ' A' ' 721' ' ' ILE . 60.6 t-80 -44.32 108.6 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.551 -0.749 . . . . 1.0 110.787 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.951 -0.3 . . . . 1.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -134.54 137.71 44.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.97 137.7 51.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.0 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.58 -48.6 3.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.688 179.529 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 N--CA 1.487 1.125 0 N-CA-C 110.045 -0.79 . . . . 1.0 110.045 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.434 ' O ' ' OG ' ' A' ' 687' ' ' SER . 21.7 pt-20 -64.6 -41.16 96.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.316 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.467 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 49.1 m -170.4 51.14 0.17 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.004 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 687' ' ' SER . 36.5 Cg_endo -66.36 147.51 83.05 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.538 2.159 . . . . 1.0 112.107 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.33 -42.61 99.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.628 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 161.85 -177.36 38.12 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.774 -0.727 . . . . 1.0 111.345 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.2 -40.71 68.76 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.234 2.623 . . . . 1.0 112.784 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 48.74 31.74 3.23 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.23 0.538 . . . . 1.0 111.285 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.7 mt -70.23 -41.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 694' ' ' LEU . 10.4 mp -62.23 -41.53 98.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.642 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.96 -42.87 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.715 0.293 . . . . 1.0 110.982 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.71 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.073 -0.651 . . . . 1.0 109.771 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.68 -42.02 99.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.927 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.36 -39.12 93.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.287 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.32 -38.28 81.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.079 0.466 . . . . 1.0 110.566 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.02 -45.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.128 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.34 -40.57 96.81 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.528 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.87 62.2 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.461 -0.876 . . . . 1.0 111.443 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.79 79.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.586 0.587 . . . . 1.0 112.586 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.54 -41.92 91.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.48 -40.02 89.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.42 -43.43 98.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.73 -35.72 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.575 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.66 -41.78 97.56 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.654 -1.378 . . . . 1.0 109.654 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.41 -43.43 97.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.42 87.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.569 -0.453 . . . . 1.0 109.94 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.25 94.12 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.155 -0.618 . . . . 1.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.73 -41.1 98.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.226 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.84 -43.11 99.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.15 -42.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.03 -49.95 67.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 118.959 -1.097 . . . . 1.0 108.618 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.6 86.14 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.245 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.65 -42.86 93.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 722' ' ' HIS . 93.2 mt -60.92 -49.49 77.26 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.731 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 90.8 mt -67.46 -42.17 86.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 113.302 0.853 . . . . 1.0 113.302 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 89.7 m -60.87 -44.95 96.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.635 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 722' ' ' HIS . 1.6 pp -92.22 1.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 721' ' ' ILE . 20.2 t-80 85.92 132.98 0.04 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.874 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -92.49 112.54 24.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.073 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -71.88 139.7 48.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.43 -0.804 . . . . 1.0 110.597 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.43 151.1 26.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.899 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -137.12 31.08 2.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.461 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.473 -179.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.426 ' H2 ' ' H ' ' A' ' 686' ' ' GLU . 10.1 Cg_endo . . . . . 0 N--CA 1.485 1.012 0 N-CA-C 109.785 -0.891 . . . . 1.0 109.785 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.426 ' H ' ' H2 ' ' A' ' 685' ' ' PRO . 81.8 tt0 -101.55 135.0 43.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.269 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.403 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.6 OUTLIER -155.56 179.34 1.37 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.913 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 23.5 Cg_exo -61.92 149.38 90.44 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.228 1.952 . . . . 1.0 111.65 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.49 136.87 44.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.943 0.401 . . . . 1.0 110.027 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -178.13 166.88 37.24 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 -18.67 38.92 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.79 2.327 . . . . 1.0 112.325 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -136.59 94.64 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.312 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 31.0 pt -73.95 -28.27 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.678 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -42.07 97.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.996 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.68 -42.01 90.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.917 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.61 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.166 -0.614 . . . . 1.0 110.236 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.68 -42.06 98.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.93 -41.04 97.49 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.665 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 37.3 m -68.29 -41.09 81.48 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 80.4 t -62.61 -45.59 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.006 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.8 mtp -63.02 -42.11 99.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.875 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.97 -45.12 75.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.75 92.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.758 0.313 . . . . 1.0 111.316 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 86.0 mt -65.02 -44.6 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.246 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.93 -41.07 95.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.335 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -41.86 98.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.094 0.473 . . . . 1.0 112.073 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.83 -43.47 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.111 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -55.25 -42.79 83.47 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.281 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.33 -43.36 97.97 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.138 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.42 83.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.97 0.414 . . . . 1.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.79 -48.28 77.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.36 -39.24 93.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.098 0.407 . . . . 1.0 112.098 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.12 -42.67 99.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 1.0 111.99 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.37 -42.81 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.756 . . . . 1.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -54.23 -47.16 72.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.009 -1.076 . . . . 1.0 108.998 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -41.45 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.742 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.81 -41.75 98.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.9 -49.93 75.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.912 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 18.6 tt -74.83 -37.0 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 1.0 112.479 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 98.7 m -59.57 -43.68 93.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 18.6 tt -94.33 4.41 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.389 0.614 . . . . 1.0 110.197 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 42.53 77.27 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 724' ' ' ARG . 60.7 t0 -70.95 134.86 47.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 723' ' ' ASP . 92.7 mtm-85 -123.1 144.56 49.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.053 0.454 . . . . 1.0 111.144 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 724' ' ' ARG . 98.2 mttt 47.02 -178.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.028 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.34 159.2 22.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.491 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.147 -0.93 . . . . 1.0 110.439 -179.835 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 109.855 -0.863 . . . . 1.0 109.855 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.62 -39.19 80.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.688 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 3.2 m -142.77 75.41 18.19 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.695 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.85 146.82 21.06 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.503 2.135 . . . . 1.0 111.596 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.02 -43.29 99.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.512 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -125.06 84.34 0.35 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.55 142.47 95.49 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.812 1.674 . . . . 1.0 111.527 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -93.27 2.74 56.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 693' ' ' ILE . 96.9 mt -66.62 -40.77 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.89 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 694' ' ' LEU . 10.8 mp -59.86 -39.61 85.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.631 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -42.46 94.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.618 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.28 -47.86 91.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.576 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.81 -41.68 99.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.258 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.09 -38.09 89.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.5 m -66.87 -43.37 83.74 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.03 -41.61 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.466 -0.894 . . . . 1.0 110.359 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.2 mtp -62.58 -42.11 99.36 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 121.099 -0.24 . . . . 1.0 111.051 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.16 88.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.53 78.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 1.0 111.463 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.74 -43.57 98.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.134 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.18 -44.65 94.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.29 -41.54 98.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 1.0 112.059 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.44 -42.86 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.018 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.71 95.31 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.75 -43.39 96.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.764 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.56 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.286 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.52 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.116 -0.634 . . . . 1.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.33 -41.61 98.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.836 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.39 -43.63 98.37 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.936 0.717 . . . . 1.0 112.936 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.4 -42.99 98.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -55.46 -48.4 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.128 -1.029 . . . . 1.0 108.313 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.88 -41.03 95.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.978 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.6 -42.02 91.64 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.523 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.9 mt -62.37 -47.74 82.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.769 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 88.6 mt -71.8 -42.26 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.5 p -68.1 -39.83 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 722' ' ' HIS . 19.2 tt -66.87 -46.39 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.775 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 15.4 m80 -43.57 129.24 5.29 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.834 -0.347 . . . . 1.0 111.174 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -64.51 -40.47 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.605 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -88.77 138.27 31.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 109.963 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.46 -42.98 99.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.526 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 49.61 22.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.954 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.478 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 109.262 -1.092 . . . . 1.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -132.37 138.39 47.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.581 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.526 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER 179.49 -45.16 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.355 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 687' ' ' SER . 20.9 Cg_exo -62.98 151.37 84.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.471 2.114 . . . . 1.0 111.371 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -99.61 143.12 30.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 88.46 77.46 1.29 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.496 -0.641 . . . . 1.0 111.496 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.49 -38.29 89.96 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.753 2.302 . . . . 1.0 111.815 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.9 138.26 58.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.426 0.632 . . . . 1.0 110.838 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 72.9 mt -70.14 -41.27 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.711 -1.132 . . . . 1.0 111.211 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.53 -41.1 96.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.287 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 63.2 t -58.45 -42.46 84.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.95 -47.55 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 121.114 0.483 . . . . 1.0 109.808 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.22 -41.82 99.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.252 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.35 -38.86 91.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 1.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.82 -39.16 80.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.141 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 69.9 t -62.65 -44.92 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.067 0.46 . . . . 1.0 109.93 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.6 mtp -62.36 -41.91 98.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.129 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.61 -45.58 75.69 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.73 -0.748 . . . . 1.0 111.69 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.08 73.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.33 0.492 . . . . 1.0 112.33 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.07 -43.42 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.728 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.7 mt -64.39 -43.18 95.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.172 0.434 . . . . 1.0 112.172 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.81 -42.84 97.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.326 -0.55 . . . . 1.0 111.9 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.66 -43.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.426 -0.806 . . . . 1.0 110.637 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.62 94.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.35 -43.81 98.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.13 89.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.775 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.726 -0.789 . . . . 1.0 110.475 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.65 -40.83 96.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.15 -43.32 95.55 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.386 0.884 . . . . 1.0 113.386 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.9 pt -65.8 -39.37 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.327 -0.549 . . . . 1.0 109.676 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -54.37 -50.4 67.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.353 -0.939 . . . . 1.0 108.817 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -40.02 89.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.558 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.17 -42.12 94.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.461 -0.496 . . . . 1.0 109.916 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.38 -50.12 74.18 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.763 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.12 -41.72 84.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 90.1 m -61.55 -44.16 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.5 0.555 . . . . 1.0 112.5 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 722' ' ' HIS . 46.8 pt -65.34 -43.85 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.169 -0.612 . . . . 1.0 111.902 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.428 ' N ' HG13 ' A' ' 721' ' ' ILE . 49.4 m80 -138.31 137.0 36.99 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -94.71 -0.5 54.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.23 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.47 -43.05 99.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.554 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.38 146.31 27.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.995 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 48.2 -169.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.134 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 117.922 -1.037 . . . . 1.0 110.663 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo . . . . . 0 N--CA 1.481 0.777 0 N-CA-C 108.924 -1.221 . . . . 1.0 108.924 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.78 136.67 58.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.987 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 59.9 m -147.64 72.19 11.62 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.083 0.468 . . . . 1.0 110.117 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -60.96 145.57 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 123.312 2.674 . . . . 1.0 112.556 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.0 tttt 48.71 36.67 8.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.08 -168.75 42.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.53 146.9 95.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.956 2.438 . . . . 1.0 111.87 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.58 143.32 57.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.371 0.605 . . . . 1.0 110.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.75 -40.01 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.144 -0.934 . . . . 1.0 110.497 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 694' ' ' LEU . 4.1 mm? -62.48 -40.99 98.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.422 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.53 -40.98 90.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.105 0.478 . . . . 1.0 110.806 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.3 -46.9 95.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.76 -41.88 99.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.119 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.93 -39.17 93.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.07 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.9 m -66.61 -38.28 86.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.533 -0.758 . . . . 1.0 109.915 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -61.75 -41.67 97.98 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.62 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.34 -45.52 60.5 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.629 -0.796 . . . . 1.0 111.743 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.31 77.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.94 -41.01 89.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.464 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.757 -0.377 . . . . 1.0 111.459 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 36.7 mt -62.18 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 12.3 tt -66.5 -34.37 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.189 -0.605 . . . . 1.0 109.881 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.22 -43.02 95.64 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.35 -42.71 98.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.94 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.4 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.9 -47.77 79.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.12 -38.48 91.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.755 0.312 . . . . 1.0 111.632 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.37 -44.45 96.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.534 . . . . 1.0 112.421 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.32 -42.76 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.587 . . . . 1.0 109.625 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -55.78 -50.07 71.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.293 -0.963 . . . . 1.0 109.185 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -38.09 85.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.327 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.11 -42.11 94.01 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.28 -50.75 71.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.049 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.15 -43.62 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -61.76 -45.87 92.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.543 -0.463 . . . . 1.0 109.887 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 722' ' ' HIS . 44.9 mm -84.95 -0.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.552 . . . . 1.0 109.743 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 721' ' ' ILE . 63.6 m80 55.28 116.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.222 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 725' ' ' LYS . 66.6 t0 -91.08 114.85 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.578 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.84 -41.27 99.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.623 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 723' ' ' ASP . 99.0 mttt -126.69 139.53 53.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.585 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.72 132.08 46.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.057 -0.973 . . . . 1.0 110.399 179.819 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.482 0.851 0 N-CA-C 109.728 -0.912 . . . . 1.0 109.728 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.36 -37.22 86.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.332 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.2 p -166.84 70.61 1.05 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.483 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.89 142.98 99.61 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.693 2.262 . . . . 1.0 112.651 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.43 -42.38 99.41 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 104.34 175.5 25.21 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.866 -0.606 . . . . 1.0 111.701 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.22 118.61 5.6 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.946 2.431 . . . . 1.0 112.925 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -97.16 -4.24 39.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.543 0.687 . . . . 1.0 109.932 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 21.3 tt -60.13 -29.92 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.893 -1.049 . . . . 1.0 109.563 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.15 -42.89 99.69 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.708 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.44 -41.89 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.362 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.3 -46.74 96.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.3 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.63 -42.42 99.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.264 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.67 -40.08 95.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.959 0.409 . . . . 1.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.9 m -66.92 -39.94 87.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.142 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.54 -46.03 96.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.311 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.76 -41.27 97.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.675 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.37 -45.01 71.49 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.352 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.11 85.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.744 0.276 . . . . 1.0 111.744 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 32.0 mm -64.12 -43.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.277 0.561 . . . . 1.0 109.852 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 5.5 tt -64.26 -41.76 96.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 111.791 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.62 -44.13 97.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.998 0.74 . . . . 1.0 112.998 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 707' ' ' ILE . 36.7 pt -66.0 -39.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.494 -0.483 . . . . 1.0 110.506 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.82 97.26 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.147 -1.181 . . . . 1.0 110.147 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.38 -44.62 96.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.41 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.68 89.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.231 -0.587 . . . . 1.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.32 -42.12 98.96 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 111.687 0.255 . . . . 1.0 111.687 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.02 -43.2 99.38 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.42 -43.08 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -53.91 -49.17 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.204 -0.998 . . . . 1.0 108.685 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -36.47 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.298 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.84 -42.85 98.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.28 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.5 ' O ' ' CD2' ' A' ' 722' ' ' HIS . 10.6 mp -61.43 -51.03 70.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.587 -0.845 . . . . 1.0 111.499 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.35 -43.1 84.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.3 m -63.17 -44.72 94.63 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 721' ' ' ILE . 87.8 mt -63.58 -45.32 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.317 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 718' ' ' LEU . 49.5 m170 -45.19 138.05 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.999 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.04 111.65 19.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.373 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -128.87 134.45 48.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.048 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 54.85 92.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.477 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 67.4 t80 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.071 -0.966 . . . . 1.0 110.609 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -43.97 71.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.7 . . . . 1.0 111.486 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.58 156.35 43.16 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.939 -0.305 . . . . 1.0 110.463 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 689' ' ' LYS . 31.8 Cg_endo -62.81 142.71 89.85 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.636 2.224 . . . . 1.0 112.394 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 688' ' ' PRO . 97.9 mttt 41.75 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.769 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 49.59 76.72 0.15 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.18 144.04 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.936 2.424 . . . . 1.0 112.71 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 50.17 31.47 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 1.0 111.744 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 19.7 tt -73.06 -36.79 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.013 0.435 . . . . 1.0 110.428 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.93 -39.92 95.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.854 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.97 -40.89 87.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.064 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.76 -48.46 88.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 1.0 110.357 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.67 -41.63 99.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.18 -39.66 93.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 1.0 110.56 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 26.7 m -66.72 -42.01 87.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.735 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.05 -46.11 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.902 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -62.11 -41.57 98.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.569 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.19 -44.78 85.65 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.148 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.35 92.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.709 -0.396 . . . . 1.0 111.702 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.7 mm -64.2 -43.79 97.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.23 -43.36 98.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.686 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.95 -40.68 95.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.272 -0.571 . . . . 1.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.16 -42.98 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.421 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.14 96.55 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.144 -0.935 . . . . 1.0 110.992 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.58 -42.9 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.933 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.4 94.57 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.563 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.67 86.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.609 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.67 -39.0 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.219 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.3 -44.23 95.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.21 -35.71 74.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -56.55 -49.11 75.78 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.224 -0.99 . . . . 1.0 109.291 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . 0.407 ' O ' ' OG1' ' A' ' 720' ' ' THR . 0.6 OUTLIER -60.23 -38.23 82.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.669 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.06 -41.32 98.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.365 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.76 -50.11 74.78 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 119.893 -0.723 . . . . 1.0 110.962 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.91 -42.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.427 -0.806 . . . . 1.0 112.086 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 716' ' ' LYS . 19.5 m -62.24 -46.08 90.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.418 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 722' ' ' HIS . 17.2 tt -83.43 -2.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.507 . . . . 1.0 109.799 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 721' ' ' ILE . 73.3 m80 56.5 130.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.068 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -71.66 149.51 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -88.2 132.07 34.5 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.367 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.84 146.34 42.06 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.613 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.99 -40.27 91.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.539 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.581 -179.876 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 109.438 -1.024 . . . . 1.0 109.438 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -114.58 123.95 50.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 7.7 t -151.07 72.02 8.59 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.627 -0.429 . . . . 1.0 111.032 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.43 146.34 95.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.978 2.452 . . . . 1.0 112.744 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 690' ' ' GLY . 64.6 mttp -127.0 138.87 53.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.943 -0.572 . . . . 1.0 109.991 179.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 689' ' ' LYS . . . -54.27 -165.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.91 142.98 99.19 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.546 2.164 . . . . 1.0 111.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -90.27 2.0 55.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.278 0.561 . . . . 1.0 110.469 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.19 -40.65 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.179 -0.919 . . . . 1.0 110.394 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.221 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.49 -44.97 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.96 -47.01 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.804 -0.758 . . . . 1.0 109.644 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.43 -42.11 96.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.06 -39.51 92.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.054 0.454 . . . . 1.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 72.2 m -65.57 -39.78 92.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.802 179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.57 -47.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.227 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.74 -42.18 99.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.87 88.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.729 -0.748 . . . . 1.0 111.356 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.96 83.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.057 0.456 . . . . 1.0 112.154 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.14 -43.1 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.161 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.24 -45.67 90.47 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.44 -41.76 96.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.954 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.95 -43.49 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.462 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.24 -39.83 96.53 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.233 -1.147 . . . . 1.0 110.233 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.87 -42.46 99.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.27 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.446 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.7 88.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.822 -0.626 . . . . 1.0 112.217 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.73 -41.24 98.08 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.63 -43.68 98.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.621 -0.432 . . . . 1.0 112.029 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.84 -43.88 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -54.16 -49.17 69.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.281 -0.968 . . . . 1.0 108.954 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.326 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.7 -42.88 98.08 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.38 -48.05 83.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.111 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.77 -42.96 83.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.854 0.687 . . . . 1.0 112.854 -178.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 85.8 m -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 722' ' ' HIS . 44.1 mm -90.83 2.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.15 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 721' ' ' ILE . 78.3 m80 42.01 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.207 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -64.41 140.33 58.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.636 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -136.14 144.03 44.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.722 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.2 144.52 29.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 1.0 110.761 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -121.57 130.32 53.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.438 179.483 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.427 -1.585 0 N-CA-C 110.143 -0.317 . . . . 1.57 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.27 -44.59 97.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 113.004 0.742 . . . . 0.62 113.004 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.809 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.5 t -61.24 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 118.617 -1.233 . . . . 0.24 108.012 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.77 -42.41 99.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.813 -1.539 . . . . 1.17 110.806 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.08 -37.84 86.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.92 110.647 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.1 m -70.2 -41.2 74.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.834 -0.621 . . . . 0.22 109.931 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 696' ' ' VAL . 98.2 t -61.02 -46.5 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.97 -0.752 . . . . 0.74 108.97 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.9 mtp -62.08 -43.97 97.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.54 -0.754 . . . . 0.23 111.502 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.11 -43.97 88.77 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.947 -0.861 . . . . 0.17 110.947 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.9 81.36 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.622 0.725 . . . . 0.18 112.356 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.65 -43.43 98.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.925 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -40.96 96.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 1.77 111.466 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.87 -38.06 89.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.11 0.957 . . . . 1.27 113.065 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 41.0 mt -65.44 -42.82 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.736 -1.575 . . . . 1.4 109.464 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.06 -41.92 92.78 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.735 -1.121 . . . . 0.16 110.83 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 14.8 mt -63.1 -44.06 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.102 -0.639 . . . . 1.66 110.113 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.3 92.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.383 -0.527 . . . . 0.18 109.678 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.32 82.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.573 -0.451 . . . . 0.15 110.526 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -40.05 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.976 0.417 . . . . 1.72 111.899 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.36 -43.26 98.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.079 1.141 . . . . 1.21 114.079 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 65.2 mt -65.59 -42.45 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.49 -1.3 . . . . 1.53 107.49 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -52.93 -52.39 58.04 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 118.036 -1.466 . . . . 0.25 107.468 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -63.97 -39.15 93.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.0 -1.0 . . . . 0.35 109.915 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 717' ' ' LEU . 18.9 tp -58.98 -45.41 90.66 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.357 -1.719 . . . . 1.77 106.357 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 56.5 mt -53.06 -55.56 22.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.219 -1.392 . . . . 0.69 108.942 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.318 -0.775 0 N-CA-C 115.704 1.742 . . . . 1.07 115.704 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.947 0.403 . . . . 1.0 110.803 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.25 -41.32 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.371 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -61.29 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.741 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.31 -42.47 99.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.414 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.9 -40.37 97.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 1.0 111.138 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 16.6 m -66.45 -41.32 89.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.046 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 696' ' ' VAL . 65.4 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.329 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -62.76 -41.67 99.33 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.58 -43.42 94.55 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.46 -1.056 . . . . 1.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.02 75.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 1.0 111.786 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.43 -43.38 96.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.071 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.46 -44.45 94.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.725 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.96 -41.55 97.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.007 0.432 . . . . 1.0 111.997 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.4 mt -62.55 -42.62 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.02 -42.05 92.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 709' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 709' ' ' LEU . 92.5 mt -63.5 -44.52 94.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.104 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.88 91.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.86 -46.78 86.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.022 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.1 -40.75 96.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.952 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 717' ' ' LEU . 32.0 mt -62.83 -43.46 98.74 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 46.5 pt -66.73 -36.34 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.636 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -56.59 -48.81 76.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.361 -0.935 . . . . 1.0 108.97 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.97 -38.26 85.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.044 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 713' ' ' LEU . 1.2 mm? -62.91 -38.78 92.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.42 -45.49 93.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 113.119 0.785 . . . . 1.0 113.119 -177.594 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.404 0.145 . . . . 1.0 111.229 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.82 -40.86 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.712 0.291 . . . . 1.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.0 -47.25 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.384 0.611 . . . . 1.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 98.3 mt -64.7 -41.25 96.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.83 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 45.1 mt -61.55 -40.58 95.22 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 17.7 m -68.02 -38.6 82.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.305 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.37 -46.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.7 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.84 -41.39 99.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.78 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.64 -46.0 79.79 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.91 -0.662 . . . . 1.0 111.794 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.98 -49.6 75.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.0 111.546 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.25 -43.19 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.617 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.89 -44.09 94.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.787 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.76 -41.69 97.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.269 0.557 . . . . 1.0 111.344 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.44 -43.33 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.177 -0.92 . . . . 1.0 109.769 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.78 96.58 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.134 -1.186 . . . . 1.0 110.134 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.49 -43.28 97.72 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.877 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.7 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -65.37 -45.2 85.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.199 -0.601 . . . . 1.0 110.987 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.39 -40.86 97.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.481 . . . . 1.0 111.253 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.85 -44.01 97.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.655 -0.702 . . . . 1.0 112.287 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.15 -43.35 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -54.31 -48.86 70.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 119.135 -1.026 . . . . 1.0 108.902 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -59.31 -40.5 86.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.845 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.27 -39.1 91.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -45.04 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.826 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 C--N 1.33 -0.261 0 N-CA-C 112.929 0.714 . . . . 1.0 112.929 -177.892 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.852 0.358 . . . . 1.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.16 -42.09 94.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.173 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.1 t -61.99 -47.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.772 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.57 -42.04 99.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.08 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.3 -40.96 98.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.3 m -68.83 -36.83 78.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.704 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 696' ' ' VAL . 63.5 t -64.72 -45.22 95.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.006 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 701' ' ' MET . . . . . 0.416 ' O ' HD23 ' A' ' 705' ' ' LEU . 93.9 mtp -63.63 -42.05 98.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.852 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.03 93.02 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.142 -1.028 . . . . 1.0 110.959 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.11 95.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.2 -43.67 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.0 110.28 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 701' ' ' MET . 3.9 mm? -63.94 -41.7 97.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.507 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.3 -42.61 99.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 1.0 111.726 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.95 -42.89 97.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.913 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.22 -40.9 92.46 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.47 -44.07 97.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.165 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.28 75.92 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.082 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.85 82.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -41.73 99.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.139 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.09 -42.41 99.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.036 0.754 . . . . 1.0 113.036 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.08 -42.61 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.7 t90 -54.94 -49.2 71.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.157 -1.017 . . . . 1.0 109.317 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.8 OUTLIER -60.92 -39.54 89.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.508 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 70.5 mt -61.07 -39.34 89.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.8 -53.13 60.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.117 -0.633 . . . . 1.0 111.208 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.434 HD11 ' HE1' ' A' ' 715' ' ' TRP . 84.8 mt . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.684 0.278 . . . . 1.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.35 -41.98 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.13 -47.32 93.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.245 0.545 . . . . 1.0 109.976 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 99.5 mt -63.66 -41.81 98.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.094 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.9 -38.24 87.63 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.311 0.577 . . . . 1.0 110.682 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 21.0 m -67.64 -40.39 84.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.73 -46.12 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.731 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -61.96 -41.6 98.17 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.541 . . . . 1.0 112.391 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.97 85.76 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.733 -0.746 . . . . 1.0 112.022 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.2 77.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 1.0 111.622 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -43.93 97.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.857 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.5 -41.34 96.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.037 0.384 . . . . 1.0 112.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.58 -41.5 98.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.309 0.576 . . . . 1.0 111.459 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.28 -42.51 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.954 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.4 -42.39 95.7 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.88 -43.64 98.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.85 85.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.33 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.52 84.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.772 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.7 -38.64 91.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.97 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.29 -42.71 99.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 4.2 mm -64.19 -43.22 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.271 0.558 . . . . 1.0 109.51 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -54.43 -50.33 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.346 -0.942 . . . . 1.0 109.295 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -61.47 -37.98 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.511 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.98 -41.42 96.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.81 -50.08 72.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.687 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -178.708 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.48 0.181 . . . . 1.0 111.226 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.75 -42.11 90.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 1.0 111.027 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.9 -48.27 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.704 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.51 -41.65 98.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.517 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 698' ' ' LEU . 29.3 mt -62.86 -40.0 96.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.3 m -68.86 -38.69 79.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.543 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.52 -44.75 98.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.693 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.4 mtp -62.87 -39.86 95.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.753 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.38 -44.81 72.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.589 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.54 81.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 30.8 pt -67.33 -40.85 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.194 -0.602 . . . . 1.0 110.443 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.66 -43.94 92.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.605 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.38 -41.22 96.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.479 -0.489 . . . . 1.0 111.654 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.98 -42.99 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.023 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.95 93.94 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.16 -44.53 95.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.54 91.37 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.67 96.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.89 -0.724 . . . . 1.0 109.882 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.95 -40.57 98.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.97 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.9 -42.12 99.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.66 -43.17 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -55.37 -49.79 71.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.156 -1.017 . . . . 1.0 108.539 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.75 -41.99 96.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.019 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 717' ' ' LEU . 41.6 tp -61.57 -42.06 98.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.932 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.98 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.998 -0.681 . . . . 1.0 111.895 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -178.123 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 111.479 0.177 . . . . 1.0 111.479 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.96 -43.39 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.691 0.281 . . . . 1.0 111.283 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.45 -48.07 88.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.343 -0.543 . . . . 1.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.03 -41.73 99.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.393 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.0 mt -62.02 -40.74 96.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.118 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.7 m -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 1.0 109.891 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.28 -46.87 94.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.995 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 91.9 mtp -63.2 -41.62 99.19 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.9 -44.35 92.01 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.9 -0.666 . . . . 1.0 111.708 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.25 95.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.15 -44.03 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.96 -42.69 97.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.376 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.37 -41.29 98.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 1.0 111.698 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.5 -43.25 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.538 -0.755 . . . . 1.0 109.997 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.59 -41.34 97.25 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.394 -0.821 . . . . 1.0 111.049 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.38 -43.27 98.08 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.48 87.57 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.16 -47.3 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.61 -39.72 94.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 1.0 112.006 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.16 -43.45 98.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.891 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.54 -43.6 98.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -54.95 -50.37 69.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 1.0 108.957 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -37.45 80.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.771 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.39 -41.12 98.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.77 -47.88 83.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.406 HD11 ' NE1' ' A' ' 715' ' ' TRP . 95.4 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.758 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp . . . . . 0 CA--C 1.529 0.149 0 N-CA-C 111.925 0.343 . . . . 1.0 111.925 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.21 -43.79 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -62.65 -48.56 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.3 -40.85 97.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.07 -40.27 97.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.3 m -65.66 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -63.81 -46.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.866 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.3 mtp -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.831 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.45 -43.98 91.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.576 -0.821 . . . . 1.0 111.064 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.05 87.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.998 0.427 . . . . 1.0 111.818 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.21 -44.44 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.558 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.734 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.62 -41.89 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 1.0 112.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.36 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.614 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.82 96.64 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.081 -1.208 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 709' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 713' ' ' LEU . 56.4 tp -63.81 -46.15 86.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.628 0.251 . . . . 1.0 110.436 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.1 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 1.0 110.038 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.3 99.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -39.82 95.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.575 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.5 mp -63.4 -44.18 95.41 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.68 -43.57 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.987 0.422 . . . . 1.0 110.02 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.426 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.5 t90 -54.06 -49.13 69.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.081 -1.047 . . . . 1.0 108.891 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -37.91 83.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.017 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 717' ' ' LEU . 37.7 mt -60.83 -41.66 96.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.09 -54.93 40.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.029 -0.669 . . . . 1.0 111.276 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.426 HD11 ' HE1' ' A' ' 715' ' ' TRP . 96.5 mt . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.626 0.251 . . . . 1.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.16 -41.39 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.219 0.452 . . . . 1.0 112.219 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 700' ' ' VAL . 94.5 t -61.19 -47.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 1.0 110.396 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.23 96.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.584 -0.734 . . . . 1.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 698' ' ' LEU . 37.7 mt -62.47 -41.33 98.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.12 0.486 . . . . 1.0 110.475 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 50.2 m -64.95 -41.97 95.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.955 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 696' ' ' VAL . 82.7 t -64.51 -45.38 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.44 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.3 mtp -61.66 -41.48 97.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.649 -0.421 . . . . 1.0 111.005 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.17 -46.51 64.6 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 69.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.069 0.461 . . . . 1.0 111.567 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.71 -43.46 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.94 -42.84 99.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.172 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.61 -41.58 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 1.0 112.084 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.16 -42.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.009 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.6 -40.68 98.22 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.19 -45.1 93.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.749 0.309 . . . . 1.0 110.428 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.28 85.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.09 97.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.84 -42.03 97.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.632 0.605 . . . . 1.0 112.632 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.16 -42.93 99.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.45 -42.56 96.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -55.54 -50.3 70.37 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.358 -0.937 . . . . 1.0 108.66 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -58.45 -38.01 76.62 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.99 -40.59 98.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.908 -0.717 . . . . 1.0 111.269 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 698' ' ' LEU . 94.8 mt . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.808 0.337 . . . . 1.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.81 -41.89 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.969 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 700' ' ' VAL . 86.1 t -60.66 -47.69 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.305 -0.558 . . . . 1.0 110.156 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.13 -42.2 96.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.539 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 694' ' ' LEU . 8.4 mp -63.14 -37.77 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.078 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.4 m -67.54 -40.0 85.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.071 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.0 t -63.61 -46.0 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.032 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.7 mtp -61.17 -42.64 98.93 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.82 -45.22 89.73 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.533 -0.841 . . . . 1.0 111.201 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.05 85.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.31 -44.04 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.134 0.492 . . . . 1.0 110.493 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.26 -42.16 96.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.703 -0.681 . . . . 1.0 111.152 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 1.0 111.739 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.85 -44.38 99.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.5 95.06 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.676 -0.97 . . . . 1.0 110.676 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.27 -44.54 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.042 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.65 88.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.195 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.95 97.54 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.355 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.1 -40.21 95.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.083 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 36.3 mt -63.79 -43.94 94.81 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.848 0.684 . . . . 1.0 112.848 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.0 pt -65.84 -38.13 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.388 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -56.4 -47.53 78.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 118.783 -1.167 . . . . 1.0 109.076 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -39.19 89.23 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.363 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 717' ' ' LEU . 89.6 mt -61.24 -40.1 92.77 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.91 -52.92 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.328 0.585 . . . . 1.0 110.891 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 1.0 112.548 -179.162 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.462 0.142 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.23 -41.63 93.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 1.0 110.882 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.56 -47.95 90.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.421 -0.512 . . . . 1.0 110.551 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 697' ' ' LEU . 91.9 mt -63.32 -40.69 98.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.538 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.51 -38.44 89.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 69.9 m -66.08 -40.38 90.79 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.612 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.47 -45.27 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 1.0 111.102 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.9 mtp -62.07 -42.24 98.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 1.0 112.308 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.91 -44.17 92.34 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.531 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.72 -44.63 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.257 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.27 -41.57 96.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.736 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.03 -42.47 97.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.147 0.499 . . . . 1.0 112.238 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.73 -43.07 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.004 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.81 94.28 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.236 -1.146 . . . . 1.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.29 -43.42 97.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.625 -0.43 . . . . 1.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.74 91.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.32 93.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.84 -40.52 97.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.578 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.77 -43.62 98.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.9 -42.81 97.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.564 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -53.39 -50.55 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.846 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -40.14 91.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.314 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.29 -42.92 96.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.99 -49.11 77.38 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.019 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.564 HD11 ' HE1' ' A' ' 715' ' ' TRP . 92.7 mt . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.0 -42.46 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.662 0.268 . . . . 1.0 111.329 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.92 -47.79 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.392 0.615 . . . . 1.0 109.885 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.55 -41.28 98.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.129 -0.942 . . . . 1.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.31 -39.55 93.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.574 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.6 m -64.53 -40.94 96.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.701 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.79 -45.52 98.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 86.6 mtp -61.63 -42.4 98.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.816 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.01 -45.52 87.04 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.627 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.32 -49.59 75.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.649 0.611 . . . . 1.0 112.649 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.58 -43.41 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.671 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.4 mt -64.44 -40.81 96.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.83 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.64 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 15.4 tt -67.31 -33.27 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.28 97.91 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.42 -1.472 . . . . 1.0 109.42 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.47 -46.09 87.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.268 -0.466 . . . . 1.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.33 88.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.7 89.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.578 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.5 -41.26 98.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.8 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.86 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.99 -42.37 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.531 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -55.07 -48.91 72.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.963 -1.095 . . . . 1.0 109.411 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -43.35 98.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.009 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.3 -39.32 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.16 -48.32 82.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.163 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.531 HD11 ' HE1' ' A' ' 715' ' ' TRP . 77.8 mt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.51 -37.67 80.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.689 -0.405 . . . . 1.0 111.317 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.28 -48.57 88.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.066 -0.654 . . . . 1.0 109.728 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 697' ' ' LEU . 4.3 mm? -63.52 -40.88 98.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.968 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.1 -38.7 92.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.358 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 53.0 m -65.95 -44.29 85.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.265 0.468 . . . . 1.0 112.265 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 700' ' ' VAL . 7.2 m -63.89 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 119.348 -0.941 . . . . 1.0 110.516 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.6 mtp -62.02 -42.29 99.0 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.738 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.18 -44.15 87.53 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.502 -0.856 . . . . 1.0 111.282 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 19.0 tt -65.25 -39.9 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.316 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.37 -43.27 95.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.009 -0.277 . . . . 1.0 111.66 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.64 -42.1 95.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.38 -37.07 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.2 -0.6 . . . . 1.0 109.792 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.62 97.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.54 -43.66 98.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 1.0 110.388 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.44 85.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.69 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.9 -39.37 94.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 111.318 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.39 -43.03 99.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.867 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.22 -43.83 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.501 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.3 t90 -55.37 -49.65 71.72 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.89 -38.85 87.11 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.091 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.4 -41.06 96.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.43 -45.01 96.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.381 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.501 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.0 mt . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 113.018 0.747 . . . . 1.0 113.018 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.4 mp . . . . . 0 C--O 1.226 -0.145 0 N-CA-C 111.642 0.238 . . . . 1.0 111.642 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.96 -42.87 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.715 0.293 . . . . 1.0 110.982 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 700' ' ' VAL . 79.5 t -60.71 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.073 -0.651 . . . . 1.0 109.771 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.68 -42.02 99.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.927 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.36 -39.12 93.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.287 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.32 -38.28 81.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.079 0.466 . . . . 1.0 110.566 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.1 t -64.02 -45.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.128 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.34 -40.57 96.81 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.528 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.87 62.2 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.461 -0.876 . . . . 1.0 111.443 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.79 79.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.586 0.587 . . . . 1.0 112.586 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.54 -41.92 91.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.48 -40.02 89.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.42 -43.43 98.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.73 -35.72 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.575 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.66 -41.78 97.56 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.654 -1.378 . . . . 1.0 109.654 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.41 -43.43 97.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.42 87.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.569 -0.453 . . . . 1.0 109.94 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.25 94.12 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.155 -0.618 . . . . 1.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.73 -41.1 98.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.226 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.84 -43.11 99.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.15 -42.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.03 -49.95 67.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 118.959 -1.097 . . . . 1.0 108.618 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.6 86.14 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.245 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.65 -42.86 93.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.92 -49.49 77.26 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.731 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 113.302 0.853 . . . . 1.0 113.302 -178.646 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.68 -42.01 90.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.917 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.7 t -60.61 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.166 -0.614 . . . . 1.0 110.236 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.68 -42.06 98.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.93 -41.04 97.49 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.665 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 37.3 m -68.29 -41.09 81.48 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 696' ' ' VAL . 80.4 t -62.61 -45.59 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.006 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.8 mtp -63.02 -42.11 99.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.875 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.97 -45.12 75.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.75 92.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.758 0.313 . . . . 1.0 111.316 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 86.0 mt -65.02 -44.6 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.246 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.93 -41.07 95.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.335 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -41.86 98.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.094 0.473 . . . . 1.0 112.073 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.83 -43.47 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.111 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -55.25 -42.79 83.47 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.281 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.33 -43.36 97.97 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.138 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.42 83.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.97 0.414 . . . . 1.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.79 -48.28 77.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.36 -39.24 93.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.098 0.407 . . . . 1.0 112.098 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.12 -42.67 99.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 1.0 111.99 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.37 -42.81 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.756 . . . . 1.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -54.23 -47.16 72.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.009 -1.076 . . . . 1.0 108.998 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -61.89 -41.45 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.742 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.81 -41.75 98.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.9 -49.93 75.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.912 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 1.0 112.479 -178.598 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.8 mp . . . . . 0 CA--C 1.522 -0.104 0 N-CA-C 111.631 0.234 . . . . 1.0 111.631 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -42.46 94.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.618 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.28 -47.86 91.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.576 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.81 -41.68 99.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.258 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.09 -38.09 89.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.5 m -66.87 -43.37 83.74 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.03 -41.61 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.466 -0.894 . . . . 1.0 110.359 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.2 mtp -62.58 -42.11 99.36 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 121.099 -0.24 . . . . 1.0 111.051 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.16 88.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.53 78.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 1.0 111.463 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.74 -43.57 98.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.134 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.18 -44.65 94.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.29 -41.54 98.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 1.0 112.059 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.44 -42.86 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.018 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.71 95.31 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.75 -43.39 96.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.764 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.56 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.286 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.52 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.116 -0.634 . . . . 1.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.33 -41.61 98.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.836 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.39 -43.63 98.37 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.936 0.717 . . . . 1.0 112.936 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.4 -42.99 98.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.457 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.2 t90 -55.46 -48.4 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.128 -1.029 . . . . 1.0 108.313 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.88 -41.03 95.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.978 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.6 -42.02 91.64 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.37 -47.74 82.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.769 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.457 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.6 mt . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 698' ' ' LEU . 81.9 mt . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.914 0.387 . . . . 1.0 111.287 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 63.2 t -58.45 -42.46 84.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.4 t -60.95 -47.55 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 121.114 0.483 . . . . 1.0 109.808 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.22 -41.82 99.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.252 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.0 mp -62.35 -38.86 91.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 1.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.82 -39.16 80.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.141 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.9 t -62.65 -44.92 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.067 0.46 . . . . 1.0 109.93 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.6 mtp -62.36 -41.91 98.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.129 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 702' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 706' ' ' LEU . . . -67.61 -45.58 75.69 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.73 -0.748 . . . . 1.0 111.69 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.08 73.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.33 0.492 . . . . 1.0 112.33 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.07 -43.42 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.728 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.7 mt -64.39 -43.18 95.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.172 0.434 . . . . 1.0 112.172 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 706' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 702' ' ' GLY . 8.0 mp -63.81 -42.84 97.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.326 -0.55 . . . . 1.0 111.9 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.66 -43.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.426 -0.806 . . . . 1.0 110.637 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.62 94.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 709' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 713' ' ' LEU . 57.0 tp -61.35 -43.81 98.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.13 89.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.775 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.726 -0.789 . . . . 1.0 110.475 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.65 -40.83 96.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 713' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.2 mp -64.15 -43.32 95.55 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.386 0.884 . . . . 1.0 113.386 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 714' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 717' ' ' LEU . 28.9 pt -65.8 -39.37 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.327 -0.549 . . . . 1.0 109.676 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -54.37 -50.4 67.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.353 -0.939 . . . . 1.0 108.817 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -40.02 89.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.558 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 714' ' ' ILE . 75.5 mt -60.17 -42.12 94.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.461 -0.496 . . . . 1.0 109.916 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.38 -50.12 74.18 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.763 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 694' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.754 0.312 . . . . 1.0 111.422 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.53 -40.98 90.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.105 0.478 . . . . 1.0 110.806 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.2 t -61.3 -46.9 95.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.76 -41.88 99.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.119 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.93 -39.17 93.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.07 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.9 m -66.61 -38.28 86.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 696' ' ' VAL . 67.1 t -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.533 -0.758 . . . . 1.0 109.915 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -61.75 -41.67 97.98 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.62 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.34 -45.52 60.5 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.629 -0.796 . . . . 1.0 111.743 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.31 77.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 704' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 705' ' ' LEU . 20.3 tt -65.94 -41.01 89.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.464 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.425 ' N ' HG23 ' A' ' 704' ' ' ILE . 89.9 mt -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.757 -0.377 . . . . 1.0 111.459 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 36.7 mt -62.18 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 12.3 tt -66.5 -34.37 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.189 -0.605 . . . . 1.0 109.881 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.22 -43.02 95.64 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.35 -42.71 98.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.94 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.4 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.9 -47.77 79.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.12 -38.48 91.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.755 0.312 . . . . 1.0 111.632 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.37 -44.45 96.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.534 . . . . 1.0 112.421 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.32 -42.76 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.587 . . . . 1.0 109.625 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -55.78 -50.07 71.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.293 -0.963 . . . . 1.0 109.185 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -38.09 85.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.327 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.11 -42.11 94.01 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.28 -50.75 71.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.049 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -178.367 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.857 0.361 . . . . 1.0 110.708 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.44 -41.89 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.362 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 700' ' ' VAL . 72.2 t -61.3 -46.74 96.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.63 -42.42 99.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.264 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.67 -40.08 95.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.959 0.409 . . . . 1.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.9 m -66.92 -39.94 87.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.142 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 696' ' ' VAL . 70.9 t -63.54 -46.03 96.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.76 -41.27 97.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.675 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.37 -45.01 71.49 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.352 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.11 85.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.744 0.276 . . . . 1.0 111.744 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 704' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 704' ' ' ILE . 32.0 mm -64.12 -43.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.277 0.561 . . . . 1.0 109.852 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 5.5 tt -64.26 -41.76 96.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 111.791 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.62 -44.13 97.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.998 0.74 . . . . 1.0 112.998 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 36.7 pt -66.0 -39.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.494 -0.483 . . . . 1.0 110.506 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.82 97.26 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.147 -1.181 . . . . 1.0 110.147 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.38 -44.62 96.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.41 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.68 89.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.231 -0.587 . . . . 1.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.32 -42.12 98.96 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 111.687 0.255 . . . . 1.0 111.687 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.02 -43.2 99.38 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.42 -43.08 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.9 t90 -53.91 -49.17 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.204 -0.998 . . . . 1.0 108.685 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.26 -36.47 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.298 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.84 -42.85 98.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.28 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.43 -51.03 70.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.587 -0.845 . . . . 1.0 111.499 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 715' ' ' TRP . 97.7 mt . . . . . 0 C--N 1.326 -0.416 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.232 0.14 0 N-CA-C 111.854 0.316 . . . . 1.0 111.854 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.97 -40.89 87.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.064 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.76 -48.46 88.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 1.0 110.357 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.67 -41.63 99.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.18 -39.66 93.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 1.0 110.56 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 26.7 m -66.72 -42.01 87.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.735 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.05 -46.11 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.902 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -62.11 -41.57 98.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.569 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.19 -44.78 85.65 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.148 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.35 92.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.709 -0.396 . . . . 1.0 111.702 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.7 mm -64.2 -43.79 97.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.23 -43.36 98.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.686 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.95 -40.68 95.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.272 -0.571 . . . . 1.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.16 -42.98 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.421 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.14 96.55 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.144 -0.935 . . . . 1.0 110.992 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.58 -42.9 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.933 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.4 94.57 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.563 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.67 86.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.609 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.67 -39.0 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.219 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.3 -44.23 95.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.21 -35.71 74.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -56.55 -49.11 75.78 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.224 -0.99 . . . . 1.0 109.291 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 716' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.23 -38.23 82.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.669 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.06 -41.32 98.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.365 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.76 -50.11 74.78 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 119.893 -0.723 . . . . 1.0 110.962 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.427 -0.806 . . . . 1.0 112.086 -178.984 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.783 0.325 . . . . 1.0 111.221 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.49 -44.97 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.7 t -61.96 -47.01 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.804 -0.758 . . . . 1.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.43 -42.11 96.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.06 -39.51 92.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.054 0.454 . . . . 1.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 72.2 m -65.57 -39.78 92.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.802 179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 696' ' ' VAL . 57.8 t -63.57 -47.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.227 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.74 -42.18 99.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.87 88.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.729 -0.748 . . . . 1.0 111.356 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.96 83.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.057 0.456 . . . . 1.0 112.154 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.14 -43.1 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.161 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.24 -45.67 90.47 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.44 -41.76 96.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.954 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.95 -43.49 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.462 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.24 -39.83 96.53 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.233 -1.147 . . . . 1.0 110.233 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.87 -42.46 99.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.27 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.446 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.7 88.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.822 -0.626 . . . . 1.0 112.217 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.73 -41.24 98.08 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.63 -43.68 98.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.621 -0.432 . . . . 1.0 112.029 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.84 -43.88 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -54.16 -49.17 69.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.281 -0.968 . . . . 1.0 108.954 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.326 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.7 -42.88 98.08 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.38 -48.05 83.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.111 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 112.854 0.687 . . . . 1.0 112.854 -178.272 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 109.003 -1.191 . . . . 14.24 109.003 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 686' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 686' ' ' GLU . 3.4 pm0 -73.9 -30.25 62.5 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.981 -1.859 . . . . 13.24 105.981 176.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.551 ' C ' ' H ' ' A' ' 689' ' ' LYS . 0.4 OUTLIER -146.23 73.44 13.16 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 112.778 -2.01 . . . . 10.61 108.114 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -75.2 20.12 0.49 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 N-CA-C 108.077 -1.547 . . . . 9.39 108.077 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 691' ' ' PRO . 19.3 mttp -52.26 -43.6 64.47 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 104.141 -2.54 . . . . 10.33 104.141 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 689' ' ' LYS . . . 32.12 -89.85 0.01 OUTLIER Glycine 0 C--N 1.363 2.042 0 N-CA-C 105.752 -2.939 . . . . 5.47 105.752 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.62 ' N ' ' O ' ' A' ' 689' ' ' LYS . 0.5 OUTLIER -108.28 121.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 107.307 -1.843 . . . . 5.19 107.307 171.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 695' ' ' VAL . 16.6 m-20 -52.3 134.17 33.97 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.655 -3.091 . . . . 2.37 102.655 177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.85 -23.97 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 121.448 1.931 . . . . 1.59 107.52 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 692' ' ' ASP . 16.0 mt -64.74 -43.23 94.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 112.809 -1.996 . . . . 1.57 110.143 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 692' ' ' ASP . 48.8 t -64.27 -44.59 97.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 113.004 0.742 . . . . 0.62 113.004 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.809 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.5 t -61.24 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 118.617 -1.233 . . . . 0.24 108.012 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.77 -42.41 99.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.813 -1.539 . . . . 1.17 110.806 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.08 -37.84 86.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.92 110.647 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.1 m -70.2 -41.2 74.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.834 -0.621 . . . . 0.22 109.931 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 696' ' ' VAL . 98.2 t -61.02 -46.5 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.97 -0.752 . . . . 0.74 108.97 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.9 mtp -62.08 -43.97 97.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.54 -0.754 . . . . 0.23 111.502 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.11 -43.97 88.77 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.947 -0.861 . . . . 0.17 110.947 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.9 81.36 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.622 0.725 . . . . 0.18 112.356 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.65 -43.43 98.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.925 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -40.96 96.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 1.77 111.466 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.87 -38.06 89.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.11 0.957 . . . . 1.27 113.065 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 41.0 mt -65.44 -42.82 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.736 -1.575 . . . . 1.4 109.464 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.06 -41.92 92.78 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.735 -1.121 . . . . 0.16 110.83 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 14.8 mt -63.1 -44.06 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.102 -0.639 . . . . 1.66 110.113 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.3 92.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.383 -0.527 . . . . 0.18 109.678 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.32 82.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.573 -0.451 . . . . 0.15 110.526 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -40.05 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.976 0.417 . . . . 1.72 111.899 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.36 -43.26 98.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.079 1.141 . . . . 1.21 114.079 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 65.2 mt -65.59 -42.45 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.49 -1.3 . . . . 1.53 107.49 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -52.93 -52.39 58.04 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 118.036 -1.466 . . . . 0.25 107.468 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -63.97 -39.15 93.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.0 -1.0 . . . . 0.35 109.915 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 717' ' ' LEU . 18.9 tp -58.98 -45.41 90.66 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.357 -1.719 . . . . 1.77 106.357 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 723' ' ' ASP . 56.5 mt -53.06 -55.56 22.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.219 -1.392 . . . . 0.69 108.942 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.504 ' HA ' ' H ' ' A' ' 723' ' ' ASP . 66.5 mt -70.88 -42.45 77.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 115.704 1.742 . . . . 1.07 115.704 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.455 ' C ' ' N ' ' A' ' 722' ' ' HIS . 96.3 m -66.83 -43.63 83.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 120.251 1.387 . . . . 0.63 111.972 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 722' ' ' HIS . 4.1 tt -61.8 -17.46 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.116 1.912 . . . . 1.69 107.582 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.486 ' CB ' ' O ' ' A' ' 721' ' ' ILE . 45.2 t60 104.25 91.19 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 108.679 -3.873 . . . . 4.13 108.403 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.504 ' H ' ' HA ' ' A' ' 719' ' ' ILE . 22.8 t0 -27.64 -81.87 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 124.324 1.015 . . . . 5.96 109.789 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 726' ' ' GLU . 6.8 ttt85 174.51 -176.91 0.09 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.761 0.791 . . . . 8.84 109.467 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 727' ' ' PHE . 12.9 mttt -86.57 26.19 1.13 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.227 -2.138 . . . . 10.03 105.227 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 724' ' ' ARG . 14.8 pt-20 -38.88 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 CA-C-N 113.881 -1.509 . . . . 10.62 109.326 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 725' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.65 0 CA-C-N 114.692 -1.14 . . . . 12.3 109.243 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.479 0.637 0 N-CA-C 109.631 -0.95 . . . . 1.0 109.631 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.75 133.26 55.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.248 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 58.0 m 46.43 60.92 13.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.09 146.91 59.54 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.533 2.155 . . . . 1.0 112.565 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.85 145.77 26.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.804 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 64.31 -166.83 28.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -62.99 145.15 94.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.735 2.29 . . . . 1.0 111.811 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.55 141.3 42.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 1.0 110.115 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 40.3 pt -49.76 -27.57 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.084 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.62 -42.11 99.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.25 -41.32 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.371 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -61.29 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.741 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.31 -42.47 99.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.414 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.9 -40.37 97.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 1.0 111.138 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 16.6 m -66.45 -41.32 89.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.046 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 696' ' ' VAL . 65.4 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.329 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -62.76 -41.67 99.33 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.58 -43.42 94.55 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.46 -1.056 . . . . 1.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.02 75.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 1.0 111.786 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.43 -43.38 96.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.071 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.46 -44.45 94.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.725 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.96 -41.55 97.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.007 0.432 . . . . 1.0 111.997 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.4 mt -62.55 -42.62 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.02 -42.05 92.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 709' ' ' LEU . 92.5 mt -63.5 -44.52 94.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.104 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.88 91.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.86 -46.78 86.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.022 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.1 -40.75 96.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.952 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 717' ' ' LEU . 32.0 mt -62.83 -43.46 98.74 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 46.5 pt -66.73 -36.34 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.636 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -56.59 -48.81 76.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.361 -0.935 . . . . 1.0 108.97 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.97 -38.26 85.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.044 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 713' ' ' LEU . 1.2 mm? -62.91 -38.78 92.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.42 -45.49 93.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 722' ' ' HIS . 21.2 tt -87.25 -35.05 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.119 0.785 . . . . 1.0 113.119 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 77.0 m -64.13 -44.8 91.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.128 -0.629 . . . . 1.0 110.85 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.58 -45.41 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.747 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 719' ' ' ILE . 40.1 m-70 -132.09 147.06 52.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.217 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -75.38 115.31 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.818 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.74 133.29 48.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.51 145.65 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.847 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 40.58 -117.59 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.796 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.523 -179.839 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo . . . . . 0 N--CA 1.484 0.952 0 N-CA-C 110.056 -0.786 . . . . 1.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -139.27 142.61 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.627 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 3.1 m 45.01 74.0 0.88 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.505 -0.77 . . . . 1.0 111.15 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.65 143.31 98.68 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.658 2.239 . . . . 1.0 112.794 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.15 -38.75 92.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 78.24 57.22 3.47 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.39 155.2 41.12 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 123.029 2.486 . . . . 1.0 112.766 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.94 149.64 48.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.891 0.853 . . . . 1.0 111.174 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 92.1 mt -65.66 -40.7 88.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.333 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.79 -41.16 97.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.229 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.82 -40.86 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.712 0.291 . . . . 1.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.0 -47.25 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.384 0.611 . . . . 1.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 98.3 mt -64.7 -41.25 96.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.83 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 45.1 mt -61.55 -40.58 95.22 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 17.7 m -68.02 -38.6 82.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.305 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.37 -46.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.7 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.84 -41.39 99.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.78 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.64 -46.0 79.79 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.91 -0.662 . . . . 1.0 111.794 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.98 -49.6 75.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.0 111.546 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.25 -43.19 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.617 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.89 -44.09 94.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.787 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.76 -41.69 97.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.269 0.557 . . . . 1.0 111.344 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.44 -43.33 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.177 -0.92 . . . . 1.0 109.769 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.78 96.58 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.134 -1.186 . . . . 1.0 110.134 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.49 -43.28 97.72 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.877 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.7 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -65.37 -45.2 85.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.199 -0.601 . . . . 1.0 110.987 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.39 -40.86 97.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.481 . . . . 1.0 111.253 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.85 -44.01 97.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.655 -0.702 . . . . 1.0 112.287 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.15 -43.35 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -54.31 -48.86 70.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 119.135 -1.026 . . . . 1.0 108.902 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -59.31 -40.5 86.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.845 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.27 -39.1 91.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -45.04 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.826 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 73.1 mt -87.19 -35.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.929 0.714 . . . . 1.0 112.929 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 99.3 m -62.66 -45.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.61 -45.06 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.204 0.526 . . . . 1.0 110.197 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -43.13 149.32 0.22 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.384 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 725' ' ' LYS . 46.9 m-20 -65.09 -36.91 85.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.619 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 62.42 -44.17 0.18 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.404 0.44 . . . . 1.0 111.217 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 723' ' ' ASP . 99.2 mttt -61.72 -41.76 98.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.944 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -78.43 147.17 34.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 1.0 110.539 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 51.4 p90 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.935 -1.031 . . . . 1.0 110.777 179.698 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.481 0.758 0 N-CA-C 108.922 -1.222 . . . . 1.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.56 128.21 34.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.36 176.2 0.07 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.474 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.58 145.32 98.38 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.018 1.812 . . . . 1.0 112.029 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.82 -41.68 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.969 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 133.95 -164.09 24.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -62.37 141.99 89.26 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.85 2.367 . . . . 1.0 111.54 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.426 0.631 . . . . 1.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 27.6 pt -51.32 -30.88 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.64 -42.63 99.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.669 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.16 -42.09 94.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.173 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.1 t -61.99 -47.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.772 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.57 -42.04 99.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.08 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.3 -40.96 98.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.3 m -68.83 -36.83 78.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.704 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 696' ' ' VAL . 63.5 t -64.72 -45.22 95.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.006 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' MET . . . . . 0.416 ' O ' HD23 ' A' ' 705' ' ' LEU . 93.9 mtp -63.63 -42.05 98.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.852 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.03 93.02 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.142 -1.028 . . . . 1.0 110.959 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.11 95.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.2 -43.67 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.0 110.28 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 701' ' ' MET . 3.9 mm? -63.94 -41.7 97.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.507 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.3 -42.61 99.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 1.0 111.726 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.95 -42.89 97.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.913 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.22 -40.9 92.46 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.47 -44.07 97.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.165 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.28 75.92 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.082 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.85 82.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -41.73 99.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.139 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.09 -42.41 99.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.036 0.754 . . . . 1.0 113.036 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.08 -42.61 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.7 t90 -54.94 -49.2 71.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.157 -1.017 . . . . 1.0 109.317 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.8 OUTLIER -60.92 -39.54 89.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.508 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.65 ' O ' HG22 ' A' ' 721' ' ' ILE . 70.5 mt -61.07 -39.34 89.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.8 -53.13 60.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.117 -0.633 . . . . 1.0 111.208 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.434 HD11 ' HE1' ' A' ' 715' ' ' TRP . 84.8 mt -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 96.4 m -65.51 -46.12 80.91 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.885 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 717' ' ' LEU . 19.8 tt -66.57 -43.93 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.311 -0.556 . . . . 1.0 110.118 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 721' ' ' ILE . 28.5 m80 -136.77 155.11 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -85.46 107.87 17.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 1.0 110.662 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -138.21 148.16 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.75 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 142.58 51.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.411 ' O ' ' OXT' ' A' ' 727' ' ' PHE . 79.4 tt0 -67.8 -37.71 82.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.974 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.411 ' OXT' ' O ' ' A' ' 726' ' ' GLU . 79.5 t80 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.974 -1.012 . . . . 1.0 111.126 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo . . . . . 0 N--CA 1.486 1.078 0 N-CA-C 110.164 -0.745 . . . . 1.0 110.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -61.65 146.18 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.055 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.23 173.16 5.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.298 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.21 -38.61 88.1 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.269 1.979 . . . . 1.0 111.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 690' ' ' GLY . 98.6 mttt -62.69 -42.24 99.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.022 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 689' ' ' LYS . . . 45.21 -172.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -59.11 141.98 98.77 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.467 2.111 . . . . 1.0 112.026 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -65.35 139.48 58.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.39 0.614 . . . . 1.0 110.085 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 694' ' ' LEU . 21.1 tt -71.7 -35.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.418 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.43 ' N ' HG23 ' A' ' 693' ' ' ILE . 97.6 mt -63.37 -40.26 96.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.824 -1.08 . . . . 1.0 110.884 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.35 -41.98 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.13 -47.32 93.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.245 0.545 . . . . 1.0 109.976 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 99.5 mt -63.66 -41.81 98.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.094 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.9 -38.24 87.63 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.311 0.577 . . . . 1.0 110.682 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 21.0 m -67.64 -40.39 84.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.73 -46.12 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.731 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -61.96 -41.6 98.17 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.541 . . . . 1.0 112.391 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.97 85.76 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.733 -0.746 . . . . 1.0 112.022 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.2 77.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 1.0 111.622 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -43.93 97.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.857 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.5 -41.34 96.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.037 0.384 . . . . 1.0 112.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.58 -41.5 98.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.309 0.576 . . . . 1.0 111.459 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.28 -42.51 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.954 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.4 -42.39 95.7 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.88 -43.64 98.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.85 85.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.33 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.52 84.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.772 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.7 -38.64 91.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.97 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.29 -42.71 99.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 4.2 mm -64.19 -43.22 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.271 0.558 . . . . 1.0 109.51 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -54.43 -50.33 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.346 -0.942 . . . . 1.0 109.295 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -61.47 -37.98 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.511 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 721' ' ' ILE . 59.0 tp -60.98 -41.42 96.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.81 -50.08 72.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.687 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.73 -42.83 83.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 76.9 m -61.68 -43.93 97.91 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.437 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 717' ' ' LEU . 17.9 tt -89.49 1.53 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.212 0.529 . . . . 1.0 109.666 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 721' ' ' ILE . 94.9 m-70 46.56 101.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.298 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -91.95 -0.65 57.49 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.362 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -137.02 144.75 43.42 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.823 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -112.69 126.76 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.829 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.13 -39.53 86.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.543 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.902 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 109.247 -1.097 . . . . 1.0 109.247 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.51 137.48 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.66 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.9 m -164.48 73.2 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.72 147.68 94.76 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.901 2.401 . . . . 1.0 111.315 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -59.37 -45.73 90.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.721 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -176.86 -171.01 40.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.138 -0.785 . . . . 1.0 111.138 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -59.27 145.17 98.67 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.458 2.105 . . . . 1.0 111.042 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -134.93 -34.99 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.691 0.758 . . . . 1.0 110.108 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.53 -41.32 88.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.351 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.06 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.226 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.75 -42.11 90.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 1.0 111.027 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.9 -48.27 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.704 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.51 -41.65 98.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.517 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 698' ' ' LEU . 29.3 mt -62.86 -40.0 96.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.3 m -68.86 -38.69 79.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.543 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.52 -44.75 98.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.693 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.4 mtp -62.87 -39.86 95.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.753 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.38 -44.81 72.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.589 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.54 81.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 30.8 pt -67.33 -40.85 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.194 -0.602 . . . . 1.0 110.443 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.66 -43.94 92.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.605 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.38 -41.22 96.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.479 -0.489 . . . . 1.0 111.654 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.98 -42.99 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.023 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.95 93.94 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.16 -44.53 95.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.54 91.37 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.67 96.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.89 -0.724 . . . . 1.0 109.882 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.95 -40.57 98.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.97 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.9 -42.12 99.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.66 -43.17 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -55.37 -49.79 71.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.156 -1.017 . . . . 1.0 108.539 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.75 -41.99 96.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.019 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 717' ' ' LEU . 41.6 tp -61.57 -42.06 98.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.932 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.481 ' O ' ' CE1' ' A' ' 722' ' ' HIS . 83.9 mt -60.98 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.998 -0.681 . . . . 1.0 111.895 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 35.6 mm -72.02 -41.41 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.5 m -62.09 -43.13 99.51 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.201 -0.312 . . . . 1.0 111.373 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.59 -47.42 93.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.672 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.481 ' CE1' ' O ' ' A' ' 718' ' ' LEU . 52.0 p-80 -140.22 139.32 35.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -98.52 113.1 24.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -62.3 -43.4 98.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.244 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.73 149.35 38.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.174 0.511 . . . . 1.0 110.781 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.52 -40.67 85.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.549 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.754 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.479 0.652 0 N-CA-C 109.375 -1.048 . . . . 1.0 109.375 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -107.97 135.78 48.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.55 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.4 OUTLIER -95.47 -178.34 0.77 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.917 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 12.5 Cg_exo -66.82 149.49 83.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.306 2.004 . . . . 1.0 111.543 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.01 -43.98 94.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.043 0.449 . . . . 1.0 110.24 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 66.4 177.27 7.88 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.22 146.8 58.42 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.531 2.154 . . . . 1.0 111.669 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -68.27 136.75 53.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.647 . . . . 1.0 110.751 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.32 -41.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.886 -1.052 . . . . 1.0 110.684 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.57 -40.58 97.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.96 -43.39 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.691 0.281 . . . . 1.0 111.283 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.45 -48.07 88.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.343 -0.543 . . . . 1.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.03 -41.73 99.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.393 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.0 mt -62.02 -40.74 96.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.118 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.7 m -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 1.0 109.891 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.28 -46.87 94.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.995 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 91.9 mtp -63.2 -41.62 99.19 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.9 -44.35 92.01 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.9 -0.666 . . . . 1.0 111.708 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.25 95.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.15 -44.03 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.96 -42.69 97.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.376 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.37 -41.29 98.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 1.0 111.698 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.5 -43.25 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.538 -0.755 . . . . 1.0 109.997 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.59 -41.34 97.25 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.394 -0.821 . . . . 1.0 111.049 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.38 -43.27 98.08 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.48 87.57 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.16 -47.3 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.61 -39.72 94.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 1.0 112.006 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.16 -43.45 98.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.891 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.54 -43.6 98.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -54.95 -50.37 69.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 1.0 108.957 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -37.45 80.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.771 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 721' ' ' ILE . 56.6 tp -63.39 -41.12 98.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.844 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.77 -47.88 83.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.406 HD11 ' NE1' ' A' ' 715' ' ' TRP . 95.4 mt -68.82 -42.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.758 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.8 m -61.77 -44.17 97.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.068 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 717' ' ' LEU . 20.2 tt -87.42 -0.73 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.276 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 721' ' ' ILE . 67.2 m80 56.4 134.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.679 -0.692 . . . . 1.0 111.632 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 726' ' ' GLU . 95.5 m-20 -68.2 145.3 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.706 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.64 -39.8 94.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.706 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.53 -44.59 96.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.423 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 723' ' ' ASP . 83.6 tt0 -97.34 123.01 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.907 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.84 -179.61 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo . . . . . 0 N--CA 1.484 0.93 0 N-CA-C 109.908 -0.843 . . . . 1.0 109.908 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -67.33 -39.11 85.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.949 -0.301 . . . . 1.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 77.9 p -146.68 76.8 11.61 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.251 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.99 144.61 93.34 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.999 2.466 . . . . 1.0 111.681 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.77 145.29 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.162 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -155.45 169.75 33.37 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.664 -0.779 . . . . 1.0 111.437 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 693' ' ' ILE . 10.9 Cg_endo -57.9 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.69 2.26 . . . . 1.0 111.63 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 62.44 -46.34 0.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.724 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 691' ' ' PRO . 96.7 mt -69.87 -40.39 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.341 0.591 . . . . 1.0 111.016 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp -62.65 -37.25 85.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.925 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.21 -43.79 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -62.65 -48.56 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.3 -40.85 97.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.07 -40.27 97.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.3 m -65.66 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -63.81 -46.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.866 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.3 mtp -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.831 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.45 -43.98 91.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.576 -0.821 . . . . 1.0 111.064 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.05 87.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.998 0.427 . . . . 1.0 111.818 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.21 -44.44 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.558 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.734 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.62 -41.89 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 1.0 112.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.36 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.614 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.82 96.64 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.081 -1.208 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 709' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 713' ' ' LEU . 56.4 tp -63.81 -46.15 86.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.628 0.251 . . . . 1.0 110.436 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.1 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 1.0 110.038 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.3 99.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -39.82 95.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.575 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.5 mp -63.4 -44.18 95.41 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.68 -43.57 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.987 0.422 . . . . 1.0 110.02 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.426 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.5 t90 -54.06 -49.13 69.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.081 -1.047 . . . . 1.0 108.891 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -37.91 83.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.017 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 717' ' ' LEU . 37.7 mt -60.83 -41.66 96.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.09 -54.93 40.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.029 -0.669 . . . . 1.0 111.276 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.426 HD11 ' HE1' ' A' ' 715' ' ' TRP . 96.5 mt -69.03 -42.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.5 m -64.05 -45.49 88.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.24 -45.99 94.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.865 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -140.58 162.07 36.25 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 56.53 42.63 27.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.37 -43.15 99.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.421 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -86.91 136.74 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.222 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -94.12 140.41 29.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.114 -0.946 . . . . 1.0 110.66 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 109.712 -0.919 . . . . 1.0 109.712 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.74 -43.87 90.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 1.0 110.411 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.7 t -163.48 73.89 1.86 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.072 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.06 -30.31 78.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.844 2.362 . . . . 1.0 112.425 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -60.15 -42.16 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.54 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -166.2 78.71 0.12 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 120.423 -0.894 . . . . 1.0 111.743 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 693' ' ' ILE . 39.2 Cg_exo -58.35 143.6 97.29 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.481 2.121 . . . . 1.0 112.626 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 62.54 -39.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 691' ' ' PRO . 35.7 pt -75.14 -35.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.998 0.428 . . . . 1.0 110.255 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.91 -39.05 90.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.007 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.16 -41.39 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.219 0.452 . . . . 1.0 112.219 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 700' ' ' VAL . 94.5 t -61.19 -47.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 1.0 110.396 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.23 96.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.584 -0.734 . . . . 1.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 698' ' ' LEU . 37.7 mt -62.47 -41.33 98.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.12 0.486 . . . . 1.0 110.475 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 50.2 m -64.95 -41.97 95.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.955 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 696' ' ' VAL . 82.7 t -64.51 -45.38 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.44 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.3 mtp -61.66 -41.48 97.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.649 -0.421 . . . . 1.0 111.005 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.17 -46.51 64.6 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 69.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.069 0.461 . . . . 1.0 111.567 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.71 -43.46 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.94 -42.84 99.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.172 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.61 -41.58 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 1.0 112.084 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.16 -42.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.009 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.6 -40.68 98.22 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.19 -45.1 93.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.749 0.309 . . . . 1.0 110.428 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.28 85.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.09 97.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.84 -42.03 97.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.632 0.605 . . . . 1.0 112.632 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.16 -42.93 99.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.45 -42.56 96.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -55.54 -50.3 70.37 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.358 -0.937 . . . . 1.0 108.66 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -58.45 -38.01 76.62 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 721' ' ' ILE . 51.9 tp -62.99 -40.59 98.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.171 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.908 -0.717 . . . . 1.0 111.269 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.47 -41.23 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 95.1 m -63.12 -44.51 95.4 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.963 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 722' ' ' HIS . 20.6 tt -66.44 -44.58 90.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.614 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 721' ' ' ILE . 48.5 t-80 -137.69 134.48 35.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.887 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -88.35 112.43 22.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.1 0.476 . . . . 1.0 110.599 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.9 143.48 39.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.684 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.91 -40.07 94.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.16 -38.92 89.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.452 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.06 -0.971 . . . . 1.0 110.649 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.487 1.146 0 N-CA-C 110.419 -0.646 . . . . 1.0 110.419 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.49 135.32 53.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.645 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 89.2 p -167.88 56.23 0.33 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.936 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.84 151.17 68.51 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.924 2.416 . . . . 1.0 112.148 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -94.79 -8.23 38.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.458 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -48.86 -53.31 18.38 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.686 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 23.5 Cg_exo -60.0 145.58 98.04 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.457 2.105 . . . . 1.0 112.653 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -65.92 133.66 51.36 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.225 0.536 . . . . 1.0 111.202 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 19.1 tt -73.87 -37.01 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.625 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 698' ' ' LEU . 94.8 mt -63.83 -40.27 96.2 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.066 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.81 -41.89 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.969 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 700' ' ' VAL . 86.1 t -60.66 -47.69 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.305 -0.558 . . . . 1.0 110.156 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.13 -42.2 96.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.539 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 694' ' ' LEU . 8.4 mp -63.14 -37.77 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.078 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.4 m -67.54 -40.0 85.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.071 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.0 t -63.61 -46.0 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.032 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.7 mtp -61.17 -42.64 98.93 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.82 -45.22 89.73 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.533 -0.841 . . . . 1.0 111.201 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.05 85.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.31 -44.04 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.134 0.492 . . . . 1.0 110.493 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.26 -42.16 96.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.703 -0.681 . . . . 1.0 111.152 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 1.0 111.739 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.85 -44.38 99.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.5 95.06 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.676 -0.97 . . . . 1.0 110.676 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.27 -44.54 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.042 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.65 88.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.195 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.95 97.54 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.355 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.1 -40.21 95.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.083 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 36.3 mt -63.79 -43.94 94.81 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.848 0.684 . . . . 1.0 112.848 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.0 pt -65.84 -38.13 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.388 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -56.4 -47.53 78.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 118.783 -1.167 . . . . 1.0 109.076 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -39.19 89.23 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.363 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 717' ' ' LEU . 89.6 mt -61.24 -40.1 92.77 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.91 -52.92 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.328 0.585 . . . . 1.0 110.891 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.47 -42.27 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 1.0 112.548 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.1 m -63.08 -45.05 93.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.64 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 721' ' ' ILE . 90.0 mt -87.19 -1.97 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.395 0.617 . . . . 1.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 52.36 171.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.099 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.2 143.68 57.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -70.59 135.48 48.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.168 0.508 . . . . 1.0 111.056 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 59.24 61.22 2.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.204 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.84 -42.27 99.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.729 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.847 -1.073 . . . . 1.0 110.093 179.369 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.484 0.913 0 N-CA-C 109.553 -0.98 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.16 -45.48 76.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.728 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.5 m -175.15 83.39 0.31 Allowed Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.542 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.39 146.61 95.66 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.208 1.939 . . . . 1.0 111.362 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.86 135.8 57.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 1.0 111.167 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 164.11 69.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.797 -0.921 . . . . 1.0 110.797 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -52.21 -42.92 56.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.541 2.16 . . . . 1.0 111.49 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -90.38 103.7 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.264 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.0 -31.85 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.027 -0.988 . . . . 1.0 110.405 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.41 -41.69 96.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.745 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.23 -41.63 93.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 1.0 110.882 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.56 -47.95 90.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.421 -0.512 . . . . 1.0 110.551 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 697' ' ' LEU . 91.9 mt -63.32 -40.69 98.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.538 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.51 -38.44 89.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 69.9 m -66.08 -40.38 90.79 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.612 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.47 -45.27 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 1.0 111.102 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.9 mtp -62.07 -42.24 98.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 1.0 112.308 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.91 -44.17 92.34 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.531 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.72 -44.63 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.257 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.27 -41.57 96.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.736 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.03 -42.47 97.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.147 0.499 . . . . 1.0 112.238 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.73 -43.07 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.004 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.81 94.28 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.236 -1.146 . . . . 1.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.29 -43.42 97.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.625 -0.43 . . . . 1.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.74 91.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.32 93.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.84 -40.52 97.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.578 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.77 -43.62 98.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.9 -42.81 97.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.564 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -53.39 -50.55 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.846 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -40.14 91.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.314 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.29 -42.92 96.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.99 -49.11 77.38 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.019 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.564 HD11 ' HE1' ' A' ' 715' ' ' TRP . 92.7 mt -67.84 -43.19 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 57.0 m -61.01 -44.96 96.65 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.712 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 721' ' ' ILE . 96.5 mt -89.15 -0.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.813 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 721' ' ' ILE . 74.6 m80 52.88 150.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.467 0.651 . . . . 1.0 112.511 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.78 -38.84 92.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.408 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -134.87 149.65 50.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.92 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -65.55 -39.85 92.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.895 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -130.92 137.26 49.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.854 -1.069 . . . . 1.0 110.723 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 N--CA 1.479 0.638 0 N-CA-C 109.613 -0.956 . . . . 1.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.81 -38.65 89.55 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.994 0.426 . . . . 1.0 110.3 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 7.7 t 47.12 71.83 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.606 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -61.55 146.85 96.6 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.851 2.367 . . . . 1.0 112.27 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.46 148.57 29.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 1.0 110.983 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.502 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -98.13 -48.38 1.9 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.889 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 36.5 Cg_exo -54.77 -37.96 91.92 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.734 2.289 . . . . 1.0 112.439 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 49.4 35.01 7.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.259 0.552 . . . . 1.0 110.467 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.23 -40.96 81.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.567 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.57 -40.6 95.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.193 -0.912 . . . . 1.0 112.262 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.0 -42.46 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.662 0.268 . . . . 1.0 111.329 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.92 -47.79 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.392 0.615 . . . . 1.0 109.885 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.55 -41.28 98.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.129 -0.942 . . . . 1.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.31 -39.55 93.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.574 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.6 m -64.53 -40.94 96.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.701 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.79 -45.52 98.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 86.6 mtp -61.63 -42.4 98.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.816 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.01 -45.52 87.04 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.627 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.32 -49.59 75.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.649 0.611 . . . . 1.0 112.649 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.58 -43.41 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.671 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.4 mt -64.44 -40.81 96.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.83 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.64 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 15.4 tt -67.31 -33.27 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.28 97.91 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.42 -1.472 . . . . 1.0 109.42 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.47 -46.09 87.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.268 -0.466 . . . . 1.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.33 88.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.7 89.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.578 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.5 -41.26 98.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.8 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.86 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.99 -42.37 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.531 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -55.07 -48.91 72.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.963 -1.095 . . . . 1.0 109.411 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -43.35 98.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.009 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.4 mm? -62.3 -39.32 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.16 -48.32 82.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.163 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.531 HD11 ' HE1' ' A' ' 715' ' ' TRP . 77.8 mt -70.28 -42.33 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 m -61.4 -44.76 96.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.414 -0.515 . . . . 1.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 717' ' ' LEU . 20.0 tt -90.0 0.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.329 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 76.3 m80 39.6 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.429 -0.351 . . . . 1.0 110.341 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.31 -39.59 89.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 726' ' ' GLU . 30.6 ptt180 -60.46 -36.25 77.8 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.525 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 51.96 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.457 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 724' ' ' ARG . 84.8 tt0 -125.88 134.64 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.244 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.447 ' OXT' ' O ' ' A' ' 726' ' ' GLU . 46.7 t80 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.908 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 109.39 -1.042 . . . . 1.0 109.39 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.23 -41.91 89.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 12.7 t -175.79 53.61 0.11 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 1.0 111.008 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 687' ' ' SER . 37.2 Cg_endo -67.33 -24.05 43.88 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.853 2.369 . . . . 1.0 112.246 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -40.88 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.659 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.87 69.48 1.29 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.32 -38.66 93.62 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.736 2.291 . . . . 1.0 111.662 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 695' ' ' VAL . 98.4 m-20 -88.08 112.1 22.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.074 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 35.4 pt -75.38 -30.82 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.876 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.93 -42.79 97.27 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 692' ' ' ASP . 5.5 m -63.51 -37.67 80.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.689 -0.405 . . . . 1.0 111.317 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.28 -48.57 88.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.066 -0.654 . . . . 1.0 109.728 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 697' ' ' LEU . 4.3 mm? -63.52 -40.88 98.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.968 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.1 -38.7 92.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.358 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 53.0 m -65.95 -44.29 85.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.265 0.468 . . . . 1.0 112.265 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 700' ' ' VAL . 7.2 m -63.89 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 119.348 -0.941 . . . . 1.0 110.516 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.6 mtp -62.02 -42.29 99.0 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.738 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.18 -44.15 87.53 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.502 -0.856 . . . . 1.0 111.282 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 19.0 tt -65.25 -39.9 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.316 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.37 -43.27 95.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.009 -0.277 . . . . 1.0 111.66 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.64 -42.1 95.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.38 -37.07 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.2 -0.6 . . . . 1.0 109.792 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.62 97.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.54 -43.66 98.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 1.0 110.388 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.44 85.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.69 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.9 -39.37 94.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 111.318 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.39 -43.03 99.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.867 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.22 -43.83 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.501 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.3 t90 -55.37 -49.65 71.72 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.89 -38.85 87.11 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.091 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 721' ' ' ILE . 55.1 tp -61.4 -41.06 96.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.43 -45.01 96.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.381 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.501 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.0 mt -84.42 -37.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.018 0.747 . . . . 1.0 113.018 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.0 m -63.21 -44.33 95.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.323 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 717' ' ' LEU . 21.0 tt -65.15 -42.58 94.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.544 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.53 ' N ' HG23 ' A' ' 721' ' ' ILE . 60.6 t-80 -44.32 108.6 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.551 -0.749 . . . . 1.0 110.787 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.951 -0.3 . . . . 1.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -134.54 137.71 44.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.97 137.7 51.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.0 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.58 -48.6 3.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.688 179.529 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 N--CA 1.487 1.125 0 N-CA-C 110.045 -0.79 . . . . 1.0 110.045 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 686' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' A' ' 687' ' ' SER . 21.7 pt-20 -64.6 -41.16 96.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.316 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.467 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 49.1 m -170.4 51.14 0.17 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.004 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 687' ' ' SER . 36.5 Cg_endo -66.36 147.51 83.05 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.538 2.159 . . . . 1.0 112.107 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.33 -42.61 99.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.628 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 161.85 -177.36 38.12 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.774 -0.727 . . . . 1.0 111.345 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.2 -40.71 68.76 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.234 2.623 . . . . 1.0 112.784 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 48.74 31.74 3.23 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.23 0.538 . . . . 1.0 111.285 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.7 mt -70.23 -41.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.4 mp -62.23 -41.53 98.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.642 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.96 -42.87 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.715 0.293 . . . . 1.0 110.982 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 700' ' ' VAL . 79.5 t -60.71 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.073 -0.651 . . . . 1.0 109.771 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.68 -42.02 99.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.927 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.36 -39.12 93.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.287 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.32 -38.28 81.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.079 0.466 . . . . 1.0 110.566 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.1 t -64.02 -45.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.128 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.34 -40.57 96.81 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.528 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.87 62.2 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.461 -0.876 . . . . 1.0 111.443 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.79 79.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.586 0.587 . . . . 1.0 112.586 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.54 -41.92 91.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.48 -40.02 89.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.42 -43.43 98.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.73 -35.72 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.575 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.66 -41.78 97.56 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.654 -1.378 . . . . 1.0 109.654 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.41 -43.43 97.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.42 87.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.569 -0.453 . . . . 1.0 109.94 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.25 94.12 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.155 -0.618 . . . . 1.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.73 -41.1 98.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.226 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.84 -43.11 99.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.15 -42.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.03 -49.95 67.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 118.959 -1.097 . . . . 1.0 108.618 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.6 86.14 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.245 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.65 -42.86 93.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 722' ' ' HIS . 93.2 mt -60.92 -49.49 77.26 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.731 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 90.8 mt -67.46 -42.17 86.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 113.302 0.853 . . . . 1.0 113.302 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 89.7 m -60.87 -44.95 96.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.635 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 722' ' ' HIS . 1.6 pp -92.22 1.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 721' ' ' ILE . 20.2 t-80 85.92 132.98 0.04 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.874 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -92.49 112.54 24.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.073 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -71.88 139.7 48.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.43 -0.804 . . . . 1.0 110.597 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.43 151.1 26.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.899 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -137.12 31.08 2.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.461 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.473 -179.951 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.485 1.012 0 N-CA-C 109.785 -0.891 . . . . 1.0 109.785 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -101.55 135.0 43.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.269 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.403 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.6 OUTLIER -155.56 179.34 1.37 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.913 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 23.5 Cg_exo -61.92 149.38 90.44 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.228 1.952 . . . . 1.0 111.65 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.49 136.87 44.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.943 0.401 . . . . 1.0 110.027 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -178.13 166.88 37.24 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 -18.67 38.92 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.79 2.327 . . . . 1.0 112.325 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -136.59 94.64 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.312 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 31.0 pt -73.95 -28.27 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.678 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -42.07 97.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.996 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.68 -42.01 90.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.917 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.7 t -60.61 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.166 -0.614 . . . . 1.0 110.236 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.68 -42.06 98.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.93 -41.04 97.49 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.665 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 37.3 m -68.29 -41.09 81.48 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 696' ' ' VAL . 80.4 t -62.61 -45.59 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.006 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.8 mtp -63.02 -42.11 99.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.875 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.97 -45.12 75.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.75 92.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.758 0.313 . . . . 1.0 111.316 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 86.0 mt -65.02 -44.6 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.246 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.93 -41.07 95.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.335 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -41.86 98.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.094 0.473 . . . . 1.0 112.073 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.83 -43.47 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.111 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -55.25 -42.79 83.47 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.281 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.33 -43.36 97.97 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.138 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.42 83.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.97 0.414 . . . . 1.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.79 -48.28 77.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.36 -39.24 93.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.098 0.407 . . . . 1.0 112.098 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.12 -42.67 99.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 1.0 111.99 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.37 -42.81 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.756 . . . . 1.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -54.23 -47.16 72.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.009 -1.076 . . . . 1.0 108.998 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -61.89 -41.45 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.742 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.764 ' O ' HG22 ' A' ' 721' ' ' ILE . 79.0 mt -61.81 -41.75 98.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.9 -49.93 75.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.912 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 18.6 tt -74.83 -37.0 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 1.0 112.479 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 98.7 m -59.57 -43.68 93.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 717' ' ' LEU . 18.6 tt -94.33 4.41 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.389 0.614 . . . . 1.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 42.53 77.27 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 724' ' ' ARG . 60.7 t0 -70.95 134.86 47.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 723' ' ' ASP . 92.7 mtm-85 -123.1 144.56 49.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.053 0.454 . . . . 1.0 111.144 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 724' ' ' ARG . 98.2 mttt 47.02 -178.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.028 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.34 159.2 22.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.491 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.147 -0.93 . . . . 1.0 110.439 -179.835 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 109.855 -0.863 . . . . 1.0 109.855 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.62 -39.19 80.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.688 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 3.2 m -142.77 75.41 18.19 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.695 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.85 146.82 21.06 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.503 2.135 . . . . 1.0 111.596 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.02 -43.29 99.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.512 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -125.06 84.34 0.35 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.55 142.47 95.49 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.812 1.674 . . . . 1.0 111.527 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -93.27 2.74 56.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -40.77 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.89 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.8 mp -59.86 -39.61 85.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.631 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -42.46 94.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.618 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.28 -47.86 91.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.576 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.81 -41.68 99.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.258 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.09 -38.09 89.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.5 m -66.87 -43.37 83.74 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.03 -41.61 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.466 -0.894 . . . . 1.0 110.359 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.2 mtp -62.58 -42.11 99.36 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 121.099 -0.24 . . . . 1.0 111.051 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.16 88.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.53 78.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 1.0 111.463 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.74 -43.57 98.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.134 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.18 -44.65 94.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.29 -41.54 98.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 1.0 112.059 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.44 -42.86 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.018 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.71 95.31 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.75 -43.39 96.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.764 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.56 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.286 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.52 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.116 -0.634 . . . . 1.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.33 -41.61 98.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.836 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.39 -43.63 98.37 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.936 0.717 . . . . 1.0 112.936 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.4 -42.99 98.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.457 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.2 t90 -55.46 -48.4 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.128 -1.029 . . . . 1.0 108.313 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.88 -41.03 95.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.978 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.6 -42.02 91.64 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.523 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.9 mt -62.37 -47.74 82.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.769 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.457 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.6 mt -71.8 -42.26 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.5 p -68.1 -39.83 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 722' ' ' HIS . 19.2 tt -66.87 -46.39 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.775 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.526 ' N ' HG23 ' A' ' 721' ' ' ILE . 15.4 m80 -43.57 129.24 5.29 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.834 -0.347 . . . . 1.0 111.174 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -64.51 -40.47 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.605 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -88.77 138.27 31.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 109.963 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.46 -42.98 99.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.526 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 49.61 22.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.954 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.478 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 109.262 -1.092 . . . . 1.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -132.37 138.39 47.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.581 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.526 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER 179.49 -45.16 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.355 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 687' ' ' SER . 20.9 Cg_exo -62.98 151.37 84.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.471 2.114 . . . . 1.0 111.371 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -99.61 143.12 30.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 88.46 77.46 1.29 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.496 -0.641 . . . . 1.0 111.496 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.49 -38.29 89.96 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.753 2.302 . . . . 1.0 111.815 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.9 138.26 58.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.426 0.632 . . . . 1.0 110.838 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 72.9 mt -70.14 -41.27 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.711 -1.132 . . . . 1.0 111.211 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 698' ' ' LEU . 81.9 mt -61.53 -41.1 96.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.287 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 63.2 t -58.45 -42.46 84.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.4 t -60.95 -47.55 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 121.114 0.483 . . . . 1.0 109.808 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.22 -41.82 99.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.252 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.0 mp -62.35 -38.86 91.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 1.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.82 -39.16 80.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.141 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.9 t -62.65 -44.92 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.067 0.46 . . . . 1.0 109.93 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.6 mtp -62.36 -41.91 98.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.129 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 706' ' ' LEU . . . -67.61 -45.58 75.69 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.73 -0.748 . . . . 1.0 111.69 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.08 73.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.33 0.492 . . . . 1.0 112.33 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.07 -43.42 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.728 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.7 mt -64.39 -43.18 95.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.172 0.434 . . . . 1.0 112.172 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 702' ' ' GLY . 8.0 mp -63.81 -42.84 97.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.326 -0.55 . . . . 1.0 111.9 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.66 -43.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.426 -0.806 . . . . 1.0 110.637 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.62 94.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 709' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 713' ' ' LEU . 57.0 tp -61.35 -43.81 98.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.13 89.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.775 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.726 -0.789 . . . . 1.0 110.475 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.65 -40.83 96.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.2 mp -64.15 -43.32 95.55 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.386 0.884 . . . . 1.0 113.386 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 717' ' ' LEU . 28.9 pt -65.8 -39.37 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.327 -0.549 . . . . 1.0 109.676 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -54.37 -50.4 67.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.353 -0.939 . . . . 1.0 108.817 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -40.02 89.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.558 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 721' ' ' ILE . 75.5 mt -60.17 -42.12 94.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.461 -0.496 . . . . 1.0 109.916 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.38 -50.12 74.18 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.763 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.12 -41.72 84.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 90.1 m -61.55 -44.16 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.5 0.555 . . . . 1.0 112.5 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 722' ' ' HIS . 46.8 pt -65.34 -43.85 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.169 -0.612 . . . . 1.0 111.902 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.453 ' N ' HG13 ' A' ' 721' ' ' ILE . 49.4 m80 -138.31 137.0 36.99 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -94.71 -0.5 54.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.23 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.47 -43.05 99.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.554 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.38 146.31 27.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.995 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 48.2 -169.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.134 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 117.922 -1.037 . . . . 1.0 110.663 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo . . . . . 0 N--CA 1.481 0.777 0 N-CA-C 108.924 -1.221 . . . . 1.0 108.924 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.78 136.67 58.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.987 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 59.9 m -147.64 72.19 11.62 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.083 0.468 . . . . 1.0 110.117 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -60.96 145.57 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 123.312 2.674 . . . . 1.0 112.556 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.0 tttt 48.71 36.67 8.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.08 -168.75 42.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.53 146.9 95.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.956 2.438 . . . . 1.0 111.87 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.58 143.32 57.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.371 0.605 . . . . 1.0 110.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.75 -40.01 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.144 -0.934 . . . . 1.0 110.497 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 694' ' ' LEU . 4.1 mm? -62.48 -40.99 98.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.422 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.53 -40.98 90.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.105 0.478 . . . . 1.0 110.806 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.2 t -61.3 -46.9 95.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.76 -41.88 99.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.119 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.93 -39.17 93.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.07 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.9 m -66.61 -38.28 86.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 696' ' ' VAL . 67.1 t -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.533 -0.758 . . . . 1.0 109.915 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -61.75 -41.67 97.98 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.62 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.34 -45.52 60.5 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.629 -0.796 . . . . 1.0 111.743 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.31 77.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 705' ' ' LEU . 20.3 tt -65.94 -41.01 89.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.464 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.425 ' N ' HG23 ' A' ' 704' ' ' ILE . 89.9 mt -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.757 -0.377 . . . . 1.0 111.459 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 36.7 mt -62.18 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 12.3 tt -66.5 -34.37 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.189 -0.605 . . . . 1.0 109.881 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.22 -43.02 95.64 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.35 -42.71 98.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.94 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.4 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.9 -47.77 79.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.12 -38.48 91.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.755 0.312 . . . . 1.0 111.632 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.37 -44.45 96.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.534 . . . . 1.0 112.421 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.32 -42.76 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.587 . . . . 1.0 109.625 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -55.78 -50.07 71.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.293 -0.963 . . . . 1.0 109.185 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -38.09 85.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.327 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.11 -42.11 94.01 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.28 -50.75 71.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.049 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.15 -43.62 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -61.76 -45.87 92.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.543 -0.463 . . . . 1.0 109.887 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 721' ' ' ILE . 44.9 mm -84.95 -0.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.552 . . . . 1.0 109.743 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 721' ' ' ILE . 63.6 m80 55.28 116.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.222 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 725' ' ' LYS . 66.6 t0 -91.08 114.85 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.578 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.84 -41.27 99.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.623 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 723' ' ' ASP . 99.0 mttt -126.69 139.53 53.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.585 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.72 132.08 46.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.057 -0.973 . . . . 1.0 110.399 179.819 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.482 0.851 0 N-CA-C 109.728 -0.912 . . . . 1.0 109.728 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.36 -37.22 86.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.332 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.2 p -166.84 70.61 1.05 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.483 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.89 142.98 99.61 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.693 2.262 . . . . 1.0 112.651 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.43 -42.38 99.41 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 104.34 175.5 25.21 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.866 -0.606 . . . . 1.0 111.701 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.22 118.61 5.6 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.946 2.431 . . . . 1.0 112.925 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -97.16 -4.24 39.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.543 0.687 . . . . 1.0 109.932 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.556 HG23 HD12 ' A' ' 694' ' ' LEU . 21.3 tt -60.13 -29.92 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.893 -1.049 . . . . 1.0 109.563 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 693' ' ' ILE . 10.4 mp -62.15 -42.89 99.69 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.708 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.44 -41.89 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.362 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 700' ' ' VAL . 72.2 t -61.3 -46.74 96.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.63 -42.42 99.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.264 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.67 -40.08 95.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.959 0.409 . . . . 1.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.9 m -66.92 -39.94 87.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.142 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 696' ' ' VAL . 70.9 t -63.54 -46.03 96.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.76 -41.27 97.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.675 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.37 -45.01 71.49 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.352 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.11 85.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.744 0.276 . . . . 1.0 111.744 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 704' ' ' ILE . 32.0 mm -64.12 -43.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.277 0.561 . . . . 1.0 109.852 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 5.5 tt -64.26 -41.76 96.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 111.791 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.62 -44.13 97.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.998 0.74 . . . . 1.0 112.998 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 36.7 pt -66.0 -39.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.494 -0.483 . . . . 1.0 110.506 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.82 97.26 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.147 -1.181 . . . . 1.0 110.147 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.38 -44.62 96.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.41 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.68 89.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.231 -0.587 . . . . 1.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.32 -42.12 98.96 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 111.687 0.255 . . . . 1.0 111.687 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.02 -43.2 99.38 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.42 -43.08 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.9 t90 -53.91 -49.17 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.204 -0.998 . . . . 1.0 108.685 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.26 -36.47 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.298 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.84 -42.85 98.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.28 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.404 ' O ' ' CG ' ' A' ' 722' ' ' HIS . 10.6 mp -61.43 -51.03 70.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.587 -0.845 . . . . 1.0 111.499 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 715' ' ' TRP . 97.7 mt -68.35 -43.1 84.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.3 m -63.17 -44.72 94.63 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.58 -45.32 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.317 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 718' ' ' LEU . 2.4 m-70 -45.19 138.05 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.999 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.04 111.65 19.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.373 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -128.87 134.45 48.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.048 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 54.85 92.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.477 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 67.4 t80 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.071 -0.966 . . . . 1.0 110.609 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -43.97 71.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.7 . . . . 1.0 111.486 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.58 156.35 43.16 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.939 -0.305 . . . . 1.0 110.463 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 689' ' ' LYS . 31.8 Cg_endo -62.81 142.71 89.85 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.636 2.224 . . . . 1.0 112.394 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 688' ' ' PRO . 97.9 mttt 41.75 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.769 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 49.59 76.72 0.15 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.18 144.04 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.936 2.424 . . . . 1.0 112.71 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 50.17 31.47 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 1.0 111.744 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 19.7 tt -73.06 -36.79 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.013 0.435 . . . . 1.0 110.428 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.93 -39.92 95.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.854 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.97 -40.89 87.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.064 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.76 -48.46 88.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 1.0 110.357 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.67 -41.63 99.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.18 -39.66 93.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 1.0 110.56 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 26.7 m -66.72 -42.01 87.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.735 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.05 -46.11 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.902 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -62.11 -41.57 98.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.569 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.19 -44.78 85.65 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.148 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.35 92.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.709 -0.396 . . . . 1.0 111.702 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.7 mm -64.2 -43.79 97.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.23 -43.36 98.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.686 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.95 -40.68 95.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.272 -0.571 . . . . 1.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.16 -42.98 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.421 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.14 96.55 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.144 -0.935 . . . . 1.0 110.992 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.58 -42.9 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.933 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.4 94.57 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.563 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.67 86.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.609 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.67 -39.0 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.219 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.3 -44.23 95.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.21 -35.71 74.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -56.55 -49.11 75.78 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.224 -0.99 . . . . 1.0 109.291 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.23 -38.23 82.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.669 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.789 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.3 mm? -62.06 -41.32 98.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.365 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.76 -50.11 74.78 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 119.893 -0.723 . . . . 1.0 110.962 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.91 -42.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.427 -0.806 . . . . 1.0 112.086 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -62.24 -46.08 90.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.418 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 717' ' ' LEU . 17.2 tt -83.43 -2.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.507 . . . . 1.0 109.799 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 721' ' ' ILE . 73.3 m80 56.5 130.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.068 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -71.66 149.51 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -88.2 132.07 34.5 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.367 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.84 146.34 42.06 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.613 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.99 -40.27 91.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.539 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.581 -179.876 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 109.438 -1.024 . . . . 1.0 109.438 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -114.58 123.95 50.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 7.7 t -151.07 72.02 8.59 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.627 -0.429 . . . . 1.0 111.032 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.43 146.34 95.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.978 2.452 . . . . 1.0 112.744 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 690' ' ' GLY . 64.6 mttp -127.0 138.87 53.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.943 -0.572 . . . . 1.0 109.991 179.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 689' ' ' LYS . . . -54.27 -165.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.91 142.98 99.19 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.546 2.164 . . . . 1.0 111.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -90.27 2.0 55.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.278 0.561 . . . . 1.0 110.469 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.19 -40.65 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.179 -0.919 . . . . 1.0 110.394 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.221 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.49 -44.97 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.7 t -61.96 -47.01 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.804 -0.758 . . . . 1.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.43 -42.11 96.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.06 -39.51 92.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.054 0.454 . . . . 1.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 72.2 m -65.57 -39.78 92.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.802 179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 696' ' ' VAL . 57.8 t -63.57 -47.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.227 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.74 -42.18 99.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.87 88.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.729 -0.748 . . . . 1.0 111.356 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.96 83.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.057 0.456 . . . . 1.0 112.154 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.14 -43.1 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.161 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.24 -45.67 90.47 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.44 -41.76 96.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.954 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.95 -43.49 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.462 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.24 -39.83 96.53 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.233 -1.147 . . . . 1.0 110.233 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.87 -42.46 99.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.27 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.446 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.7 88.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.822 -0.626 . . . . 1.0 112.217 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.73 -41.24 98.08 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.63 -43.68 98.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.621 -0.432 . . . . 1.0 112.029 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.84 -43.88 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -54.16 -49.17 69.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.281 -0.968 . . . . 1.0 108.954 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.326 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.7 -42.88 98.08 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.38 -48.05 83.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.111 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.77 -42.96 83.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.854 0.687 . . . . 1.0 112.854 -178.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 85.8 m -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 721' ' ' ILE . 44.1 mm -90.83 2.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.15 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 721' ' ' ILE . 78.3 m80 42.01 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.207 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -64.41 140.33 58.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.636 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -136.14 144.03 44.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.722 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.2 144.52 29.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 1.0 110.761 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -121.57 130.32 53.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.438 179.483 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.427 -1.585 0 N-CA-C 110.143 -0.317 . . . . 1.57 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.27 -44.59 97.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 113.004 0.742 . . . . 0.62 113.004 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.809 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.5 t -61.24 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 118.617 -1.233 . . . . 0.24 108.012 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.77 -42.41 99.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.813 -1.539 . . . . 1.17 110.806 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.08 -37.84 86.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.92 110.647 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.1 m -70.2 -41.2 74.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.834 -0.621 . . . . 0.22 109.931 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 696' ' ' VAL . 98.2 t -61.02 -46.5 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.97 -0.752 . . . . 0.74 108.97 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.9 mtp -62.08 -43.97 97.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.54 -0.754 . . . . 0.23 111.502 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.11 -43.97 88.77 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.947 -0.861 . . . . 0.17 110.947 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.9 81.36 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.622 0.725 . . . . 0.18 112.356 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.65 -43.43 98.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.925 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -40.96 96.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 1.77 111.466 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.87 -38.06 89.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.11 0.957 . . . . 1.27 113.065 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 41.0 mt -65.44 -42.82 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.736 -1.575 . . . . 1.4 109.464 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.06 -41.92 92.78 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.735 -1.121 . . . . 0.16 110.83 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 14.8 mt -63.1 -44.06 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.102 -0.639 . . . . 1.66 110.113 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.3 92.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.383 -0.527 . . . . 0.18 109.678 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.32 82.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.573 -0.451 . . . . 0.15 110.526 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -40.05 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.976 0.417 . . . . 1.72 111.899 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.36 -43.26 98.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.079 1.141 . . . . 1.21 114.079 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 65.2 mt -65.59 -42.45 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.49 -1.3 . . . . 1.53 107.49 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -52.93 -52.39 58.04 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 118.036 -1.466 . . . . 0.25 107.468 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -63.97 -39.15 93.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.0 -1.0 . . . . 0.35 109.915 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 717' ' ' LEU . 18.9 tp -58.98 -45.41 90.66 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.357 -1.719 . . . . 1.77 106.357 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 56.5 mt -53.06 -55.56 22.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.219 -1.392 . . . . 0.69 108.942 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.318 -0.775 0 N-CA-C 115.704 1.742 . . . . 1.07 115.704 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.947 0.403 . . . . 1.0 110.803 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.25 -41.32 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.371 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -61.29 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.741 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.31 -42.47 99.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.414 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.9 -40.37 97.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 1.0 111.138 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 16.6 m -66.45 -41.32 89.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.046 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 696' ' ' VAL . 65.4 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.329 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -62.76 -41.67 99.33 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.58 -43.42 94.55 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.46 -1.056 . . . . 1.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.02 75.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 1.0 111.786 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.43 -43.38 96.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.071 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.46 -44.45 94.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.725 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.96 -41.55 97.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.007 0.432 . . . . 1.0 111.997 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.4 mt -62.55 -42.62 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.02 -42.05 92.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 709' ' ' LEU . 92.5 mt -63.5 -44.52 94.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.104 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.88 91.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.86 -46.78 86.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.022 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.1 -40.75 96.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.952 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 717' ' ' LEU . 32.0 mt -62.83 -43.46 98.74 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 46.5 pt -66.73 -36.34 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.636 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -56.59 -48.81 76.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.361 -0.935 . . . . 1.0 108.97 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.97 -38.26 85.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.044 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 713' ' ' LEU . 1.2 mm? -62.91 -38.78 92.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.42 -45.49 93.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 113.119 0.785 . . . . 1.0 113.119 -177.594 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.404 0.145 . . . . 1.0 111.229 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.82 -40.86 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.712 0.291 . . . . 1.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.0 -47.25 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.384 0.611 . . . . 1.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 98.3 mt -64.7 -41.25 96.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.83 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 45.1 mt -61.55 -40.58 95.22 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 17.7 m -68.02 -38.6 82.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.305 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.37 -46.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.7 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.84 -41.39 99.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.78 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.64 -46.0 79.79 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.91 -0.662 . . . . 1.0 111.794 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.98 -49.6 75.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.0 111.546 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.25 -43.19 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.617 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.89 -44.09 94.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.787 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.76 -41.69 97.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.269 0.557 . . . . 1.0 111.344 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.44 -43.33 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.177 -0.92 . . . . 1.0 109.769 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.78 96.58 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.134 -1.186 . . . . 1.0 110.134 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.49 -43.28 97.72 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.877 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.7 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -65.37 -45.2 85.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.199 -0.601 . . . . 1.0 110.987 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.39 -40.86 97.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.481 . . . . 1.0 111.253 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.85 -44.01 97.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.655 -0.702 . . . . 1.0 112.287 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.15 -43.35 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -54.31 -48.86 70.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 119.135 -1.026 . . . . 1.0 108.902 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -59.31 -40.5 86.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.845 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.27 -39.1 91.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -45.04 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.826 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 C--N 1.33 -0.261 0 N-CA-C 112.929 0.714 . . . . 1.0 112.929 -177.892 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.852 0.358 . . . . 1.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.16 -42.09 94.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.173 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.1 t -61.99 -47.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.772 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.57 -42.04 99.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.08 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.3 -40.96 98.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.3 m -68.83 -36.83 78.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.704 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 696' ' ' VAL . 63.5 t -64.72 -45.22 95.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.006 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . 0.416 ' O ' HD23 ' A' ' 705' ' ' LEU . 93.9 mtp -63.63 -42.05 98.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.852 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.03 93.02 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.142 -1.028 . . . . 1.0 110.959 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.11 95.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.2 -43.67 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.0 110.28 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 701' ' ' MET . 3.9 mm? -63.94 -41.7 97.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.507 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.3 -42.61 99.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 1.0 111.726 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.95 -42.89 97.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.913 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.22 -40.9 92.46 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.47 -44.07 97.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.165 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.28 75.92 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.082 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.85 82.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -41.73 99.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.139 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.09 -42.41 99.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.036 0.754 . . . . 1.0 113.036 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.08 -42.61 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.7 t90 -54.94 -49.2 71.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.157 -1.017 . . . . 1.0 109.317 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.8 OUTLIER -60.92 -39.54 89.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.508 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 70.5 mt -61.07 -39.34 89.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.8 -53.13 60.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.117 -0.633 . . . . 1.0 111.208 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.434 HD11 ' HE1' ' A' ' 715' ' ' TRP . 84.8 mt . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.684 0.278 . . . . 1.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.35 -41.98 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.13 -47.32 93.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.245 0.545 . . . . 1.0 109.976 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 99.5 mt -63.66 -41.81 98.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.094 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.9 -38.24 87.63 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.311 0.577 . . . . 1.0 110.682 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 21.0 m -67.64 -40.39 84.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.73 -46.12 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.731 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -61.96 -41.6 98.17 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.541 . . . . 1.0 112.391 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.97 85.76 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.733 -0.746 . . . . 1.0 112.022 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.2 77.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 1.0 111.622 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -43.93 97.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.857 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.5 -41.34 96.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.037 0.384 . . . . 1.0 112.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.58 -41.5 98.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.309 0.576 . . . . 1.0 111.459 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.28 -42.51 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.954 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.4 -42.39 95.7 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.88 -43.64 98.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.85 85.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.33 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.52 84.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.772 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.7 -38.64 91.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.97 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.29 -42.71 99.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 4.2 mm -64.19 -43.22 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.271 0.558 . . . . 1.0 109.51 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -54.43 -50.33 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.346 -0.942 . . . . 1.0 109.295 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -61.47 -37.98 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.511 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.98 -41.42 96.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.81 -50.08 72.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.687 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -178.708 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.48 0.181 . . . . 1.0 111.226 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.75 -42.11 90.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 1.0 111.027 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.9 -48.27 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.704 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.51 -41.65 98.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.517 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 698' ' ' LEU . 29.3 mt -62.86 -40.0 96.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.3 m -68.86 -38.69 79.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.543 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.52 -44.75 98.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.693 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.4 mtp -62.87 -39.86 95.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.753 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.38 -44.81 72.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.589 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.54 81.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 30.8 pt -67.33 -40.85 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.194 -0.602 . . . . 1.0 110.443 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.66 -43.94 92.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.605 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.38 -41.22 96.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.479 -0.489 . . . . 1.0 111.654 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.98 -42.99 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.023 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.95 93.94 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.16 -44.53 95.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.54 91.37 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.67 96.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.89 -0.724 . . . . 1.0 109.882 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.95 -40.57 98.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.97 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.9 -42.12 99.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.66 -43.17 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -55.37 -49.79 71.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.156 -1.017 . . . . 1.0 108.539 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.75 -41.99 96.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.019 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 717' ' ' LEU . 41.6 tp -61.57 -42.06 98.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.932 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.98 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.998 -0.681 . . . . 1.0 111.895 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -178.123 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 111.479 0.177 . . . . 1.0 111.479 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.96 -43.39 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.691 0.281 . . . . 1.0 111.283 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.45 -48.07 88.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.343 -0.543 . . . . 1.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.03 -41.73 99.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.393 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.0 mt -62.02 -40.74 96.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.118 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.7 m -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 1.0 109.891 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.28 -46.87 94.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.995 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 91.9 mtp -63.2 -41.62 99.19 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.9 -44.35 92.01 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.9 -0.666 . . . . 1.0 111.708 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.25 95.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.15 -44.03 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.96 -42.69 97.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.376 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.37 -41.29 98.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 1.0 111.698 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.5 -43.25 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.538 -0.755 . . . . 1.0 109.997 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.59 -41.34 97.25 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.394 -0.821 . . . . 1.0 111.049 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.38 -43.27 98.08 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.48 87.57 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.16 -47.3 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.61 -39.72 94.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 1.0 112.006 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.16 -43.45 98.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.891 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.54 -43.6 98.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -54.95 -50.37 69.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 1.0 108.957 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -37.45 80.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.771 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.39 -41.12 98.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.77 -47.88 83.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.406 HD11 ' NE1' ' A' ' 715' ' ' TRP . 95.4 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.758 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp . . . . . 0 CA--C 1.529 0.149 0 N-CA-C 111.925 0.343 . . . . 1.0 111.925 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.21 -43.79 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -62.65 -48.56 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.3 -40.85 97.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.07 -40.27 97.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.3 m -65.66 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -63.81 -46.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.866 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.3 mtp -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.831 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.45 -43.98 91.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.576 -0.821 . . . . 1.0 111.064 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.05 87.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.998 0.427 . . . . 1.0 111.818 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.21 -44.44 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.558 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.734 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.62 -41.89 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 1.0 112.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.36 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.614 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.82 96.64 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.081 -1.208 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 713' ' ' LEU . 56.4 tp -63.81 -46.15 86.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.628 0.251 . . . . 1.0 110.436 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.1 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 1.0 110.038 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.3 99.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -39.82 95.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.575 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.5 mp -63.4 -44.18 95.41 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.68 -43.57 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.987 0.422 . . . . 1.0 110.02 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.426 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.5 t90 -54.06 -49.13 69.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.081 -1.047 . . . . 1.0 108.891 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -37.91 83.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.017 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 717' ' ' LEU . 37.7 mt -60.83 -41.66 96.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.09 -54.93 40.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.029 -0.669 . . . . 1.0 111.276 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.426 HD11 ' HE1' ' A' ' 715' ' ' TRP . 96.5 mt . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.626 0.251 . . . . 1.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.16 -41.39 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.219 0.452 . . . . 1.0 112.219 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 700' ' ' VAL . 94.5 t -61.19 -47.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 1.0 110.396 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.23 96.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.584 -0.734 . . . . 1.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 698' ' ' LEU . 37.7 mt -62.47 -41.33 98.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.12 0.486 . . . . 1.0 110.475 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 50.2 m -64.95 -41.97 95.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.955 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 696' ' ' VAL . 82.7 t -64.51 -45.38 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.44 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.3 mtp -61.66 -41.48 97.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.649 -0.421 . . . . 1.0 111.005 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.17 -46.51 64.6 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 69.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.069 0.461 . . . . 1.0 111.567 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.71 -43.46 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.94 -42.84 99.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.172 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.61 -41.58 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 1.0 112.084 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.16 -42.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.009 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.6 -40.68 98.22 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.19 -45.1 93.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.749 0.309 . . . . 1.0 110.428 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.28 85.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.09 97.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.84 -42.03 97.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.632 0.605 . . . . 1.0 112.632 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.16 -42.93 99.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.45 -42.56 96.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -55.54 -50.3 70.37 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.358 -0.937 . . . . 1.0 108.66 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -58.45 -38.01 76.62 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.99 -40.59 98.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.908 -0.717 . . . . 1.0 111.269 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 698' ' ' LEU . 94.8 mt . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.808 0.337 . . . . 1.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.81 -41.89 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.969 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 700' ' ' VAL . 86.1 t -60.66 -47.69 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.305 -0.558 . . . . 1.0 110.156 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.13 -42.2 96.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.539 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 694' ' ' LEU . 8.4 mp -63.14 -37.77 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.078 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.4 m -67.54 -40.0 85.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.071 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.0 t -63.61 -46.0 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.032 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.7 mtp -61.17 -42.64 98.93 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.82 -45.22 89.73 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.533 -0.841 . . . . 1.0 111.201 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.05 85.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.31 -44.04 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.134 0.492 . . . . 1.0 110.493 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.26 -42.16 96.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.703 -0.681 . . . . 1.0 111.152 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 1.0 111.739 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.85 -44.38 99.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.5 95.06 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.676 -0.97 . . . . 1.0 110.676 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.27 -44.54 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.042 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.65 88.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.195 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.95 97.54 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.355 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.1 -40.21 95.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.083 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 36.3 mt -63.79 -43.94 94.81 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.848 0.684 . . . . 1.0 112.848 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.0 pt -65.84 -38.13 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.388 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -56.4 -47.53 78.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 118.783 -1.167 . . . . 1.0 109.076 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -39.19 89.23 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.363 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 717' ' ' LEU . 89.6 mt -61.24 -40.1 92.77 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.91 -52.92 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.328 0.585 . . . . 1.0 110.891 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 1.0 112.548 -179.162 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.462 0.142 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.23 -41.63 93.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 1.0 110.882 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.56 -47.95 90.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.421 -0.512 . . . . 1.0 110.551 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 697' ' ' LEU . 91.9 mt -63.32 -40.69 98.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.538 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.51 -38.44 89.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 69.9 m -66.08 -40.38 90.79 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.612 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.47 -45.27 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 1.0 111.102 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.9 mtp -62.07 -42.24 98.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 1.0 112.308 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.91 -44.17 92.34 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.531 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.72 -44.63 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.257 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.27 -41.57 96.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.736 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.03 -42.47 97.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.147 0.499 . . . . 1.0 112.238 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.73 -43.07 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.004 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.81 94.28 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.236 -1.146 . . . . 1.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.29 -43.42 97.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.625 -0.43 . . . . 1.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.74 91.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.32 93.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.84 -40.52 97.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.578 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.77 -43.62 98.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.9 -42.81 97.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.564 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -53.39 -50.55 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.846 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -40.14 91.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.314 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.29 -42.92 96.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.99 -49.11 77.38 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.019 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.564 HD11 ' HE1' ' A' ' 715' ' ' TRP . 92.7 mt . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.0 -42.46 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.662 0.268 . . . . 1.0 111.329 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.92 -47.79 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.392 0.615 . . . . 1.0 109.885 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.55 -41.28 98.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.129 -0.942 . . . . 1.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.31 -39.55 93.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.574 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.6 m -64.53 -40.94 96.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.701 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.79 -45.52 98.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 86.6 mtp -61.63 -42.4 98.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.816 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.01 -45.52 87.04 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.627 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.32 -49.59 75.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.649 0.611 . . . . 1.0 112.649 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.58 -43.41 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.671 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.4 mt -64.44 -40.81 96.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.83 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.64 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 15.4 tt -67.31 -33.27 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.28 97.91 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.42 -1.472 . . . . 1.0 109.42 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.47 -46.09 87.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.268 -0.466 . . . . 1.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.33 88.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.7 89.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.578 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.5 -41.26 98.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.8 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.86 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.99 -42.37 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.531 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -55.07 -48.91 72.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.963 -1.095 . . . . 1.0 109.411 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -43.35 98.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.009 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.3 -39.32 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.16 -48.32 82.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.163 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.531 HD11 ' HE1' ' A' ' 715' ' ' TRP . 77.8 mt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.51 -37.67 80.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.689 -0.405 . . . . 1.0 111.317 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.28 -48.57 88.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.066 -0.654 . . . . 1.0 109.728 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 697' ' ' LEU . 4.3 mm? -63.52 -40.88 98.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.968 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.1 -38.7 92.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.358 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 53.0 m -65.95 -44.29 85.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.265 0.468 . . . . 1.0 112.265 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 700' ' ' VAL . 7.2 m -63.89 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 119.348 -0.941 . . . . 1.0 110.516 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.6 mtp -62.02 -42.29 99.0 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.738 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.18 -44.15 87.53 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.502 -0.856 . . . . 1.0 111.282 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 19.0 tt -65.25 -39.9 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.316 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.37 -43.27 95.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.009 -0.277 . . . . 1.0 111.66 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.64 -42.1 95.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.38 -37.07 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.2 -0.6 . . . . 1.0 109.792 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.62 97.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.54 -43.66 98.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 1.0 110.388 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.44 85.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.69 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.9 -39.37 94.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 111.318 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.39 -43.03 99.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.867 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.22 -43.83 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.501 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.3 t90 -55.37 -49.65 71.72 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.89 -38.85 87.11 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.091 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.4 -41.06 96.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.43 -45.01 96.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.381 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.501 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.0 mt . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 113.018 0.747 . . . . 1.0 113.018 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.4 mp . . . . . 0 C--O 1.226 -0.145 0 N-CA-C 111.642 0.238 . . . . 1.0 111.642 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.96 -42.87 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.715 0.293 . . . . 1.0 110.982 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 700' ' ' VAL . 79.5 t -60.71 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.073 -0.651 . . . . 1.0 109.771 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.68 -42.02 99.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.927 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.36 -39.12 93.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.287 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.32 -38.28 81.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.079 0.466 . . . . 1.0 110.566 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.1 t -64.02 -45.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.128 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.34 -40.57 96.81 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.528 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.87 62.2 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.461 -0.876 . . . . 1.0 111.443 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.79 79.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.586 0.587 . . . . 1.0 112.586 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.54 -41.92 91.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.48 -40.02 89.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.42 -43.43 98.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.73 -35.72 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.575 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.66 -41.78 97.56 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.654 -1.378 . . . . 1.0 109.654 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.41 -43.43 97.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.42 87.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.569 -0.453 . . . . 1.0 109.94 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.25 94.12 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.155 -0.618 . . . . 1.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.73 -41.1 98.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.226 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.84 -43.11 99.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.15 -42.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.03 -49.95 67.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 118.959 -1.097 . . . . 1.0 108.618 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.6 86.14 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.245 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.65 -42.86 93.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.92 -49.49 77.26 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.731 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 113.302 0.853 . . . . 1.0 113.302 -178.646 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.68 -42.01 90.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.917 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.7 t -60.61 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.166 -0.614 . . . . 1.0 110.236 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.68 -42.06 98.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.93 -41.04 97.49 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.665 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 37.3 m -68.29 -41.09 81.48 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 696' ' ' VAL . 80.4 t -62.61 -45.59 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.006 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.8 mtp -63.02 -42.11 99.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.875 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.97 -45.12 75.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.75 92.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.758 0.313 . . . . 1.0 111.316 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 86.0 mt -65.02 -44.6 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.246 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.93 -41.07 95.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.335 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -41.86 98.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.094 0.473 . . . . 1.0 112.073 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.83 -43.47 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.111 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -55.25 -42.79 83.47 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.281 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.33 -43.36 97.97 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.138 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.42 83.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.97 0.414 . . . . 1.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.79 -48.28 77.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.36 -39.24 93.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.098 0.407 . . . . 1.0 112.098 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.12 -42.67 99.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 1.0 111.99 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.37 -42.81 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.756 . . . . 1.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -54.23 -47.16 72.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.009 -1.076 . . . . 1.0 108.998 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -61.89 -41.45 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.742 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.81 -41.75 98.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.9 -49.93 75.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.912 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 1.0 112.479 -178.598 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.8 mp . . . . . 0 CA--C 1.522 -0.104 0 N-CA-C 111.631 0.234 . . . . 1.0 111.631 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -42.46 94.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.618 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.28 -47.86 91.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.576 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.81 -41.68 99.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.258 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.09 -38.09 89.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.5 m -66.87 -43.37 83.74 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.03 -41.61 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.466 -0.894 . . . . 1.0 110.359 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.2 mtp -62.58 -42.11 99.36 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 121.099 -0.24 . . . . 1.0 111.051 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.16 88.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.53 78.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 1.0 111.463 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.74 -43.57 98.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.134 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.18 -44.65 94.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.29 -41.54 98.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 1.0 112.059 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.44 -42.86 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.018 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.71 95.31 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.75 -43.39 96.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.764 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.56 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.286 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.52 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.116 -0.634 . . . . 1.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.33 -41.61 98.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.836 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.39 -43.63 98.37 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.936 0.717 . . . . 1.0 112.936 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.4 -42.99 98.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.457 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.2 t90 -55.46 -48.4 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.128 -1.029 . . . . 1.0 108.313 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.88 -41.03 95.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.978 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.6 -42.02 91.64 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.37 -47.74 82.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.769 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.457 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.6 mt . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 698' ' ' LEU . 81.9 mt . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.914 0.387 . . . . 1.0 111.287 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 63.2 t -58.45 -42.46 84.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.4 t -60.95 -47.55 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 121.114 0.483 . . . . 1.0 109.808 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.22 -41.82 99.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.252 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.0 mp -62.35 -38.86 91.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 1.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.82 -39.16 80.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.141 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.9 t -62.65 -44.92 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.067 0.46 . . . . 1.0 109.93 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.6 mtp -62.36 -41.91 98.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.129 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 706' ' ' LEU . . . -67.61 -45.58 75.69 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.73 -0.748 . . . . 1.0 111.69 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.08 73.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.33 0.492 . . . . 1.0 112.33 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.07 -43.42 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.728 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.7 mt -64.39 -43.18 95.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.172 0.434 . . . . 1.0 112.172 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 702' ' ' GLY . 8.0 mp -63.81 -42.84 97.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.326 -0.55 . . . . 1.0 111.9 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.66 -43.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.426 -0.806 . . . . 1.0 110.637 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.62 94.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 713' ' ' LEU . 57.0 tp -61.35 -43.81 98.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.13 89.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.775 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.726 -0.789 . . . . 1.0 110.475 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.65 -40.83 96.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.2 mp -64.15 -43.32 95.55 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.386 0.884 . . . . 1.0 113.386 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 717' ' ' LEU . 28.9 pt -65.8 -39.37 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.327 -0.549 . . . . 1.0 109.676 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -54.37 -50.4 67.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.353 -0.939 . . . . 1.0 108.817 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -40.02 89.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.558 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 714' ' ' ILE . 75.5 mt -60.17 -42.12 94.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.461 -0.496 . . . . 1.0 109.916 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.38 -50.12 74.18 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.763 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 694' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.754 0.312 . . . . 1.0 111.422 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.53 -40.98 90.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.105 0.478 . . . . 1.0 110.806 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.2 t -61.3 -46.9 95.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.76 -41.88 99.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.119 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.93 -39.17 93.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.07 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.9 m -66.61 -38.28 86.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 696' ' ' VAL . 67.1 t -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.533 -0.758 . . . . 1.0 109.915 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -61.75 -41.67 97.98 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.62 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.34 -45.52 60.5 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.629 -0.796 . . . . 1.0 111.743 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.31 77.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 705' ' ' LEU . 20.3 tt -65.94 -41.01 89.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.464 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.425 ' N ' HG23 ' A' ' 704' ' ' ILE . 89.9 mt -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.757 -0.377 . . . . 1.0 111.459 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 36.7 mt -62.18 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 12.3 tt -66.5 -34.37 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.189 -0.605 . . . . 1.0 109.881 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.22 -43.02 95.64 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.35 -42.71 98.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.94 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.4 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.9 -47.77 79.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.12 -38.48 91.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.755 0.312 . . . . 1.0 111.632 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.37 -44.45 96.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.534 . . . . 1.0 112.421 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.32 -42.76 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.587 . . . . 1.0 109.625 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -55.78 -50.07 71.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.293 -0.963 . . . . 1.0 109.185 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -38.09 85.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.327 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.11 -42.11 94.01 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.28 -50.75 71.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.049 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -178.367 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.857 0.361 . . . . 1.0 110.708 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.44 -41.89 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.362 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 700' ' ' VAL . 72.2 t -61.3 -46.74 96.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.63 -42.42 99.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.264 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.67 -40.08 95.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.959 0.409 . . . . 1.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.9 m -66.92 -39.94 87.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.142 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 696' ' ' VAL . 70.9 t -63.54 -46.03 96.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.76 -41.27 97.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.675 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.37 -45.01 71.49 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.352 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.11 85.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.744 0.276 . . . . 1.0 111.744 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 704' ' ' ILE . 32.0 mm -64.12 -43.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.277 0.561 . . . . 1.0 109.852 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 5.5 tt -64.26 -41.76 96.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 111.791 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.62 -44.13 97.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.998 0.74 . . . . 1.0 112.998 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 36.7 pt -66.0 -39.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.494 -0.483 . . . . 1.0 110.506 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.82 97.26 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.147 -1.181 . . . . 1.0 110.147 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.38 -44.62 96.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.41 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.68 89.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.231 -0.587 . . . . 1.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.32 -42.12 98.96 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 111.687 0.255 . . . . 1.0 111.687 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.02 -43.2 99.38 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.42 -43.08 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.9 t90 -53.91 -49.17 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.204 -0.998 . . . . 1.0 108.685 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.26 -36.47 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.298 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.84 -42.85 98.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.28 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.43 -51.03 70.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.587 -0.845 . . . . 1.0 111.499 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 715' ' ' TRP . 97.7 mt . . . . . 0 C--N 1.326 -0.416 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.232 0.14 0 N-CA-C 111.854 0.316 . . . . 1.0 111.854 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.97 -40.89 87.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.064 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.76 -48.46 88.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 1.0 110.357 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.67 -41.63 99.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.18 -39.66 93.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 1.0 110.56 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 26.7 m -66.72 -42.01 87.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.735 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.05 -46.11 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.902 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -62.11 -41.57 98.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.569 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.19 -44.78 85.65 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.148 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.35 92.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.709 -0.396 . . . . 1.0 111.702 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.7 mm -64.2 -43.79 97.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.23 -43.36 98.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.686 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.95 -40.68 95.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.272 -0.571 . . . . 1.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.16 -42.98 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.421 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.14 96.55 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.144 -0.935 . . . . 1.0 110.992 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.58 -42.9 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.933 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.4 94.57 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.563 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.67 86.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.609 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.67 -39.0 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.219 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.3 -44.23 95.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.21 -35.71 74.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -56.55 -49.11 75.78 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.224 -0.99 . . . . 1.0 109.291 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.23 -38.23 82.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.669 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.06 -41.32 98.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.365 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.76 -50.11 74.78 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 119.893 -0.723 . . . . 1.0 110.962 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.427 -0.806 . . . . 1.0 112.086 -178.984 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.783 0.325 . . . . 1.0 111.221 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.49 -44.97 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.7 t -61.96 -47.01 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.804 -0.758 . . . . 1.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.43 -42.11 96.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.06 -39.51 92.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.054 0.454 . . . . 1.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 72.2 m -65.57 -39.78 92.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.802 179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 696' ' ' VAL . 57.8 t -63.57 -47.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.227 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.74 -42.18 99.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.87 88.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.729 -0.748 . . . . 1.0 111.356 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.96 83.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.057 0.456 . . . . 1.0 112.154 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.14 -43.1 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.161 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.24 -45.67 90.47 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.44 -41.76 96.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.954 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.95 -43.49 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.462 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.24 -39.83 96.53 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.233 -1.147 . . . . 1.0 110.233 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.87 -42.46 99.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.27 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.446 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.7 88.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.822 -0.626 . . . . 1.0 112.217 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.73 -41.24 98.08 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.63 -43.68 98.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.621 -0.432 . . . . 1.0 112.029 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.84 -43.88 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -54.16 -49.17 69.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.281 -0.968 . . . . 1.0 108.954 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.326 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.7 -42.88 98.08 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.38 -48.05 83.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.111 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 112.854 0.687 . . . . 1.0 112.854 -178.272 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 109.003 -1.191 . . . . 14.24 109.003 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 686' ' ' GLU . 3.4 pm0 -73.9 -30.25 62.5 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.981 -1.859 . . . . 13.24 105.981 176.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.551 ' C ' ' H ' ' A' ' 689' ' ' LYS . 0.4 OUTLIER -146.23 73.44 13.16 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 112.778 -2.01 . . . . 10.61 108.114 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -75.2 20.12 0.49 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 N-CA-C 108.077 -1.547 . . . . 9.39 108.077 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 691' ' ' PRO . 19.3 mttp -52.26 -43.6 64.47 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 104.141 -2.54 . . . . 10.33 104.141 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 689' ' ' LYS . . . 32.12 -89.85 0.01 OUTLIER Glycine 0 C--N 1.363 2.042 0 N-CA-C 105.752 -2.939 . . . . 5.47 105.752 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.62 ' N ' ' O ' ' A' ' 689' ' ' LYS . 0.5 OUTLIER -108.28 121.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 107.307 -1.843 . . . . 5.19 107.307 171.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 695' ' ' VAL . 16.6 m-20 -52.3 134.17 33.97 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.655 -3.091 . . . . 2.37 102.655 177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.85 -23.97 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 121.448 1.931 . . . . 1.59 107.52 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 692' ' ' ASP . 16.0 mt -64.74 -43.23 94.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 112.809 -1.996 . . . . 1.57 110.143 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 692' ' ' ASP . 48.8 t -64.27 -44.59 97.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 113.004 0.742 . . . . 0.62 113.004 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.809 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.5 t -61.24 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 118.617 -1.233 . . . . 0.24 108.012 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.77 -42.41 99.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.813 -1.539 . . . . 1.17 110.806 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.08 -37.84 86.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.92 110.647 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.1 m -70.2 -41.2 74.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.834 -0.621 . . . . 0.22 109.931 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 696' ' ' VAL . 98.2 t -61.02 -46.5 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.97 -0.752 . . . . 0.74 108.97 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.9 mtp -62.08 -43.97 97.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.54 -0.754 . . . . 0.23 111.502 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.11 -43.97 88.77 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.947 -0.861 . . . . 0.17 110.947 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.9 81.36 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.622 0.725 . . . . 0.18 112.356 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.65 -43.43 98.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.925 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -40.96 96.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 1.77 111.466 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.87 -38.06 89.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.11 0.957 . . . . 1.27 113.065 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 41.0 mt -65.44 -42.82 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.736 -1.575 . . . . 1.4 109.464 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.06 -41.92 92.78 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.735 -1.121 . . . . 0.16 110.83 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 14.8 mt -63.1 -44.06 96.75 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.102 -0.639 . . . . 1.66 110.113 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.3 92.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.383 -0.527 . . . . 0.18 109.678 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.32 82.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.573 -0.451 . . . . 0.15 110.526 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.46 -40.05 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.976 0.417 . . . . 1.72 111.899 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.36 -43.26 98.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.079 1.141 . . . . 1.21 114.079 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 65.2 mt -65.59 -42.45 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.49 -1.3 . . . . 1.53 107.49 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -52.93 -52.39 58.04 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 118.036 -1.466 . . . . 0.25 107.468 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -63.97 -39.15 93.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.0 -1.0 . . . . 0.35 109.915 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 717' ' ' LEU . 18.9 tp -58.98 -45.41 90.66 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.357 -1.719 . . . . 1.77 106.357 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 723' ' ' ASP . 56.5 mt -53.06 -55.56 22.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.219 -1.392 . . . . 0.69 108.942 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.504 ' HA ' ' H ' ' A' ' 723' ' ' ASP . 66.5 mt -70.88 -42.45 77.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 115.704 1.742 . . . . 1.07 115.704 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.455 ' C ' ' N ' ' A' ' 722' ' ' HIS . 96.3 m -66.83 -43.63 83.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 120.251 1.387 . . . . 0.63 111.972 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 722' ' ' HIS . 4.1 tt -61.8 -17.46 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.116 1.912 . . . . 1.69 107.582 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.486 ' CB ' ' O ' ' A' ' 721' ' ' ILE . 45.2 t60 104.25 91.19 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 108.679 -3.873 . . . . 4.13 108.403 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.504 ' H ' ' HA ' ' A' ' 719' ' ' ILE . 22.8 t0 -27.64 -81.87 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 124.324 1.015 . . . . 5.96 109.789 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 726' ' ' GLU . 6.8 ttt85 174.51 -176.91 0.09 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.761 0.791 . . . . 8.84 109.467 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 727' ' ' PHE . 12.9 mttt -86.57 26.19 1.13 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.227 -2.138 . . . . 10.03 105.227 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 724' ' ' ARG . 14.8 pt-20 -38.88 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 CA-C-N 113.881 -1.509 . . . . 10.62 109.326 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 725' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.65 0 CA-C-N 114.692 -1.14 . . . . 12.3 109.243 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.479 0.637 0 N-CA-C 109.631 -0.95 . . . . 1.0 109.631 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.75 133.26 55.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.248 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 58.0 m 46.43 60.92 13.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.09 146.91 59.54 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.533 2.155 . . . . 1.0 112.565 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.85 145.77 26.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.804 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 64.31 -166.83 28.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -62.99 145.15 94.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.735 2.29 . . . . 1.0 111.811 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.55 141.3 42.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 1.0 110.115 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 40.3 pt -49.76 -27.57 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.084 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.62 -42.11 99.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.25 -41.32 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.371 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -61.29 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.741 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.31 -42.47 99.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.414 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.9 -40.37 97.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 1.0 111.138 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 16.6 m -66.45 -41.32 89.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.046 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 696' ' ' VAL . 65.4 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.329 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -62.76 -41.67 99.33 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.58 -43.42 94.55 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.46 -1.056 . . . . 1.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.02 75.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 1.0 111.786 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.43 -43.38 96.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.071 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.46 -44.45 94.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.725 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.96 -41.55 97.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.007 0.432 . . . . 1.0 111.997 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.4 mt -62.55 -42.62 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.02 -42.05 92.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 709' ' ' LEU . 92.5 mt -63.5 -44.52 94.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.104 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.88 91.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.86 -46.78 86.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.022 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.1 -40.75 96.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.952 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 717' ' ' LEU . 32.0 mt -62.83 -43.46 98.74 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 46.5 pt -66.73 -36.34 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.636 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -56.59 -48.81 76.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.361 -0.935 . . . . 1.0 108.97 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.97 -38.26 85.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.044 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 713' ' ' LEU . 1.2 mm? -62.91 -38.78 92.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.42 -45.49 93.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 722' ' ' HIS . 21.2 tt -87.25 -35.05 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.119 0.785 . . . . 1.0 113.119 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 77.0 m -64.13 -44.8 91.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.128 -0.629 . . . . 1.0 110.85 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.58 -45.41 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.747 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 719' ' ' ILE . 40.1 m-70 -132.09 147.06 52.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.217 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -75.38 115.31 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.818 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -68.74 133.29 48.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.51 145.65 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.847 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 40.58 -117.59 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.796 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.523 -179.839 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo . . . . . 0 N--CA 1.484 0.952 0 N-CA-C 110.056 -0.786 . . . . 1.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -139.27 142.61 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.627 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 3.1 m 45.01 74.0 0.88 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.505 -0.77 . . . . 1.0 111.15 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.65 143.31 98.68 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.658 2.239 . . . . 1.0 112.794 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.15 -38.75 92.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 78.24 57.22 3.47 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.39 155.2 41.12 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 123.029 2.486 . . . . 1.0 112.766 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.94 149.64 48.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.891 0.853 . . . . 1.0 111.174 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 92.1 mt -65.66 -40.7 88.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.333 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.79 -41.16 97.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.229 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.82 -40.86 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.712 0.291 . . . . 1.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.0 -47.25 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.384 0.611 . . . . 1.0 110.257 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 98.3 mt -64.7 -41.25 96.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.83 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 45.1 mt -61.55 -40.58 95.22 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 17.7 m -68.02 -38.6 82.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.305 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.37 -46.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.7 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.84 -41.39 99.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.78 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.64 -46.0 79.79 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.91 -0.662 . . . . 1.0 111.794 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.98 -49.6 75.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.0 111.546 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.8 mt -63.25 -43.19 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.617 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.89 -44.09 94.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.787 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.76 -41.69 97.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.269 0.557 . . . . 1.0 111.344 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.44 -43.33 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.177 -0.92 . . . . 1.0 109.769 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.78 96.58 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.134 -1.186 . . . . 1.0 110.134 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.49 -43.28 97.72 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.877 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.7 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -65.37 -45.2 85.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.199 -0.601 . . . . 1.0 110.987 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.39 -40.86 97.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.481 . . . . 1.0 111.253 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.85 -44.01 97.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.655 -0.702 . . . . 1.0 112.287 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.15 -43.35 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -54.31 -48.86 70.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 119.135 -1.026 . . . . 1.0 108.902 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -59.31 -40.5 86.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.845 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.27 -39.1 91.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -45.04 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.826 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 73.1 mt -87.19 -35.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.929 0.714 . . . . 1.0 112.929 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 99.3 m -62.66 -45.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.61 -45.06 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.204 0.526 . . . . 1.0 110.197 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -43.13 149.32 0.22 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.384 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 725' ' ' LYS . 46.9 m-20 -65.09 -36.91 85.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.619 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 62.42 -44.17 0.18 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.404 0.44 . . . . 1.0 111.217 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 723' ' ' ASP . 99.2 mttt -61.72 -41.76 98.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.944 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -78.43 147.17 34.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 1.0 110.539 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 51.4 p90 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.935 -1.031 . . . . 1.0 110.777 179.698 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.481 0.758 0 N-CA-C 108.922 -1.222 . . . . 1.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.56 128.21 34.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.36 176.2 0.07 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.474 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.58 145.32 98.38 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.018 1.812 . . . . 1.0 112.029 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.82 -41.68 97.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.969 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 133.95 -164.09 24.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -62.37 141.99 89.26 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.85 2.367 . . . . 1.0 111.54 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.426 0.631 . . . . 1.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 27.6 pt -51.32 -30.88 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.64 -42.63 99.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.669 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.16 -42.09 94.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.173 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.1 t -61.99 -47.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.772 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.57 -42.04 99.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.08 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.3 -40.96 98.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.3 m -68.83 -36.83 78.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.704 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 696' ' ' VAL . 63.5 t -64.72 -45.22 95.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.006 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . 0.416 ' O ' HD23 ' A' ' 705' ' ' LEU . 93.9 mtp -63.63 -42.05 98.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.852 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.03 93.02 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.142 -1.028 . . . . 1.0 110.959 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.11 95.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.2 -43.67 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.0 110.28 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 701' ' ' MET . 3.9 mm? -63.94 -41.7 97.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.684 -0.689 . . . . 1.0 111.507 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.3 -42.61 99.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 1.0 111.726 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.95 -42.89 97.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.913 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.22 -40.9 92.46 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.47 -44.07 97.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.165 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.28 75.92 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.082 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.85 82.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -41.73 99.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.139 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.09 -42.41 99.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.036 0.754 . . . . 1.0 113.036 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.08 -42.61 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.7 t90 -54.94 -49.2 71.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.157 -1.017 . . . . 1.0 109.317 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.8 OUTLIER -60.92 -39.54 89.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.508 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.65 ' O ' HG22 ' A' ' 721' ' ' ILE . 70.5 mt -61.07 -39.34 89.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.8 -53.13 60.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.117 -0.633 . . . . 1.0 111.208 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.434 HD11 ' HE1' ' A' ' 715' ' ' TRP . 84.8 mt -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 96.4 m -65.51 -46.12 80.91 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.885 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 717' ' ' LEU . 19.8 tt -66.57 -43.93 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.311 -0.556 . . . . 1.0 110.118 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 721' ' ' ILE . 28.5 m80 -136.77 155.11 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -85.46 107.87 17.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 1.0 110.662 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -138.21 148.16 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.75 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 142.58 51.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.411 ' O ' ' OXT' ' A' ' 727' ' ' PHE . 79.4 tt0 -67.8 -37.71 82.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.974 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.411 ' OXT' ' O ' ' A' ' 726' ' ' GLU . 79.5 t80 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.974 -1.012 . . . . 1.0 111.126 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo . . . . . 0 N--CA 1.486 1.078 0 N-CA-C 110.164 -0.745 . . . . 1.0 110.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -61.65 146.18 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.055 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.23 173.16 5.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.298 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.21 -38.61 88.1 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.269 1.979 . . . . 1.0 111.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 690' ' ' GLY . 98.6 mttt -62.69 -42.24 99.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.022 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 689' ' ' LYS . . . 45.21 -172.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -59.11 141.98 98.77 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.467 2.111 . . . . 1.0 112.026 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -65.35 139.48 58.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.39 0.614 . . . . 1.0 110.085 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 694' ' ' LEU . 21.1 tt -71.7 -35.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.418 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.43 ' N ' HG23 ' A' ' 693' ' ' ILE . 97.6 mt -63.37 -40.26 96.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.824 -1.08 . . . . 1.0 110.884 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.35 -41.98 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.13 -47.32 93.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.245 0.545 . . . . 1.0 109.976 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 99.5 mt -63.66 -41.81 98.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.094 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.9 -38.24 87.63 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.311 0.577 . . . . 1.0 110.682 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 21.0 m -67.64 -40.39 84.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.73 -46.12 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.731 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -61.96 -41.6 98.17 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.541 . . . . 1.0 112.391 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.14 -44.97 85.76 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.733 -0.746 . . . . 1.0 112.022 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.2 77.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 1.0 111.622 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -43.93 97.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.857 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.5 -41.34 96.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.037 0.384 . . . . 1.0 112.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.58 -41.5 98.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.309 0.576 . . . . 1.0 111.459 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.28 -42.51 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.954 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.4 -42.39 95.7 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.88 -43.64 98.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.85 85.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.33 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.52 84.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.772 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.7 -38.64 91.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.97 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.29 -42.71 99.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 4.2 mm -64.19 -43.22 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.271 0.558 . . . . 1.0 109.51 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -54.43 -50.33 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.346 -0.942 . . . . 1.0 109.295 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -61.47 -37.98 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.511 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 721' ' ' ILE . 59.0 tp -60.98 -41.42 96.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.81 -50.08 72.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.687 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.73 -42.83 83.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 76.9 m -61.68 -43.93 97.91 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.437 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 717' ' ' LEU . 17.9 tt -89.49 1.53 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.212 0.529 . . . . 1.0 109.666 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 721' ' ' ILE . 94.9 m-70 46.56 101.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.298 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -91.95 -0.65 57.49 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.362 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -137.02 144.75 43.42 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.823 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -112.69 126.76 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.829 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.13 -39.53 86.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.543 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.101 -0.952 . . . . 1.0 110.902 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 109.247 -1.097 . . . . 1.0 109.247 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -121.51 137.48 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.66 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.9 m -164.48 73.2 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.72 147.68 94.76 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.901 2.401 . . . . 1.0 111.315 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -59.37 -45.73 90.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.721 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -176.86 -171.01 40.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.138 -0.785 . . . . 1.0 111.138 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -59.27 145.17 98.67 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.458 2.105 . . . . 1.0 111.042 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -134.93 -34.99 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.691 0.758 . . . . 1.0 110.108 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.53 -41.32 88.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.351 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.06 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.226 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.75 -42.11 90.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 1.0 111.027 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.9 -48.27 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.704 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.51 -41.65 98.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.517 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 698' ' ' LEU . 29.3 mt -62.86 -40.0 96.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.3 m -68.86 -38.69 79.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.543 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.52 -44.75 98.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.693 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.4 mtp -62.87 -39.86 95.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.753 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.38 -44.81 72.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.777 -0.725 . . . . 1.0 111.589 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.54 81.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 30.8 pt -67.33 -40.85 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.194 -0.602 . . . . 1.0 110.443 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.66 -43.94 92.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.605 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.38 -41.22 96.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.479 -0.489 . . . . 1.0 111.654 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.98 -42.99 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.023 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.95 93.94 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.16 -44.53 95.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.54 91.37 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.67 96.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.89 -0.724 . . . . 1.0 109.882 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.95 -40.57 98.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.97 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.9 -42.12 99.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.66 -43.17 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -55.37 -49.79 71.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.156 -1.017 . . . . 1.0 108.539 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.75 -41.99 96.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.019 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 717' ' ' LEU . 41.6 tp -61.57 -42.06 98.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.932 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.481 ' O ' ' CE1' ' A' ' 722' ' ' HIS . 83.9 mt -60.98 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.998 -0.681 . . . . 1.0 111.895 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 35.6 mm -72.02 -41.41 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.5 m -62.09 -43.13 99.51 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.201 -0.312 . . . . 1.0 111.373 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.59 -47.42 93.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.672 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.481 ' CE1' ' O ' ' A' ' 718' ' ' LEU . 52.0 p-80 -140.22 139.32 35.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -98.52 113.1 24.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -62.3 -43.4 98.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.244 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.73 149.35 38.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.174 0.511 . . . . 1.0 110.781 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.52 -40.67 85.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.549 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.754 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.479 0.652 0 N-CA-C 109.375 -1.048 . . . . 1.0 109.375 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -107.97 135.78 48.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.55 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.4 OUTLIER -95.47 -178.34 0.77 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.917 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 12.5 Cg_exo -66.82 149.49 83.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.306 2.004 . . . . 1.0 111.543 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.01 -43.98 94.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.043 0.449 . . . . 1.0 110.24 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 66.4 177.27 7.88 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.22 146.8 58.42 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.531 2.154 . . . . 1.0 111.669 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -68.27 136.75 53.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.647 . . . . 1.0 110.751 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.32 -41.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.886 -1.052 . . . . 1.0 110.684 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.57 -40.58 97.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.96 -43.39 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.691 0.281 . . . . 1.0 111.283 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.45 -48.07 88.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.343 -0.543 . . . . 1.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.03 -41.73 99.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.393 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 30.0 mt -62.02 -40.74 96.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.118 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.7 m -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 1.0 109.891 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.28 -46.87 94.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.995 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 91.9 mtp -63.2 -41.62 99.19 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.9 -44.35 92.01 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.9 -0.666 . . . . 1.0 111.708 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.25 95.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.15 -44.03 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.96 -42.69 97.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.376 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.37 -41.29 98.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 1.0 111.698 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.5 -43.25 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.538 -0.755 . . . . 1.0 109.997 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.59 -41.34 97.25 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.394 -0.821 . . . . 1.0 111.049 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.38 -43.27 98.08 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.48 87.57 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.16 -47.3 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.61 -39.72 94.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 1.0 112.006 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.16 -43.45 98.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.891 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.54 -43.6 98.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -54.95 -50.37 69.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.2 -0.909 . . . . 1.0 108.957 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -37.45 80.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.771 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 721' ' ' ILE . 56.6 tp -63.39 -41.12 98.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.844 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.77 -47.88 83.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.406 HD11 ' NE1' ' A' ' 715' ' ' TRP . 95.4 mt -68.82 -42.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.758 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.8 m -61.77 -44.17 97.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.068 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 717' ' ' LEU . 20.2 tt -87.42 -0.73 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.276 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 721' ' ' ILE . 67.2 m80 56.4 134.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.679 -0.692 . . . . 1.0 111.632 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 726' ' ' GLU . 95.5 m-20 -68.2 145.3 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.706 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.64 -39.8 94.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.706 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.53 -44.59 96.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.423 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 723' ' ' ASP . 83.6 tt0 -97.34 123.01 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.907 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.84 -179.61 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo . . . . . 0 N--CA 1.484 0.93 0 N-CA-C 109.908 -0.843 . . . . 1.0 109.908 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -67.33 -39.11 85.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.949 -0.301 . . . . 1.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 77.9 p -146.68 76.8 11.61 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.251 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.99 144.61 93.34 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.999 2.466 . . . . 1.0 111.681 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.77 145.29 51.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.162 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -155.45 169.75 33.37 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.664 -0.779 . . . . 1.0 111.437 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 693' ' ' ILE . 10.9 Cg_endo -57.9 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.69 2.26 . . . . 1.0 111.63 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 62.44 -46.34 0.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.724 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 691' ' ' PRO . 96.7 mt -69.87 -40.39 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.341 0.591 . . . . 1.0 111.016 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp -62.65 -37.25 85.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.925 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.21 -43.79 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.1 t -62.65 -48.56 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.3 -40.85 97.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.07 -40.27 97.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.3 m -65.66 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -63.81 -46.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.866 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.3 mtp -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.831 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.45 -43.98 91.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.576 -0.821 . . . . 1.0 111.064 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.05 87.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.998 0.427 . . . . 1.0 111.818 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.21 -44.44 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.558 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.734 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.62 -41.89 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 1.0 112.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.36 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.614 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.82 96.64 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.081 -1.208 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 713' ' ' LEU . 56.4 tp -63.81 -46.15 86.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.628 0.251 . . . . 1.0 110.436 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.1 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 1.0 110.038 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.3 99.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -39.82 95.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.575 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.5 mp -63.4 -44.18 95.41 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.68 -43.57 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.987 0.422 . . . . 1.0 110.02 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.426 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.5 t90 -54.06 -49.13 69.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.081 -1.047 . . . . 1.0 108.891 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -37.91 83.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.017 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 717' ' ' LEU . 37.7 mt -60.83 -41.66 96.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.09 -54.93 40.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.029 -0.669 . . . . 1.0 111.276 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.426 HD11 ' HE1' ' A' ' 715' ' ' TRP . 96.5 mt -69.03 -42.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.5 m -64.05 -45.49 88.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.433 ' O ' ' CD2' ' A' ' 722' ' ' HIS . 96.1 mt -64.24 -45.99 94.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.865 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 721' ' ' ILE . 32.6 m170 -140.58 162.07 36.25 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.09 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 56.53 42.63 27.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.37 -43.15 99.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.421 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -86.91 136.74 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.222 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -94.12 140.41 29.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.114 -0.946 . . . . 1.0 110.66 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 109.712 -0.919 . . . . 1.0 109.712 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.74 -43.87 90.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 1.0 110.411 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.7 t -163.48 73.89 1.86 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.072 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.06 -30.31 78.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.844 2.362 . . . . 1.0 112.425 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -60.15 -42.16 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.54 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -166.2 78.71 0.12 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 120.423 -0.894 . . . . 1.0 111.743 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 693' ' ' ILE . 39.2 Cg_exo -58.35 143.6 97.29 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.481 2.121 . . . . 1.0 112.626 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 62.54 -39.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 691' ' ' PRO . 35.7 pt -75.14 -35.06 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.998 0.428 . . . . 1.0 110.255 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.91 -39.05 90.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.007 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.16 -41.39 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.219 0.452 . . . . 1.0 112.219 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 700' ' ' VAL . 94.5 t -61.19 -47.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 1.0 110.396 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.23 96.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.584 -0.734 . . . . 1.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 698' ' ' LEU . 37.7 mt -62.47 -41.33 98.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.12 0.486 . . . . 1.0 110.475 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 50.2 m -64.95 -41.97 95.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.955 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 696' ' ' VAL . 82.7 t -64.51 -45.38 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.44 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.3 mtp -61.66 -41.48 97.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.649 -0.421 . . . . 1.0 111.005 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.17 -46.51 64.6 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 69.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.069 0.461 . . . . 1.0 111.567 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.71 -43.46 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.94 -42.84 99.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.172 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.61 -41.58 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 1.0 112.084 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.16 -42.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.009 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.6 -40.68 98.22 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.19 -45.1 93.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.749 0.309 . . . . 1.0 110.428 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.28 85.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.09 97.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.84 -42.03 97.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.632 0.605 . . . . 1.0 112.632 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.16 -42.93 99.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.45 -42.56 96.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -55.54 -50.3 70.37 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.358 -0.937 . . . . 1.0 108.66 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -58.45 -38.01 76.62 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 721' ' ' ILE . 51.9 tp -62.99 -40.59 98.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.171 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.908 -0.717 . . . . 1.0 111.269 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.47 -41.23 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 95.1 m -63.12 -44.51 95.4 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.963 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 722' ' ' HIS . 20.6 tt -66.44 -44.58 90.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.614 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 721' ' ' ILE . 48.5 t-80 -137.69 134.48 35.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.887 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -88.35 112.43 22.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.1 0.476 . . . . 1.0 110.599 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.9 143.48 39.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.684 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.91 -40.07 94.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.16 -38.92 89.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.452 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.06 -0.971 . . . . 1.0 110.649 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.487 1.146 0 N-CA-C 110.419 -0.646 . . . . 1.0 110.419 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.49 135.32 53.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.645 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 89.2 p -167.88 56.23 0.33 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.936 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.84 151.17 68.51 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.924 2.416 . . . . 1.0 112.148 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -94.79 -8.23 38.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.458 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -48.86 -53.31 18.38 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.686 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 23.5 Cg_exo -60.0 145.58 98.04 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.457 2.105 . . . . 1.0 112.653 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -65.92 133.66 51.36 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.225 0.536 . . . . 1.0 111.202 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 19.1 tt -73.87 -37.01 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.625 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 698' ' ' LEU . 94.8 mt -63.83 -40.27 96.2 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.066 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.81 -41.89 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.969 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 700' ' ' VAL . 86.1 t -60.66 -47.69 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.305 -0.558 . . . . 1.0 110.156 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.13 -42.2 96.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.539 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 694' ' ' LEU . 8.4 mp -63.14 -37.77 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.078 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 58.4 m -67.54 -40.0 85.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.071 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.0 t -63.61 -46.0 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.032 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.7 mtp -61.17 -42.64 98.93 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.82 -45.22 89.73 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.533 -0.841 . . . . 1.0 111.201 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.05 85.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.31 -44.04 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.134 0.492 . . . . 1.0 110.493 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.26 -42.16 96.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.703 -0.681 . . . . 1.0 111.152 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 1.0 111.739 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.85 -44.38 99.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.5 95.06 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.676 -0.97 . . . . 1.0 110.676 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.27 -44.54 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.042 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.65 88.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.195 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.95 97.54 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.355 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.1 -40.21 95.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.083 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 36.3 mt -63.79 -43.94 94.81 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.848 0.684 . . . . 1.0 112.848 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 28.0 pt -65.84 -38.13 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.388 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -56.4 -47.53 78.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 118.783 -1.167 . . . . 1.0 109.076 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -39.19 89.23 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.363 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 717' ' ' LEU . 89.6 mt -61.24 -40.1 92.77 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.91 -52.92 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.328 0.585 . . . . 1.0 110.891 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.47 -42.27 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 1.0 112.548 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.1 m -63.08 -45.05 93.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.64 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 721' ' ' ILE . 90.0 mt -87.19 -1.97 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.395 0.617 . . . . 1.0 109.835 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 52.36 171.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.099 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.2 143.68 57.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -70.59 135.48 48.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.168 0.508 . . . . 1.0 111.056 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 59.24 61.22 2.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.204 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.84 -42.27 99.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.729 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.847 -1.073 . . . . 1.0 110.093 179.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.484 0.913 0 N-CA-C 109.553 -0.98 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.16 -45.48 76.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.728 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.5 m -175.15 83.39 0.31 Allowed Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.542 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.39 146.61 95.66 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.208 1.939 . . . . 1.0 111.362 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.86 135.8 57.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 1.0 111.167 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 164.11 69.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.797 -0.921 . . . . 1.0 110.797 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -52.21 -42.92 56.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.541 2.16 . . . . 1.0 111.49 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -90.38 103.7 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.264 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.0 -31.85 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.027 -0.988 . . . . 1.0 110.405 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.41 -41.69 96.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.745 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.23 -41.63 93.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 1.0 110.882 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.56 -47.95 90.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.421 -0.512 . . . . 1.0 110.551 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 697' ' ' LEU . 91.9 mt -63.32 -40.69 98.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.538 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.51 -38.44 89.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 69.9 m -66.08 -40.38 90.79 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.612 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.47 -45.27 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 1.0 111.102 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.9 mtp -62.07 -42.24 98.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 1.0 112.308 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.91 -44.17 92.34 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.531 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.72 -44.63 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.257 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.27 -41.57 96.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.736 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.03 -42.47 97.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.147 0.499 . . . . 1.0 112.238 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.73 -43.07 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.004 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.81 94.28 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.236 -1.146 . . . . 1.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.29 -43.42 97.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.625 -0.43 . . . . 1.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.74 91.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.32 93.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.84 -40.52 97.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.578 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.77 -43.62 98.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.9 -42.81 97.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.564 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -53.39 -50.55 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.846 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -40.14 91.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.314 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.29 -42.92 96.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.99 -49.11 77.38 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.019 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.564 HD11 ' HE1' ' A' ' 715' ' ' TRP . 92.7 mt -67.84 -43.19 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 57.0 m -61.01 -44.96 96.65 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.712 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 721' ' ' ILE . 96.5 mt -89.15 -0.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.813 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 721' ' ' ILE . 74.6 m80 52.88 150.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.467 0.651 . . . . 1.0 112.511 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.78 -38.84 92.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.408 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -134.87 149.65 50.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.92 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -65.55 -39.85 92.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.895 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -130.92 137.26 49.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.854 -1.069 . . . . 1.0 110.723 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 N--CA 1.479 0.638 0 N-CA-C 109.613 -0.956 . . . . 1.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.81 -38.65 89.55 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.994 0.426 . . . . 1.0 110.3 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 7.7 t 47.12 71.83 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.606 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -61.55 146.85 96.6 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.851 2.367 . . . . 1.0 112.27 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.46 148.57 29.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 1.0 110.983 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.502 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -98.13 -48.38 1.9 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.889 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 36.5 Cg_exo -54.77 -37.96 91.92 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.734 2.289 . . . . 1.0 112.439 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 49.4 35.01 7.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.259 0.552 . . . . 1.0 110.467 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.23 -40.96 81.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.567 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.57 -40.6 95.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.193 -0.912 . . . . 1.0 112.262 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.0 -42.46 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.662 0.268 . . . . 1.0 111.329 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.92 -47.79 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.392 0.615 . . . . 1.0 109.885 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.55 -41.28 98.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.129 -0.942 . . . . 1.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.31 -39.55 93.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.574 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 19.6 m -64.53 -40.94 96.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.701 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.79 -45.52 98.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 86.6 mtp -61.63 -42.4 98.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.816 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.01 -45.52 87.04 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.627 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.32 -49.59 75.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.649 0.611 . . . . 1.0 112.649 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.58 -43.41 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.671 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.4 mt -64.44 -40.81 96.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.83 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.64 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 15.4 tt -67.31 -33.27 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.28 97.91 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.42 -1.472 . . . . 1.0 109.42 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.47 -46.09 87.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.268 -0.466 . . . . 1.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.33 88.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.7 89.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.578 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.5 -41.26 98.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.8 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.86 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.99 -42.37 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.531 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.1 t90 -55.07 -48.91 72.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.963 -1.095 . . . . 1.0 109.411 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -43.35 98.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.009 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.4 mm? -62.3 -39.32 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.16 -48.32 82.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.163 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.531 HD11 ' HE1' ' A' ' 715' ' ' TRP . 77.8 mt -70.28 -42.33 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 m -61.4 -44.76 96.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.414 -0.515 . . . . 1.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 717' ' ' LEU . 20.0 tt -90.0 0.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.329 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 76.3 m80 39.6 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.429 -0.351 . . . . 1.0 110.341 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.31 -39.59 89.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 726' ' ' GLU . 30.6 ptt180 -60.46 -36.25 77.8 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.525 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 51.96 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.457 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 724' ' ' ARG . 84.8 tt0 -125.88 134.64 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.244 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.447 ' OXT' ' O ' ' A' ' 726' ' ' GLU . 46.7 t80 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.908 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 109.39 -1.042 . . . . 1.0 109.39 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.23 -41.91 89.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 12.7 t -175.79 53.61 0.11 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 1.0 111.008 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 687' ' ' SER . 37.2 Cg_endo -67.33 -24.05 43.88 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.853 2.369 . . . . 1.0 112.246 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -40.88 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.659 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.87 69.48 1.29 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.32 -38.66 93.62 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.736 2.291 . . . . 1.0 111.662 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 695' ' ' VAL . 98.4 m-20 -88.08 112.1 22.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.074 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 35.4 pt -75.38 -30.82 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.876 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.93 -42.79 97.27 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 692' ' ' ASP . 5.5 m -63.51 -37.67 80.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.689 -0.405 . . . . 1.0 111.317 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.28 -48.57 88.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.066 -0.654 . . . . 1.0 109.728 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 697' ' ' LEU . 4.3 mm? -63.52 -40.88 98.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.968 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.1 -38.7 92.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.358 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 53.0 m -65.95 -44.29 85.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.265 0.468 . . . . 1.0 112.265 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 700' ' ' VAL . 7.2 m -63.89 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 119.348 -0.941 . . . . 1.0 110.516 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.6 mtp -62.02 -42.29 99.0 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.738 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.18 -44.15 87.53 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.502 -0.856 . . . . 1.0 111.282 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 19.0 tt -65.25 -39.9 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.316 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.37 -43.27 95.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.009 -0.277 . . . . 1.0 111.66 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.64 -42.1 95.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.38 -37.07 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.2 -0.6 . . . . 1.0 109.792 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.62 97.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.54 -43.66 98.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 1.0 110.388 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.44 85.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -64.96 -47.69 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.9 -39.37 94.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 111.318 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.39 -43.03 99.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.867 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.22 -43.83 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.501 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.3 t90 -55.37 -49.65 71.72 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.89 -38.85 87.11 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.091 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 721' ' ' ILE . 55.1 tp -61.4 -41.06 96.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.43 -45.01 96.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.381 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.501 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.0 mt -84.42 -37.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.018 0.747 . . . . 1.0 113.018 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.0 m -63.21 -44.33 95.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.323 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 717' ' ' LEU . 21.0 tt -65.15 -42.58 94.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.544 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.53 ' N ' HG23 ' A' ' 721' ' ' ILE . 60.6 t-80 -44.32 108.6 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.551 -0.749 . . . . 1.0 110.787 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.65 140.94 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.951 -0.3 . . . . 1.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -134.54 137.71 44.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.97 137.7 51.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.0 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.58 -48.6 3.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.688 179.529 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 N--CA 1.487 1.125 0 N-CA-C 110.045 -0.79 . . . . 1.0 110.045 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' A' ' 687' ' ' SER . 21.7 pt-20 -64.6 -41.16 96.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.316 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.467 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 49.1 m -170.4 51.14 0.17 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.004 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 687' ' ' SER . 36.5 Cg_endo -66.36 147.51 83.05 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.538 2.159 . . . . 1.0 112.107 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.33 -42.61 99.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.628 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 161.85 -177.36 38.12 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.774 -0.727 . . . . 1.0 111.345 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.2 -40.71 68.76 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.234 2.623 . . . . 1.0 112.784 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 48.74 31.74 3.23 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.23 0.538 . . . . 1.0 111.285 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 89.7 mt -70.23 -41.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.4 mp -62.23 -41.53 98.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.642 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.96 -42.87 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.715 0.293 . . . . 1.0 110.982 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 700' ' ' VAL . 79.5 t -60.71 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.073 -0.651 . . . . 1.0 109.771 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.68 -42.02 99.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.927 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.36 -39.12 93.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.287 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.32 -38.28 81.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.079 0.466 . . . . 1.0 110.566 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.1 t -64.02 -45.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 1.0 111.128 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.34 -40.57 96.81 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.528 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.87 62.2 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.461 -0.876 . . . . 1.0 111.443 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.79 79.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.586 0.587 . . . . 1.0 112.586 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 20.3 tt -65.54 -41.92 91.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.48 -40.02 89.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.42 -43.43 98.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.73 -35.72 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.575 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.66 -41.78 97.56 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.654 -1.378 . . . . 1.0 109.654 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.41 -43.43 97.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.42 87.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.569 -0.453 . . . . 1.0 109.94 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.25 94.12 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.155 -0.618 . . . . 1.0 110.517 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.73 -41.1 98.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.226 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.84 -43.11 99.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.15 -42.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -54.03 -49.95 67.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 118.959 -1.097 . . . . 1.0 108.618 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.6 86.14 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.245 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.65 -42.86 93.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 722' ' ' HIS . 93.2 mt -60.92 -49.49 77.26 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.731 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 90.8 mt -67.46 -42.17 86.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 113.302 0.853 . . . . 1.0 113.302 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 89.7 m -60.87 -44.95 96.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.635 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 722' ' ' HIS . 1.6 pp -92.22 1.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 721' ' ' ILE . 20.2 t-80 85.92 132.98 0.04 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.874 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -92.49 112.54 24.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.073 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -71.88 139.7 48.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.43 -0.804 . . . . 1.0 110.597 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.43 151.1 26.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.899 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -137.12 31.08 2.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.461 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.473 -179.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.485 1.012 0 N-CA-C 109.785 -0.891 . . . . 1.0 109.785 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -101.55 135.0 43.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.269 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.403 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.6 OUTLIER -155.56 179.34 1.37 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.913 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 23.5 Cg_exo -61.92 149.38 90.44 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.228 1.952 . . . . 1.0 111.65 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.49 136.87 44.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.943 0.401 . . . . 1.0 110.027 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -178.13 166.88 37.24 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 -18.67 38.92 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.79 2.327 . . . . 1.0 112.325 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -136.59 94.64 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.312 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 31.0 pt -73.95 -28.27 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.678 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -42.07 97.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.996 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.68 -42.01 90.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.917 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.7 t -60.61 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.166 -0.614 . . . . 1.0 110.236 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.68 -42.06 98.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.93 -41.04 97.49 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.665 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 37.3 m -68.29 -41.09 81.48 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 696' ' ' VAL . 80.4 t -62.61 -45.59 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.006 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 95.8 mtp -63.02 -42.11 99.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.875 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.97 -45.12 75.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.75 92.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.758 0.313 . . . . 1.0 111.316 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 86.0 mt -65.02 -44.6 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.246 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.93 -41.07 95.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.335 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -41.86 98.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.094 0.473 . . . . 1.0 112.073 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.83 -43.47 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.111 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -55.25 -42.79 83.47 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.281 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.33 -43.36 97.97 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.138 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.42 83.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.97 0.414 . . . . 1.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.79 -48.28 77.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.36 -39.24 93.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.098 0.407 . . . . 1.0 112.098 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.12 -42.67 99.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 1.0 111.99 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.37 -42.81 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.756 . . . . 1.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -54.23 -47.16 72.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.009 -1.076 . . . . 1.0 108.998 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -61.89 -41.45 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.742 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.764 ' O ' HG22 ' A' ' 721' ' ' ILE . 79.0 mt -61.81 -41.75 98.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.9 -49.93 75.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.912 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 18.6 tt -74.83 -37.0 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 1.0 112.479 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 98.7 m -59.57 -43.68 93.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 717' ' ' LEU . 18.6 tt -94.33 4.41 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.389 0.614 . . . . 1.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 42.53 77.27 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 724' ' ' ARG . 60.7 t0 -70.95 134.86 47.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 723' ' ' ASP . 92.7 mtm-85 -123.1 144.56 49.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.053 0.454 . . . . 1.0 111.144 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 724' ' ' ARG . 98.2 mttt 47.02 -178.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.028 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.34 159.2 22.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.491 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.147 -0.93 . . . . 1.0 110.439 -179.835 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 109.855 -0.863 . . . . 1.0 109.855 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.62 -39.19 80.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.688 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 3.2 m -142.77 75.41 18.19 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.695 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.85 146.82 21.06 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.503 2.135 . . . . 1.0 111.596 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.02 -43.29 99.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.512 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -125.06 84.34 0.35 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.55 142.47 95.49 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.812 1.674 . . . . 1.0 111.527 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -93.27 2.74 56.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -40.77 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.89 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 694' ' ' LEU . 10.8 mp -59.86 -39.61 85.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.631 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -42.46 94.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.618 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.28 -47.86 91.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.576 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.81 -41.68 99.4 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.258 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.09 -38.09 89.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 67.5 m -66.87 -43.37 83.74 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.03 -41.61 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.466 -0.894 . . . . 1.0 110.359 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.2 mtp -62.58 -42.11 99.36 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 121.099 -0.24 . . . . 1.0 111.051 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.16 88.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.53 78.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 1.0 111.463 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.74 -43.57 98.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.134 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.18 -44.65 94.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.29 -41.54 98.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 1.0 112.059 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.44 -42.86 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.018 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.71 95.31 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.75 -43.39 96.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.764 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.56 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.286 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.52 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.116 -0.634 . . . . 1.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.33 -41.61 98.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.836 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.39 -43.63 98.37 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.936 0.717 . . . . 1.0 112.936 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.4 -42.99 98.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.457 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.2 t90 -55.46 -48.4 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.128 -1.029 . . . . 1.0 108.313 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.88 -41.03 95.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.978 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.6 -42.02 91.64 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.523 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.9 mt -62.37 -47.74 82.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.769 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.457 HD11 ' HE1' ' A' ' 715' ' ' TRP . 88.6 mt -71.8 -42.26 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.5 p -68.1 -39.83 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 722' ' ' HIS . 19.2 tt -66.87 -46.39 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.775 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.526 ' N ' HG23 ' A' ' 721' ' ' ILE . 15.4 m80 -43.57 129.24 5.29 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.834 -0.347 . . . . 1.0 111.174 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -64.51 -40.47 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.605 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -88.77 138.27 31.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 109.963 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.46 -42.98 99.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.526 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 49.61 22.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.954 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.478 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 109.262 -1.092 . . . . 1.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -132.37 138.39 47.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.581 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.526 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER 179.49 -45.16 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.355 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 687' ' ' SER . 20.9 Cg_exo -62.98 151.37 84.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.471 2.114 . . . . 1.0 111.371 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -99.61 143.12 30.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 88.46 77.46 1.29 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.496 -0.641 . . . . 1.0 111.496 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.49 -38.29 89.96 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.753 2.302 . . . . 1.0 111.815 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.9 138.26 58.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.426 0.632 . . . . 1.0 110.838 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 72.9 mt -70.14 -41.27 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.711 -1.132 . . . . 1.0 111.211 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 698' ' ' LEU . 81.9 mt -61.53 -41.1 96.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.287 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 63.2 t -58.45 -42.46 84.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 700' ' ' VAL . 54.4 t -60.95 -47.55 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 121.114 0.483 . . . . 1.0 109.808 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.22 -41.82 99.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.252 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.0 mp -62.35 -38.86 91.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 1.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.4 m -68.82 -39.16 80.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.141 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 696' ' ' VAL . 69.9 t -62.65 -44.92 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.067 0.46 . . . . 1.0 109.93 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 90.6 mtp -62.36 -41.91 98.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.129 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 706' ' ' LEU . . . -67.61 -45.58 75.69 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.73 -0.748 . . . . 1.0 111.69 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.08 73.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.33 0.492 . . . . 1.0 112.33 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.07 -43.42 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.728 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.7 mt -64.39 -43.18 95.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.172 0.434 . . . . 1.0 112.172 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 702' ' ' GLY . 8.0 mp -63.81 -42.84 97.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.326 -0.55 . . . . 1.0 111.9 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 3.3 mm -64.66 -43.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.426 -0.806 . . . . 1.0 110.637 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.62 94.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.8 -1.32 . . . . 1.0 109.8 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 713' ' ' LEU . 57.0 tp -61.35 -43.81 98.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.13 89.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.775 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.726 -0.789 . . . . 1.0 110.475 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.65 -40.83 96.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 709' ' ' LEU . 9.2 mp -64.15 -43.32 95.55 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.386 0.884 . . . . 1.0 113.386 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 717' ' ' LEU . 28.9 pt -65.8 -39.37 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.327 -0.549 . . . . 1.0 109.676 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -54.37 -50.4 67.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.353 -0.939 . . . . 1.0 108.817 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -40.02 89.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.558 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 721' ' ' ILE . 75.5 mt -60.17 -42.12 94.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.461 -0.496 . . . . 1.0 109.916 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.38 -50.12 74.18 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.763 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.12 -41.72 84.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 90.1 m -61.55 -44.16 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.5 0.555 . . . . 1.0 112.5 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 722' ' ' HIS . 46.8 pt -65.34 -43.85 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.169 -0.612 . . . . 1.0 111.902 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.453 ' N ' HG13 ' A' ' 721' ' ' ILE . 49.4 m80 -138.31 137.0 36.99 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -94.71 -0.5 54.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.23 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.47 -43.05 99.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.554 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.38 146.31 27.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.995 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 48.2 -169.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.134 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 117.922 -1.037 . . . . 1.0 110.663 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo . . . . . 0 N--CA 1.481 0.777 0 N-CA-C 108.924 -1.221 . . . . 1.0 108.924 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.78 136.67 58.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.987 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 59.9 m -147.64 72.19 11.62 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.083 0.468 . . . . 1.0 110.117 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -60.96 145.57 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 123.312 2.674 . . . . 1.0 112.556 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.0 tttt 48.71 36.67 8.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.08 -168.75 42.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.53 146.9 95.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.956 2.438 . . . . 1.0 111.87 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.58 143.32 57.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.371 0.605 . . . . 1.0 110.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.75 -40.01 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.144 -0.934 . . . . 1.0 110.497 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 694' ' ' LEU . 4.1 mm? -62.48 -40.99 98.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.422 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.53 -40.98 90.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.105 0.478 . . . . 1.0 110.806 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 700' ' ' VAL . 57.2 t -61.3 -46.9 95.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.76 -41.88 99.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.119 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.93 -39.17 93.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.07 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 49.9 m -66.61 -38.28 86.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 696' ' ' VAL . 67.1 t -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.533 -0.758 . . . . 1.0 109.915 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -61.75 -41.67 97.98 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.62 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.34 -45.52 60.5 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.629 -0.796 . . . . 1.0 111.743 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.31 77.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 705' ' ' LEU . 20.3 tt -65.94 -41.01 89.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.464 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.425 ' N ' HG23 ' A' ' 704' ' ' ILE . 89.9 mt -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.757 -0.377 . . . . 1.0 111.459 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 36.7 mt -62.18 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 12.3 tt -66.5 -34.37 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.189 -0.605 . . . . 1.0 109.881 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -58.22 -43.02 95.64 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.35 -42.71 98.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.94 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.4 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.9 -47.77 79.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.12 -38.48 91.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.755 0.312 . . . . 1.0 111.632 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.37 -44.45 96.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.534 . . . . 1.0 112.421 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.32 -42.76 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.587 . . . . 1.0 109.625 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -55.78 -50.07 71.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.293 -0.963 . . . . 1.0 109.185 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -38.09 85.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.327 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.11 -42.11 94.01 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.28 -50.75 71.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.049 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.15 -43.62 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.951 0.723 . . . . 1.0 112.951 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -61.76 -45.87 92.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.543 -0.463 . . . . 1.0 109.887 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 721' ' ' ILE . 44.9 mm -84.95 -0.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.552 . . . . 1.0 109.743 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 721' ' ' ILE . 63.6 m80 55.28 116.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.222 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 725' ' ' LYS . 66.6 t0 -91.08 114.85 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.578 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.84 -41.27 99.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.623 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 723' ' ' ASP . 99.0 mttt -126.69 139.53 53.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.585 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.72 132.08 46.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.057 -0.973 . . . . 1.0 110.399 179.819 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.482 0.851 0 N-CA-C 109.728 -0.912 . . . . 1.0 109.728 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.36 -37.22 86.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.332 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.2 p -166.84 70.61 1.05 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.483 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.89 142.98 99.61 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.693 2.262 . . . . 1.0 112.651 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.43 -42.38 99.41 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 104.34 175.5 25.21 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.866 -0.606 . . . . 1.0 111.701 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.22 118.61 5.6 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.946 2.431 . . . . 1.0 112.925 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -97.16 -4.24 39.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.543 0.687 . . . . 1.0 109.932 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.556 HG23 HD12 ' A' ' 694' ' ' LEU . 21.3 tt -60.13 -29.92 44.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.893 -1.049 . . . . 1.0 109.563 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 693' ' ' ILE . 10.4 mp -62.15 -42.89 99.69 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.708 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.44 -41.89 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.362 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 700' ' ' VAL . 72.2 t -61.3 -46.74 96.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.63 -42.42 99.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.264 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.67 -40.08 95.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.959 0.409 . . . . 1.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 15.9 m -66.92 -39.94 87.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.142 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 696' ' ' VAL . 70.9 t -63.54 -46.03 96.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.76 -41.27 97.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.675 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -68.37 -45.01 71.49 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.352 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.11 85.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.744 0.276 . . . . 1.0 111.744 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 704' ' ' ILE . 32.0 mm -64.12 -43.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.277 0.561 . . . . 1.0 109.852 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 5.5 tt -64.26 -41.76 96.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 111.791 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.62 -44.13 97.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.998 0.74 . . . . 1.0 112.998 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 36.7 pt -66.0 -39.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.494 -0.483 . . . . 1.0 110.506 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.82 97.26 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.147 -1.181 . . . . 1.0 110.147 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.38 -44.62 96.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.41 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.68 89.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.231 -0.587 . . . . 1.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.32 -42.12 98.96 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 111.687 0.255 . . . . 1.0 111.687 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.02 -43.2 99.38 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.42 -43.08 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 719' ' ' ILE . 10.9 t90 -53.91 -49.17 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.204 -0.998 . . . . 1.0 108.685 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.7 OUTLIER -60.26 -36.47 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.298 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.84 -42.85 98.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.28 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.5 ' O ' ' CD2' ' A' ' 722' ' ' HIS . 10.6 mp -61.43 -51.03 70.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.587 -0.845 . . . . 1.0 111.499 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 715' ' ' TRP . 97.7 mt -68.35 -43.1 84.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 97.3 m -63.17 -44.72 94.63 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.58 -45.32 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.317 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 718' ' ' LEU . 49.5 m170 -45.19 138.05 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.999 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.04 111.65 19.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.373 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -128.87 134.45 48.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.048 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.96 -43.27 99.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.331 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 54.85 92.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.477 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 67.4 t80 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.071 -0.966 . . . . 1.0 110.609 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -43.97 71.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.7 . . . . 1.0 111.486 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.58 156.35 43.16 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.939 -0.305 . . . . 1.0 110.463 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 689' ' ' LYS . 31.8 Cg_endo -62.81 142.71 89.85 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.636 2.224 . . . . 1.0 112.394 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 688' ' ' PRO . 97.9 mttt 41.75 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.769 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 49.59 76.72 0.15 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.18 144.04 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.936 2.424 . . . . 1.0 112.71 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 50.17 31.47 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 1.0 111.744 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 19.7 tt -73.06 -36.79 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.013 0.435 . . . . 1.0 110.428 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.93 -39.92 95.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.854 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.97 -40.89 87.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.064 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.76 -48.46 88.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 1.0 110.357 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.67 -41.63 99.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.18 -39.66 93.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 1.0 110.56 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 26.7 m -66.72 -42.01 87.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.735 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.05 -46.11 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.902 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.5 mtp -62.11 -41.57 98.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.569 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.19 -44.78 85.65 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.148 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.35 92.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.709 -0.396 . . . . 1.0 111.702 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 3.7 mm -64.2 -43.79 97.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.23 -43.36 98.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.686 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.95 -40.68 95.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.272 -0.571 . . . . 1.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.16 -42.98 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.421 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.14 96.55 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.144 -0.935 . . . . 1.0 110.992 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.58 -42.9 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.933 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.4 94.57 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.563 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.67 86.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.609 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.67 -39.0 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.219 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.3 -44.23 95.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.029 0.751 . . . . 1.0 113.029 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.21 -35.71 74.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -56.55 -49.11 75.78 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.224 -0.99 . . . . 1.0 109.291 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 716' ' ' LYS . 0.6 OUTLIER -60.23 -38.23 82.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.669 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.789 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.3 mm? -62.06 -41.32 98.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.365 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.76 -50.11 74.78 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 119.893 -0.723 . . . . 1.0 110.962 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.91 -42.4 82.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.427 -0.806 . . . . 1.0 112.086 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -62.24 -46.08 90.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.418 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 717' ' ' LEU . 17.2 tt -83.43 -2.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.507 . . . . 1.0 109.799 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 721' ' ' ILE . 73.3 m80 56.5 130.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.068 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -71.66 149.51 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -88.2 132.07 34.5 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.367 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.84 146.34 42.06 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.613 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.99 -40.27 91.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.539 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.581 -179.876 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 109.438 -1.024 . . . . 1.0 109.438 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -114.58 123.95 50.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 7.7 t -151.07 72.02 8.59 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.627 -0.429 . . . . 1.0 111.032 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.43 146.34 95.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.978 2.452 . . . . 1.0 112.744 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 690' ' ' GLY . 64.6 mttp -127.0 138.87 53.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.943 -0.572 . . . . 1.0 109.991 179.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 689' ' ' LYS . . . -54.27 -165.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.91 142.98 99.19 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.546 2.164 . . . . 1.0 111.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -90.27 2.0 55.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.278 0.561 . . . . 1.0 110.469 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.19 -40.65 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.179 -0.919 . . . . 1.0 110.394 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.221 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.49 -44.97 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 700' ' ' VAL . 56.7 t -61.96 -47.01 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 119.804 -0.758 . . . . 1.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.43 -42.11 96.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.06 -39.51 92.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.054 0.454 . . . . 1.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 72.2 m -65.57 -39.78 92.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.802 179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 696' ' ' VAL . 57.8 t -63.57 -47.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.227 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.74 -42.18 99.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.87 88.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.729 -0.748 . . . . 1.0 111.356 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.96 83.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.057 0.456 . . . . 1.0 112.154 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.14 -43.1 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 1.0 111.161 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.24 -45.67 90.47 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.44 -41.76 96.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.954 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.95 -43.49 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.462 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -60.24 -39.83 96.53 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.233 -1.147 . . . . 1.0 110.233 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.87 -42.46 99.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.27 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.446 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 711' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.7 88.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.822 -0.626 . . . . 1.0 112.217 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.73 -41.24 98.08 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.63 -43.68 98.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.621 -0.432 . . . . 1.0 112.029 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.84 -43.88 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -54.16 -49.17 69.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.281 -0.968 . . . . 1.0 108.954 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 716' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.326 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.7 -42.88 98.08 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.38 -48.05 83.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.111 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.77 -42.96 83.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.854 0.687 . . . . 1.0 112.854 -178.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 85.8 m -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 721' ' ' ILE . 44.1 mm -90.83 2.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.15 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 721' ' ' ILE . 78.3 m80 42.01 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.207 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -64.41 140.33 58.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.636 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -136.14 144.03 44.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.722 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.2 144.52 29.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 1.0 110.761 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -121.57 130.32 53.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.438 179.483 . . . . . . . . 0 0 . 1 stop_ save_